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Summary 
 
Mycobacterium tuberculosis, one of the deadliest human pathogens, causes several 
million new infections and about two million fatalities annually. The cell wall of M. 
tuberculosis is endowed with a highly impermeable, complex array of diverse lipids 
such as mycolic acids, which bestow the bacterium with not only virulence, but also 
resistance to host immunity and antibiotics. Mycobacterial lipid metabolism has thus 
emerged as an attractive target for the design and development of novel anti-
mycobacterial therapeutics. The first committed step in the biosynthesis of long-chain 
fatty acids – the carboxylation of acetyl-CoA to malonyl-CoA - is catalysed by the 
multi-functional multi-subunit acetyl-CoA carboxylase (ACC) enzyme. Some ACC 
complexes, especially from actinobacteria, are active on diverse substrates and are 
generally referred to as acyl-CoA carboxylases (YCCs). Typically, YCCs are 
composed of biotin carboxylase, biotin carboxyl carrier protein (collectively known as 
alpha) and carboxyltransferase (beta) subunits. Interestingly, the genomes of most 
mycobacteria code for three alpha subunits (AccA1 - AccA3), six beta subunits 
(AccD1 - AccD6), and a unique epsilon subunit (AccE5) while most other forms of 
life possess not more than two YCCs. Despite the significant roles of YCCs in 
mycobacterial fatty and mycolic acid biosyntheses and hence in cell wall integrity and 
antibiotic resistance, a comprehensive understanding of their properties and functions 
is lacking. 
 
This dissertation is focused on the structural and functional characterisation of the 
essential components (AccA3, AccD4 - AccD6, and AccE5) of M. tuberculosis YCCs 
implicated or known to be involved in fatty acid metabolism. X-ray crystallography 
and complementary biophysical and biochemical approaches have been employed in 
an attempt to address questions concerning interactions between YCC components 
and differences in !-subunit substrate specificity.  
 
Multiple co-expression and co-purification strategies yielded YCC complexes (the 
propionyl-CoA carboxylase AccA3-AccD5 and the putative long-chain acyl-CoA 
carboxylase AccA3-AccD4) that were catalytically active but did not assemble into 
stable forms amenable to structural analyses; possible explanations for these 
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observations have been discussed in detail. Significant effort was invested in the 
production of the "-subunit AccE5, but its association with its interacting partners 
(AccA3 and AccD5) could not be investigated due to technical impediments 
stemming, presumably, from the intrinsic disordered nature of the protein. 
Biophysical studies of AccD4 and AccD6 (the !-subunit of ACC) revealed 
unexpected structural diversity in the M. tuberculosis YCC !-subunit subfamily. 
Unlike all other actinobacterial homohexameric !-subunits characterised to date, 
AccD4 and AccD6 were found to function as lower oligomers, highlighting that 
hexameric assembly is not a requisite for carboxyltransferase function. Endeavours to 
crystallize AccD4, in apo-form or in complex with substrate/cofactor analogs, were 
unsuccessful. The high-resolution crystal structure of AccD6, on the other hand, was 
determined by the method of molecular replacement. The structure of AccD6 has 
elucidated the molecular basis of homodimeric arrangement, besides throwing light 
on the conserved and non-conserved features of the active site, and the putative 
determinants of substrate specificity.  
 
Taken together, the findings of this study have added to the existing knowledge of the 
M. tuberculosis structural proteome and have furthered our understanding of the 
biophysical attributes and functions of YCC !-subunits, validated anti-mycobacterial 
drug targets. Interesting insights into the likely molecular evolution of YCC !-
subunits have been acquired. 
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Zusammenfassung 
 
Mycobacterium tuberculosis ist der Tuberkuloseerreger, dem jährlich zwei Millionen 
Menschen zum Opfer fallen und der jedes Jahr viele Millionen Neuinfektionen 
aufweist. Die Zellwand von M. tuberculosis besteht aus verschiedenen Fettsäuren und 
weist einen hohen Anteil von Mykolsäuren auf. Die damit einhergehende hochgradige 
Impermeabilität der Zellwand trägt entscheidend zur Virulenz von M. tuberculosis 
bei, indem sie sowohl Schutz vor der Immunreaktion des Wirtsorganismus vermittelt, 
als auch die Aufnahme von Antibiotika erschwert. Die Synthese mykobakterieller 
Lipide ist daher ein attraktives Zielobjekt für die Entwicklung neuer Antibiotika. Die 
erste Reaktion dieser Synthese ist die Carboxylierung von Acetyl-CoA zu Malonyl-
CoA und wird durch die multi-funktionelle multimere Acetyl-CoA Carboxylase 
(ACC) katalysiert. Einige ACC Komplexe, vor allem die der Aktinobakterien, 
carboxylieren unterschiedliche Substrate und werden daher Acyl-CoA Carboxylasen 
(YCC) genannt. Sie bestehen aus einer Biotin Caboxylase und einer Biotin-carboxyl 
Transportprotein Untereinheit (alpha Untereinheit), sowie aus einer 
Carboxyltransferase Untereinheit (beta Untereinheit). Interessanterweise verfügen 
Mycobakterien über Gene, die drei alpha Untereinheiten (AccA1 – AccA3), sechs 
beta Untereinheiten (AccD1 - AccD6) sowie eine epsilon Untereinheit (AccE5) 
kodieren, während die meisten Lebensformen häufig nicht mehr als zwei YCCs Gene 
aufweisen. Trotz ihrer wichtigen Rolle im mykobakteriellen Lipidmetabolismus sind 
die Grundlagen der Funktionsweise dieser Proteinkomplexe weitgehend unbekannt. 
 
Diese Dissertation handelt über die strukturelle und funktionelle Beschreibung der 
essentiellen Komponenten (AccA3, AccD4 - AccD6, und AccE5) der M. tuberculosis 
YCCs, die für die Synthese der charakteristischen Mykolsäuren verantwortlich sind. 
Röntgenkristallografie sowie andere komplementäre biophysische und biochemische 
Methoden wurden genutzt, um die Interaktion zwischen diesen YCC Komponenten zu 
untersuchen und deren Substratspezifität zu erklären. 
 
Mehrere Strategien zur Herstellung von YCC Komplexen wurden verfolgt um aktive 
Enzyme zu produzieren. Der Komplex aus Propionyl-CoA Carboxylase (AccA3-
AccD5) sowie der Komplex aus Acyl-CoA Carboxylase (AccA3-AccD4), welche 
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lange Acylketten carboxyliert, wurden koexpremiert und waren biochemisch aktiv. 
Beide Proteinkomplexe waren jedoch als Komplex nicht stabil und somit nicht für 
strukturelle Untersuchungen geeignet. Mögliche Gründe hierfür werden in dieser 
Arbeit ausgiebig beschrieben und analysiert. Das Epsilonprotein AccE5 konnte mit 
einer aufwendigen Prozedur hergestellt werden. Dabei erwies es sich als ein 
intrinsisch ungeordnetes Protein. Die biophysikalische Analyse von AccD4 und 
AccD6 deutet auf eine ungewöhnliche Struktur dieser beiden Untereinheiten hin, die 
sich von derjenigen der beta Untereinheiten der meisten anderen Aktinobakterien 
deutlich unterscheidet. Im Gegensatz zu diesen aktinobakteriellen homologen beta 
Untereinheiten bilden AccD4 und AccD6 keine homohexamere, sondern eine 
niederhomooligomere Strukturen. Die Kristallisation und Lösung der Röntgenstruktur 
von AccD6 zeigte ebenfalls, dass diese Untereinheiten Homodimere bilden. Darüber 
hinaus erlaubt diese Kristallstruktur eine detaillierte Beschreibung der Aminosäuren, 
die für Substratbindung und Katalyse notwendig sind.  
 
Diese Dissertation liefert einen wichtigen Beitrag zum molekularen und funktionellen 
Verständnis der M. tuberculosis Mykolsäuresynthesemaschinerie. Da YCC beta 
Untereinheiten potentielle Zielproteine für antimykobakterielle Wirkstoffe sind, 
liefert diese Arbeit Grundlagen für die zukünftige Erforschung und Entwicklung 
dieser Wirkstoffe. Darüber hinaus gewährt diese Arbeit auch interessante Einblicke in 
die Evolution dieser Proteinfamilie. 
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1 Introduction 
1.1 Mycobacterium tuberculosis 
Mycobacterium tuberculosis, an aerobic actinobacterium, is the causative pathogen of 
tuberculosis (TB), one of the main fatal infections in human beings. With an annual 
global incidence rate of over nine million (Global Tuberculosis Report 2012, World 
Health Organisation), the rapid emergence of multidrug-resistant (MDR) strains and 
the ominous crosstalk with human immunodeficiency virus (HIV), the disease is far 
from being completely eradicated. Diagnostic and treatment delay, inefficient follow-
up methods of tuberculosis management and the decline of socioeconomic standards 
in developing countries have been aggravating the problem by large. The disease has 
been declared as a global public health emergency as it is believed that one-third of 
the world’s population is infected and one-tenth of these have a lifetime risk of 
developing disease symptoms (Global Tuberculosis Report 2012, WHO). 
Epidemiological data underline the urgent requirement of new drugs and a novel 
vaccine to control this deadly disease.   
 
 
 
Figure 1-1. TB: two sides of the coin. (A) Measures to control drug-susceptible strains 
have reduced the total global incidence of TB, although the rate of co-infection with HIV is 
alarming. (B) World map depicting the percentage of new MDR-TB cases in 2011. The 
failure of health-care systems in some developing countries has fostered the global prevalence 
of drug-resistant strains. (Adapted, with permission, from the Global Tuberculosis Report 
2012, WHO). 
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1.1.1 Transmission and pathogenesis 
The events associated with M. tuberculosis infection have been elucidated through 
studies based on animal models and human TB (Flynn & Chan, 2005, Russell, 2007). 
All M. tuberculosis infections occur by airborne transmission of droplet nuclei 
containing one or a few viable bacilli produced by a sputum-positive infected 
individual. Upon inhalation, the droplet nuclei are deposited in the air sacs of the 
lungs, where they are engulfed by alveolar macrophages, key cells of the innate 
immune system that act as the primary barrier against infection. Phagocytosis of the 
bacteria by macrophages is initiated by bacterial contact with macrophage mannose 
and/or complement receptors (Schlesinger, 1993). Surfactant protein A, a glycoprotein 
found on alveolar surfaces enhances the binding and uptake of M. tuberculosis by 
upregulating mannose receptor activity (Gaynor, et al., 1995). Cholesterol in cell 
plasma membranes is thought to be important for the uptake process, as removal of 
this steroid from human neutrophils hinders the phagocytosis of M. kansasii (Peyron, 
et al., 2000) and similar depletion experiments prevented the entry of M. bovis BCG 
into mouse macrophages (Gatfield & Pieters, 2000). The human toll-like receptor 2 
(TLR2) also plays a key role in macrophage activation and hence in M. tuberculosis 
uptake (Noss, et al., 2001). 
 
Upon entry into a host macrophage, M. tuberculosis initially resides in an endocytic 
vacuole called the phagosome. In the event of a normal phagosome-lysosome fusion, 
these bacteria encounter an adverse environment created by acidic pH, toxic peptides, 
reactive oxygen intermediates (ROIs) and lysosomal enzymes. Reactive nitrogen 
intermediates (RNIs) have been known to act strongly against virulent mycobacteria 
in mouse macrophages (Chan, et al., 1992, Chan, et al., 1995) and alveolar 
macrophages of a majority of TB-infected patients exhibit inducible nitric oxide 
synthase (iNOS) activity (Nicholson, et al., 1996). Interestingly, the resistance to 
RNIs among various strains of M. tuberculosis correlates with virulence (Chan, et al., 
1992, O'Brien, et al., 1994, Chan, et al., 1995). Given that most macrophage-killing 
of bacteria occurs in the phagolysosome (Fenton & Vermeulen, 1996), intracellular 
pathogens have evolved several ways to escape this unfavourable vacuolar 
microenvironment. It has been demonstrated that M. tuberculosis has the ability to 
prevent phagosome-lysosome fusion (Armstrong & Hart, 1975, Frehel, et al., 1986). 
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There has also been evidence that virulent mycobacteria can prevent acidification of 
the phagolysosome, presumably by modulating the activity of a membrane proton 
pump (Crowle, et al., 1991). 
 
Following phagocytosis, the alveolar macrophages invade the surrounding epithelial 
layer, giving rise to a localized inflammatory response that results in the chemokine-
mediated recruitment of monocytes and neutrophils from adjacent blood vessels (van 
Crevel, et al., 2002). None of these cell types kill bacteria very efficiently (Fenton & 
Vermeulen, 1996), but their recruitment provides fresh host cells for the expanding 
bacterial population. The amorphous bundle of macrophages, monocytes and 
neutrophils constitutes the granuloma, the hallmark pathologic characteristic of TB. 
Granuloma formation is an effective means of containing the spread of bacteria. The 
macrophages in the granulomas undergo differentiation to form multinucleate giant 
cells, epithelioid cells and foam cells filled with lipid droplets. The development of an 
acquired immune response triggers the granuloma to adopt a more organized 
structure: layers of fibrous extracellular matrix material embedded with lymphocytes, 
surrounding a macrophage-rich centre (Dannenberg, 1994).  
 
M. tuberculosis bacilli are postulated to be unable to multiply within this caseous 
tissue due to its acidic pH, the low availability of oxygen and the presence of toxic 
fatty acids; however, some organisms may remain dormant (but alive) for decades 
within the caseous granuloma (Via, et al., 2008). This enclosed, balanced state is 
referred to as latent TB and can persist throughout a person’s life in an asymptomatic 
and non-transmissible form. The strength of the host cellular immune response 
determines if an infection is arrested at this stage or progresses further. In cases of 
weak or no immune response, disease progression is characterised by the loss of 
vascularisation, increased necrosis and the accumulation of caseous tissue in the 
centre of the granuloma (Russell, et al., 2009). Eventually, rupture of the granuloma 
occurs, releasing thousands of infectious cells into the airways, which can spread as 
aerosol through a productive cough (Kaplan, et al., 2003). 
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1.1.2 The fight against TB 
Tuberculosis is a disease of antiquity and contrary to the popular belief that it 
emerged in the agricultural era due to transmission by cows, it appears that the disease 
has evolved in parallel with human life for thousands of centuries (Smith, et al., 
2009). Though the history of anti-tuberculosis chemotherapy dates back to as recent 
as the 1940s, the competitive interaction between the human immune system and the 
disease has apparently been a much longer battle.  
 
1.1.2.1 Host defence mechanisms 
Understanding host defence mechanisms are of paramount importance in the design 
and development of strategies to treat and combat disease. The phenomenon of host 
defence involves successful pathogen recognition, innate and acquired immune 
mechanisms. 
 
M. tuberculosis activates two germ-line encoded pattern recognition receptors: the 
Toll-like receptors (TLR) and the nucleotide oligomerization domain (NOD)-like 
receptors. The TLR1-TLR2 heterodimer and NOD2 specifically recognise a 
triacylated lipoprotein derivative and a peptidoglycan (muramyl dipeptide) of M. 
tuberculosis respectively (Thoma-Uszynski, et al., 2001, Girardin, et al., 2003), 
resulting in an NF-#B-mediated inflammatory response and antimicrobial activity 
(Liu, et al., 2006, Delbridge & O'Riordan, 2007). 
 
Autophagy has been found to be an important innate immune defence strategy 
(Gutierrez, et al., 2004) and can be induced in macrophages via several methods like 
the activation of the cytokine interferon-gamma (IFN-$) and TLRs (Delgado, et al., 
2008); ubiquitin-derived peptides have direct antimicrobial activity against M. 
tuberculosis and are transported to phagosomes harboring mycobacteria in an 
autophagy-dependent manner (Alonso, et al., 2007). Serum vitamin D levels also 
have an influence on TB disease progression and susceptibility (Rook, et al., 1986, 
Crowle, et al., 1987); under conditions where vitamin D prohormone (25D) is present 
at sufficient levels, TLR2/1 activation of monocytes leads to a 25-hydroxyvitamin 
D3-1a-hydroxylase (CYP27b1) and vitamin D receptor (VDR) dependent expression 
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of the antimicrobial peptide, cathelicidin, and direct microbicidal activity against 
intracellular M. tuberculosis (Liu, et al., 2007, Martineau, et al., 2007). 
 
 
 
Figure 1-2. The immune response in tuberculosis. Mycobacterial peptides are 
presented, either directly or by cross-priming, to CD8+ and CD4+ T cells via MHC I and 
MHC II molecules respectively. The stimulated T cells produce a variety of cytokines for 
activation of T cells, macrophages and polymorphonuclear granulocytes. Some T cells have 
direct cytolytic function against bacilli whereas some other T cells (Treg) counter-regulate 
protection mediated by other T cells. Memory T cells that mount a stronger and faster 
immune response succeed the effector T cells. During active containment in solid granuloma, 
the bacilli are immune to attack and live in a dormant stage. The suppression of Th1 cells by 
cytokines from Treg cells allows resuscitation of bacilli, which leads to granuloma caseation 
and active disease. (Figure reprinted from (Kaufmann, et al., 2010), with kind permission 
from Elsevier).  
 
Acquired immunity against M. tuberculosis infection is mainly mediated by T 
lymphocytes and is associated with the emergence of delayed-type hypersensitivity 
reactions (Dannenberg, 1994). These responses typically occur 4 to 6 weeks post 
infection. The activation of T lymphocytes by specific mycobacterial antigens leads to 
a series of immunological events that ultimately limit the replication of M. 
tuberculosis: T cells of the helper/inducer phenotype (CD4+) upregulate populations 
of antigen-specific effector T cells (CD4+) and cytotoxic T cells (CD8+). The effector 
T cells secrete various cytokines which activate macrophages and present them with 
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enhanced mycobactericidal and mycobacteriostatic abilities. The CD4+ cells have 
been dichotomized into functional subsets based on the respective cytokine profiles 
(Mosmann, et al., 1986); the Th1 helper cells produce IFN-$ and interleukin-2 (IL-2), 
promoting the inflammatory response and cell-mediated immunity; the Th2 helper 
cells secrete the cytokines IL-4, IL-5 and IL-10 and drive the immune response 
towards antibody production (Mosmann, et al., 1986, Mosmann & Coffman, 1989). 
The cytotoxic T cells, on the other hand, attack and lyse infected macrophages 
displaying mycobacterial antigens, thereby releasing the engulfed bacilli from their 
protective niche and exposing them to the killing action of activated macrophages 
(Kaufmann & Young, 1992).  
 
1.1.2.2 Anti-tuberculosis chemotherapy 
The human immune system and M. tuberculosis have co-evolved. The capability of 
the organism to evade the host immune processes is one of the important reasons for 
the inability of the host to achieve sterile immunity against M. tuberculosis, requiring 
the use of antibiotics to fight the disease. 
 
1.1.2.2.1 First-line drugs 
TB can be treated using the first-line drugs mentioned in Table 1-1.  
 
Table 1-1. First-line agents against tuberculosis 
Antibiotic Target of inhibition Reference 
Isoniazid (INH) Mycolic acid synthesis 
(InhA, KasA, DfrA) 
 
(Zhang, et al., 1992) 
Rifampicin (RIF) Transcription  
(RNA polymerase !-subunit) 
 
(Russell & Chopra, 1996) 
Ethambutol (ETH) Arabinogalactan synthesis 
 
(Telenti, et al., 1997) 
Pyrazinamide (PZA) Unknown (FAS-I?) 
 
(Scorpio & Zhang, 1996) 
Source: Report No. TDR/PRD/TB/03.1W (WHO, Geneva, 2003) 
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The first-line therapy is often ineffective for several reasons: lengthy treatment period 
(that results in lack of compliance and hence failure of treatment), toxic side effects, 
and the emergence of multidrug-resistant (MDR) and extremely drug-resistant (XDR) 
TB. MDR-TB is defined as tuberculosis that is resistant to at least INH and RIF 
(Dalton, et al., 2012) and XDR-TB is defined as TB that has developed resistance to 
at least INH and RIF as well as to any member of the quinolone family and at least 
one of the second-line anti-TB injectable drugs: amikacin, kanamycin or capreomycin 
(WHO press release, 2006). Streptomycin that exhibits anti-tuberculosis activity by 
means of inhibiting protein synthesis (Blanchard, 1996) is no longer considered a 
first-line agent because of high rates of resistance.  
 
1.1.2.2.2 Second-line drugs 
Anti-tuberculosis agents that are less effective than first-line drugs and/or have toxic 
side effects and/or are unavailable in many developing countries are classified as 
second-line drugs. These drugs are administered under special circumstances like 
resistance to first-line therapy and diagnosis of XDR- and MDR-TB. 
 
Table 1-2. Second-line agents against tuberculosis 
Antibiotic class (example) Target of inhibition Reference 
Aminoglycosides 
(kanamycin, amikacin) 
Protein synthesis (Doluisio & 
Swintosky, 1965, 
Adamis, et al., 2004) 
Fluoroquinolones 
(ciprofloxacin, levofloxacin, 
moxifloxacin) 
 
DNA gyrase (Wright, et al., 2000) 
Polypeptides (capreomycin, 
viomycin, enviomycin) 
 
Protein synthesis (Blumberg, et al., 
2003) 
Thioamides (ethionamide, 
prothionamide) 
 
Mycolic acid synthesis (McIlleron, et al., 
2006) 
Cycloserine (closerin) 
 
 
Peptidoglycan synthesis (Wishart, et al., 2006) 
Para-aminosalicylic acid Folate metabolism, 
possibly dihydropteroate 
synthase 
(Lehmann, 1946) 
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Table 1-3. New TB drugs in clinical trials 
Compound 
(other names) 
Chemical class Key features Reference 
Moxifloxacin, 
gatifloxacin 
 
 
Fluoroquinolones Safe (used in other 
infections); shorter 
course of therapy 
(Cynamon, et 
al., 2007) 
Rifapentine 
 
 
Rifampicin analog Longer serum half-life 
than rifampicin 
(Burman, et al., 
2001) 
Rifalazil 
(KRM-1648) 
 
 
 
Benzoxazinorifamycin Can be co-administered 
with drugs that are 
sensitive to oxidative 
metabolism 
(Fujii, et al., 
1995) 
SQ109 
 
 
 
Ethambutol analog Superior to ethambutol 
in in vitro and in vivo 
activity 
(Jia, et al., 
2005) 
Bedaquiline 
(Sirturo, 
TMC207) 
 
 
 
 
 
 
Diarylquinoline Impressive in vitro and 
in vivo efficacy against 
drug-sensitive and 
drug-resistant strains; 
targets ATP synthase; 
the only FDA-
approved TB drug in 4 
decades 
(Andries, et al., 
2005) 
Sudoterb 
 
 
Pyrrole No cross-resistance 
with existing therapies 
(Casenghi, et 
al., 2007) 
Metronidazole 
 
 
Nitroimidazole Kills only dormant M. 
tuberculosis 
(Wayne & 
Sramek, 1994) 
PA-824 
 
 
 
 
 
Nitroimidazopyran No cross-resistance 
with existing drugs; 
effective against non-
growing cells under 
hypoxia 
(Stover, et al., 
2000) 
OPC-67683 Nitroimidazole Inhibits mycolic acid 
biosynthesis; superior 
to INH, ETH, RIF and 
PA-824 
(Matsumoto, et 
al., 2006) 
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1.1.2.2.3 Promising anti-tuberculosis agents 
It is a matter of urgency to develop novel anti-tuberculosis agents mainly because 
XDR-TB is resistant to first- and second-line drugs. Hundreds of research studies 
based on genetic approaches to target identification, high-throughput chemical 
screening, structural biology and virtual screening have identified a few more 
potential next-generation antituberculars that are currently under clinical testing. Key 
strong features of some of these compounds have been listed in Table 1-3.  
 
1.1.2.2.4 Emerging drug targets 
The availability of the complete genome sequence of M. tuberculosis (Cole, et al., 
1998) triggered and strengthened the search for new drug targets. Amino acid 
biosynthesis, especially the shikimate pathway involved in the synthesis of aromatic 
amino acids in lower life forms, but absent in mammals, is an important target for 
anti-TB drugs (Ducati, et al., 2007). The PhoPR two-component signal transduction 
system is a key drug target as it has a major role in the secretion of the 
immunodominant protein antigens ESAT-6 and CFP-10 and is hence vital for 
mycobacterial virulence (Ryndak, et al., 2008). The components of siderophore 
biosynthesis are indispensable for the survival of M. tuberculosis in iron-deficit 
conditions of the host and are therefore valuable drug targets (Ferreras, et al., 2005, 
Monfeli & Beeson, 2007). Inhibiting the stringent response enzyme can shorten the 
duration of therapy, as the enzyme is required for the long-time survival of M. 
tuberculosis within the host (Primm, et al., 2000). Another interesting group of targets 
is constituted by enzymes like isocitrate lyase involved in lipid metabolism as the 
repertoire of lipophilic molecules is unusually larger in M. tuberculosis than in other 
forms of life (McKinney, et al., 2000, Khasnobis, et al., 2002). A subset of this group 
comprises of the enzymes responsible for the biosynthesis of the cell wall of M. 
tuberculosis, a unique biological entity whose integrity is of paramount importance 
for the survival of the bacteria in constrained conditions like within human 
macrophages. The mode of action of the first-line drugs INH and ETH is indeed the 
inhibition of cell wall synthesis (Brennan & Crick, 2007). 
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1.1.3  The cell wall of Mycobacterium tuberculosis 
Mycobacteria are classified as Gram-positive bacteria, but possess features of both 
Gram-positive and Gram-negative organisms because of the unique cell wall 
architecture. Pioneering studies on the chemical nature of the cell wall of M. 
tuberculosis revealed the presence of trehalose-containing compounds, phthiocerols, 
mycolic acids and other unusual lipids in the mycobacterial cell wall (Mudd, et al., 
1941, Goren, 1972, Minnikin, et al., 1982). 
 
1.1.3.1 Biochemical nature of the cell wall 
The cell wall of mycobacteria is a unique multilayered structure composed of 
peptidoglycan (PG), arabinogalactan (AG), mycolic acids, glycolipids and a 
polysaccharide capsule placed outside the plasma membrane as represented in Figure 
1-3. This impermeable, hydrophobic structure confers natural protection against 
adverse conditions like unfavourable pH, reactive oxygen species, the action of the 
immune system and many antibiotics, and thus plays an important role in the survival 
of the pathogen (Briken, et al., 2004, Hunter, et al., 2006). Up to 60% of the dry 
weight of the cell wall is composed of lipids; moreover, decoding the genome 
sequence of M. tuberculosis revealed that a large proportion of the genes are devoted 
to the synthesis, processing or breakdown of these lipids (Cole, et al., 1998). 
Precisely, 233 out of total 3,845 ORFs have been annotated as encoding enzymes for 
fatty acid metabolism. (Camus, et al., 2002, Ehebauer & Wilmanns, 2011). 
 
The base of the mycobacterial cell wall consists of a plasma membrane (typical of all 
prokaryotes) that can be resolved into a thick outer layer and a thin inner layer using 
electron microscopy (Paul & Beveridge, 1992, Zuber, et al., 2008). The thickness of 
the outer layer is associated with the presence of carbohydrates and phospholipids, 
including phosphatidylinositol mannosides (PIMs) that are anchor molecules for 
polysaccharides like lipoarabinomannan and lipomannan in the cell wall (Sibley, et 
al., 1988, Lemassu & Daffe, 1994, Guerardel, et al., 2002, Pitarque, et al., 2008). The 
plasma membrane hosts a diversity of other compounds like menaquinones, 
carotenoids and various glycosylphosphopolyprenols (Brennan & Nikaido, 1995). 
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Figure 1-3. Schematic of the mycobacterial cell envelope. The mycobacterial cell 
wall is a complex biological entity composed of, in addition to the typical prokaryotic inner 
membrane, an outer capsule and a waxy mycomembrane that is essential for mycobacterial 
survival. 
 
The peptidoglycan layer is composed of peptide side chains with L-alanyl-D-
isoglutaminyl-meso-diaminopimelyl-o-alanine, in which the diaminopimelic acids are 
amidated (Lederer, et al., 1975). This hydrophobic polymer not only provides the 
structural framework of the cell wall, but also serves as a permeability barrier against 
a number of antibiotics. The PG layer is covalently linked to the AG, which is in turn 
esterified with the mycolic acids that are specialized biomolecules that make up the 
mycomembrane (Misaki, et al., 1974, McNeil, et al., 1991, Brennan & Nikaido, 
1995). Mycolic acids, the hallmark of mycobacteria, are very long-chain %-alkyl, !-
hydroxy fatty acids synthesized by the sequential and concerted action of three 
enzyme systems: fatty acid synthases FAS-I and FAS-II and a polyketide synthase 
(PKS13) (Glickman, et al., 2000, Vilcheze, et al., 2000, Bhatt, et al., 2005, Bhatt, et 
al., 2007, Brown, et al., 2007). Mycolic acids are present as free mycolates or as 
esters of trehalose sugars called trehalose monomycolates (TMM) and trehalose 
dimycolates (TDM) (Noll & Bloch, 1955, Noll, et al., 1956, Takayama, et al., 2005). 
These fatty acids not only play a crucial structural role in cell envelope architecture 
but also are essential for mycobacterial growth (Barry, et al., 1998, Asselineau, et al., 
2002). 
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A number of other surface-exposed lipids like sulfolipids, polyacyltrehaloses, 
phthiocerol dimycocerosates (PDIM), mannosyl-b-1-phosphomycoketides and diacyl 
trehaloses intercalate into the cell wall. In addition, the cell wall harbours a number of 
proteins, including the antigen 85 complex and porins, which constitute the complex 
cell-wall assembly (Brennan & Nikaido, 1995, Asselineau & Laneelle, 1998, Draper, 
1998, Gokhale, et al., 2007). 
 
1.1.3.2 Fatty acid biosynthesis 
The complexity of lipid metabolism in mycobacteria is evident from the fact that 
these organisms harbor both type I and type II FAS systems whilst other 
actinomycetes (e.g., corynebacteria) possess only a FAS-I evolved for de novo fatty 
acid biosynthesis and most bacteria (including Streptomyces) have only FAS-II. The 
FAS-I system of mycobacteria is dedicated to de novo fatty acid biosynthesis whereas 
the FAS-II is responsible for the elongation of existing long-chain fatty acids to 
produce the meromycolate part of mycolic acids (Brennan, 2003). 
 
1.1.3.2.1 Fatty acid synthase-I 
In mycobacteria, the multifunctional FAS-I polypeptide catalyzes the de novo 
synthesis of long-chain acyl-CoAs (C16:0 and C18:0) using acetyl-CoA and malonyl-
CoA as the starter and extender units respectively (Smith, et al., 2003). These acyl-
CoA molecules can either be used directly for the synthesis of membrane 
phospholipids or further elongated by FAS-II to produce C24:0 as in the case of M. 
smegmatis (Peterson & Bloch, 1977) or C26:0 as in the cases of M. bovis and M. 
tuberculosis (Kikuchi, et al., 1992). In M. tuberculosis, the C26:0 fatty acid likely gets 
carboxylated by a dedicated acyl-CoA carboxylase (described in section 1.2.2.5.3) to 
%-carboxy C26:0 fatty acid that could be utilized by PKS13 in the biosynthesis of 
mycolic acids (Portevin, et al., 2005).  
 
The connector between the FAS-I and FAS-II systems is the condensing enzyme !-
ketoacyl-acyl carrier protein (ACP) synthase III known as mtFabH. This enzyme is 
responsible for the condensation of malonyl-ACP with the acyl-CoA product of FAS-
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I to produce 3-ketoacyl-ACP that is further reduced to an acyl-ACP and directed into 
the FAS-II cycle (Musayev, et al., 2005, Bhatt, et al., 2007).  
 
1.1.3.2.2 Fatty acid synthase-II 
Fatty acid elongation by FAS-II requires the substrate malonyl-ACP, the product of a 
transacylation reaction (between malonyl-CoA and holo-ACP) catalyzed by mtFabD 
(Kremer, et al., 2001). ACP, as the name suggests, is responsible for shuttling acyl 
intermediates between enzymes. Acyl-CoA primers are condensed with malonyl-ACP 
by the action of mtFabH. The resulting acyl-ACP precursor undergoes a cycle of 
keto-reduction (Marrakchi, et al., 2002), dehydration and enoyl-reduction (Quemard, 
et al., 1995) catalysed by the enzymes MabA, HadABC and InhA respectively [Figure 
1-4]. The acyl-ACP, that is now longer by two carbon units, undergoes a number of 
iterative cycles of reduction, the only exception being that mtFabH is replaced by the 
!-ketoacyl-ACP synthases KasA or KasB (Schaeffer, et al., 2001, Kremer, et al., 
2002, Slayden & Barry, 2002). 
 
 
Figure 1-4. Schematic overview of fatty acid biosynthesis in M. tuberculosis. Fatty 
acid biosynthesis in M. tuberculosis is carried out by the concerted action of FAS-I and FAS-
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II. FAS-I catalyzes de novo synthesis of fatty acyl-CoA and FAS-II iteratively produces 
meromycolates; these moieties are later condensed by PKS13 to form mycolic acids. 
(Reprinted from (Veyron-Churlet, et al., 2010), with kind permission from the American 
Society for Biochemistry and Molecular Biology). 
 
The first committed step in long-chain fatty acid biosynthesis is the production of 
malonyl-CoA, carried out by the enzyme acetyl-CoA carboxylase (ACC) (Wakil, et 
al., 1983). This enzyme and its close relatives, collectively known as acyl-CoA 
carboxylases, form the subject matter of this study and will be introduced in more 
detail in the following section.  
 
1.2 Acyl-CoA carboxylase 
1.2.1 Biotin-dependent carboxylases 
Acyl-CoA carboxylases (YCC) belong to the large family of biotin-dependent 
carboxylases: multi-functional enzymes that were discovered more than 50 years ago 
and are found in all forms of life. Members of this family have diverse functions, 
including but not limited to metabolism of amino acids, carbohydrates and fatty acids 
(Wakil, et al., 1983, Cronan & Waldrop, 2002, Tong, 2005, Jitrapakdee, et al., 2008), 
biosyntheses of mycolic acids, methyl-branched fatty acids (Gago, et al., 2011), and 
polyketides (Zhang, et al., 2010), autotrophic carbon fixation (Berg, et al., 2010, 
Pratscher, et al., 2011), urea utilization (Navarathna, et al., 2010, Strope, et al., 2011), 
methanol assimilation (Smejkalova, et al., 2010), and acetyl-CoA assimilation (Erb, et 
al., 2007, Alber, 2011, Khomyakova, et al., 2011). These enzymes hence play crucial 
catabolic and anabolic roles. 
 
1.2.1.1 Functional components 
Biotin-dependent carboxylases possess two enzymatic activities and catalyse their 
reactions in two steps executed by three structural components: biotin carboxylase 
(BC), biotin carboxyl carrier protein (BCCP) and carboxyltransferase (CT) (Knowles, 
1989, Attwood & Wallace, 2002). In many organisms like mycobacteria, BC and 
BCCP together form the "-subunit while CT, the core catalytic domain, constitutes 
the !-subunit.  
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In the first step, BC carries out the ATP-dependent transfer of the carboxyl moiety 
from bicarbonate to the N1’ atom of the biotin cofactor via a carboxyphosphate 
intermediate. In vivo, the biotin remains covalently linked (through an amide bond to 
a conserved Lys side chain) to the BCCP, which facilitates its translocation between 
active sites. In the second step, the !-subunit catalyses the transfer of the carboxyl 
group from carboxybiotin to the substrate, which is usually a small compound (such 
as urea and pyruvate) or a CoA ester of an organic acid. If the substrate is a derivative 
of a saturated organic acid (such as acetyl-CoA and propionyl-CoA), the "-carbon 
gets carboxylated. If, on the other hand, the substrate is a derivative of an "-! 
unsaturated organic acid (such as 3-methylcrotonyl-CoA and geranyl-CoA), the $-
carbon serves as the site of carboxylation. 
 
HCO3- + Mg-ATP + enzyme-biotin !" Enzyme-biotin-CO2- + Mg-ADP + Pi 
Enzyme-biotin-CO2- + acyl-CoA (substrate) !" Enzyme-biotin + carboxyacyl-CoA 
 
To carry out the two steps outlined above, the cofactor biotin has to visit the active 
sites of both BC and CT. Earlier, it was believed that this requirement could be met 
by a ‘swinging-arm’ model, which supports the translocation of biotin by about 30 Å, 
in turn made possible by the flexible biotin-BCCP connection that comprises of eight 
methylene groups and ten rotatable single bonds (Perham, 2000). This swinging arm, 
in its fully extended form, can reach a length of about 16 Å (the distance between the 
N1’ atom of biotin and the C"-atom of the biotinylated Lysine residue). However, the 
swinging-arm model has recently been replaced by a ‘swinging-domain’ model as 
structures of a few biotin-dependent carboxylases (St Maurice, et al., 2007, Xiang & 
Tong, 2008, Huang, et al., 2010, Huang, et al., 2011, Fan, et al., 2012) have shown 
that the distance between the active sites of BC and CT ranges from 55 to 85 Å, 
thereby rendering the swinging-arm model insufficient for biotin to reach both sites. 
The swinging-domain model explains the translocation of the entire BCCP domain 
during catalysis. 
 
1.2.1.2 Classification of biotin-dependent carboxylases 
Biotin-dependent carboxylases can be grouped on the basis of component architecture 
and the chemical nature of the substrate acted upon. The BC, BCCP and CT 
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components can be present as individual subunits, as in the case of bacteria, or can be 
fused into a large, multi-domain enzyme as in eukaryotes. Intermediates between 
these two extreme scenarios also exist in nature.  
 
Figure 1-5. Classification of biotin-dependent carboxylases. Biotin-dependent 
carboxylases can be classified into 4 groups based on substrate nature and 13 sub-families 
based on domain architecture. Homologous domains are shown with the same colour. The 
proteins are drawn to size; the black bar at the bottom corresponds to 500 residues. (Adapted 
from (Tong, 2013), with kind permission from Springer Science and Business Media). 
 
Most of the characterised biotin-dependent carboxylases fall under the subfamily of 
acyl-CoA carboxylases (YCCs) that utilize CoA-esters of small organic acids as 
substrates. Some members of this subfamily have distinct substrate preferences while 
other members can act on a wider group of substrates. There are a few additional 
members whose substrate preferences are yet to be studied, but have been identified 
and classified based on sequence information alone (Tong, 2005). The primary 
sequences of the YCC !-subunits share high levels of amino acid sequence 
conservation, presumably because all these enzymes bind esters of CoA. Despite high 
sequence homology, recent data (Huang, et al., 2011) have shown that differences 
exist in the organization of their components and have led to the understanding that 
YCCs are of two distinct lineages: one (subfamilies 1.1 through 1.7) that includes 
acetyl-CoA carboxylase (ACC), propionyl-CoA carboxylase (PCC), etc. and the other 
(subfamily 2) that consists of methylcrotonyl-CoA carboxylase (MCC) and geranyl-
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CoA carboxylase (GCC) [Figure 1-5]. Besides YCCs, two other major subfamilies of 
biotin-dependent carboxylases are constituted by pyruvate carboxylases (PC) and urea 
carboxylases (UC), designated as subfamilies 3.x and 4.x respectively.  
 
1.2.2 Actinobacterial acyl-CoA carboxylases 
Actinobacteria, a dominant phylum of the bacterial domain, constitute a 
heterogeneous group of GC-rich Gram positive bacteria that include economically 
important genera like Corynebacterium, Mycobacterium, Nocardia, Rhodococcus and 
Streptomyces. Acetyl-CoA carboxylase complexes purified from actinomycetes were 
found to have activity on a wider variety of substrates; these enzymes have hence 
been generally referred to as YCCs (Erfle, 1973, Henrikson & Allen, 1979, Hunaiti & 
Kolattukudy, 1982). A unique feature of some actinobacterial YCC complexes is the 
presence of, in addition to the "- and !-subunits, a recently discovered "-subunit 
(Diacovich, et al., 2002, Gago, et al., 2006).  
 
1.2.2.1 Physiological roles of actinobacterial YCCs 
The availability of huge volumes of sequence data from genome sequencing projects 
has facilitated the physiological, biochemical, biophysical and structural 
characterisation of YCCs from several actinobacteria (Diacovich, et al., 2002, Gande, 
et al., 2004, Gago, et al., 2006, Oh, et al., 2006, Daniel, et al., 2007, Gande, et al., 
2007). YCC complexes from actinomycetes not only generate malonyl-CoA for fatty 
acid biosynthesis, but also catalyze the carboxylation of a diverse range of substrates, 
such as propionyl-, butyryl- or long-chain acyl-CoAs, thereby producing precursors 
for the biosynthesis of various complex lipids and polyketides. There seems to exist a 
direct correlation between the number of putative YCC genes in an actinobacterium 
and the diversity of its lipids (Gago, et al., 2011). The genome of Corynebacterium 
glutamicum carries genes encoding an "-subunit (accBC), four !-subunits (accD1 – 
D4) and an "-subunit (accE), whereas the Streptomyces coelicolor genome harbors 
four genes coding for putative "-subunits (accA1, accA2, pccA, SCO4381), four genes 
coding for putative !-subunits (accB, pccB, SCO2776, SCO4380) and two genes 
encoding "-subunits (accE, pccE) (Bramwell, et al., 1996, Rodriguez & Gramajo, 
1999, Rodriguez, et al., 2001, Diacovich, et al., 2004). While most other life forms 
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possess one or two YCC-related genes, the M. tuberculosis genome (Cole, et al., 
1998) encodes an unusually high number of putative YCC genes: three "-subunits 
(accA1, accA2, accA3), six !-subunits (accD1 – D6), and one "-subunit (accE5) 
(Gago, et al., 2006, Oh, et al., 2006). The three "-subunit genes are conserved across 
mycobacteria, except M. leprae wherein only the ortholog of accA3 is found. This 
observation, together with transposon mutagenesis experiments in M. tuberculosis 
(Sassetti, et al., 2003, Griffin, et al., 2011), has shown that accA3 encodes the "-
subunit of the essential YCC complexes in M. tuberculosis. The different !-subunits 
presumably act on different fatty acyl-CoA extender units as substrates and hence 
contribute to the rich diversity of mycobacterial lipids. Existing literature on the 
biochemical and structural properties of a few YCCs of S. coelicolor and M. 
tuberculosis have been reviewed in more detail under sections 1.2.2.4 and 1.2.2.5 
respectively.  
 
1.2.2.2 Phylogeny of the !-subunits 
Phylogenomic analyses aimed at gaining insights into the early evolution of biotin-
dependent carboxylases have suggested that the last common bacterial ancestor had 
three biotin-dependent carboxylases, one of which probably belonged to the large 
family of CoA-bearing-substrate-carboxylases, defined based on protein domain 
composition and phylogenetic analysis (Lombard & Moreira, 2011). These studies 
have further indicated that the cenancestor (the common ancestor of all organisms) 
had two different carboxylases capable of the specific carboxylation of pyruvate and 
the non-specific carboxylation of several CoA-derivatives respectively. These 
enzymes may have had crucial roles in diverse metabolic pathways like the ancestral 
versions of anaplerosis, fatty acid biosynthesis, gluconeogenesis, etc. (Lombard & 
Moreira, 2011). Phylogenetic analysis based only on sequences of the putative !-
subunits from several actinomycetes has identified six clearly distinguishable groups 
(Gago, et al., 2011). 
 
Group I includes the mycobacterial !-subunits AccD1 and AccD2 that constitute 
YCC complexes which, based on genomic organization, have been implicated in fatty 
acid degradation (Cole, et al., 1998). The accA1 and accD1 genes are organized as an 
operon in a locus next to fadD35 and fadE10 while the accA2 and accD2 genes are 
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found clustered together with fadE12, fadE13 and echA7. Therefore, it was assumed 
that these complexes are involved in fatty acid !-oxidation; however recent lipidome 
analyses of the corresponding M. smegmatis knockouts have negated this assumption 
by demonstrating no involvement whatsoever in lipid metabolism (Ehebauer, et al., 
unpublished). Furthermore, data from enzymatic assays and metabolomic analyses of 
the knockouts show that at least one of these complexes possesses methylcrotonyl-
CoA carboxylase activity and hence might be a key player in leucine catabolism 
(Ehebauer, et al., unpublished). Group I also includes two S. coelicolor !-subunits, 
one of which is part of a partially characterised PCC complex (Bramwell, et al., 
1996). There are no CT orthologs from corynebacteria in group I.  
 
 
 
Figure 1-6. Genetic organization and phylogenetic analysis of actinomycete YCC 
!-subunits. The unrooted phylogenetic tree shows evolutionary relationships between YCC 
CT subunits of selected actinomycetes. The tree is drawn to scale; the lengths of the branches 
are indicative of the inferred evolutionary distances. The bar at the bottom indicates the 
relative number of substitutions per site. The insets depict the synteny and genetic 
organization of the !-subunits. Cg, Corynebacterium glutamicum; Cg, C. efficiens; DIP, C. 
diptheriae; Mt, M. tuberculosis; Mb, M. bovis; Ml, M. leprae; Ms, M. smegmatis; SCO, 
Streptomyces coelicolor; SAV, S. avermitilis; SGR, S. griseus; Sv, S. venezuelae; PPA, 
Propionibacterium acnes; Tfu, Thermobifida fusca. (Reprinted from (Gago, et al., 2011), 
with kind permission from John Wiley and Sons). 
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Group II encompasses representatives from all organisms analysed, implying that 
members of this group might carry out fundamental functions in actinobacteria. 
Members of this group are the mycobacterial AccD5 (whose encoding gene accD5 is 
arranged in a locus with accA3, accE5 and birA, the gene for biotin ligase) [Figure 1-
6], the S. coelicolor PccB (whose encoding gene pccB shares a genetic locus with 
accA2, pccE and birA) and the C. glutamicum AccD2 (whose encoding gene accD2 is 
clustered with accBC, accE, birA and accD1 that codes for a !-subunit highly 
homologous to AccD2, suggesting the occurrence of a gene duplication event. The 
nomenclature of C. glutamicum YCCs is different from that of mycobacterial YCCs; 
C. glutamicum AccD1 and AccD2 are actually orthologous to mycobacterial AccD5 
and relatively more distantly related to mycobacterial AccD1 and AccD2. 
 
Group III contains enzymes that are involved in mycolic acid production, suggesting 
that the corresponding !-subunits have highly specialized functions (Gande, et al., 
2004, Portevin, et al., 2005, Gande, et al., 2007). The mycobacterial member of this 
group is AccD4, the !-subunit of a long-chain YCC that likely provides "-C26 
carboxylic acid required in the final condensation step of mycolic acid biosynthesis 
(Trivedi, et al., 2004). The representatives of C. glutamicum in this group are AccD3 
and AccD2 (orthologous to the mycobacterial AccD4 and AccD5), components of the 
complex AccBC-AccD2-AccD3-AccE that provides extender units for the 
biosynthesis of corynomycolic acid. (Gande, et al., 2004, Gande, et al., 2007).  
 
Group IV includes AccB, the !-subunit of an essential YCC (AccA1/AccA2-AccB-
AccE) that carboxylates acetyl-CoA in S. coelicolor (Rodriguez, et al., 2001, 
Diacovich, et al., 2002). Although this complex is promiscuous in terms of substrate 
specificity and has a similar specificity constant for acetyl-, propionyl- and butyryl-
CoA in vitro, its main physiological role seems to be the generation of malonyl-CoA 
for the biosynthesis of fatty acids and the polyketide actinorhodin (Rodriguez & 
Gramajo, 1999, Rodriguez, et al., 2001, Diacovich, et al., 2002). Members of group 
IV are absent in mycobacteria and corynebacteria.  
 
Group V contains representatives only from mycobacteria. The mycobacterial !-
subunit AccD6 serves as the CT component of the essential AccA3-AccD6 complex, 
whose biological function is to carboxylate acetyl-CoA to malonyl-CoA, the key 
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extender unit in iterative fatty acid biosynthesis (Daniel, et al., 2007, Kurth, et al., 
2009). This complex does not require an "-subunit for its catalytic activity. 
 
Group VI is only distantly related to groups I-V and includes ‘outlier’ members like 
the less-characterised mycobacterial AccD3 and the C. glutamicum AccD4 (Gande, et 
al., 2004). These members seem unlikely to be directly involved in lipid metabolism; 
their physiological functions remain unclear.  
 
1.2.2.3 Quaternary structure of acyl-CoA carboxylases 
All YCC complexes reported so far possess an "-subunit : !-subunit stoichiometry of 
1:1. The quaternary structures of YCC complexes of M. tuberculosis (Gago, et al., 
2006), M. smegmatis (Haase, et al., 1982), S. coelicolor (Diacovich, et al., 2002) and 
Myxococcus xanthus (Kimura, et al., 1998) have all been deciphered to be "6!6 
whereas Sacharopolyspora erythraea YCC has a quaternary structure of "4!4 (Hunaiti 
& Kolattukudy, 1982). The presence of an additional "-subunit enhances the activity 
of some of these complexes (Rodriguez, et al., 2001, Diacovich, et al., 2002, Gago, et 
al., 2006, Oh, et al., 2006); however the exact stoichiometry and mode of interaction 
of this subunit with the other two subunits is unknown. The !-subunit mostly forms a 
stable hexamer (Diacovich, et al., 2004, Holton, et al., 2006, Lin, et al., 2006) while 
the "-subunit exists both as a hexamer and a trimer (Gago, et al., 2006).  
 
1.2.2.4 Acyl-CoA carboxylases of Streptomyces coelicolor 
The structural basis of actinobacterial YCC !-subunit function and the role of the "-
subunit in YCC activity were first illustrated in S. coelicolor (Diacovich, et al., 2002). 
Genetic and biochemical analyses of actinomycete YCCs were also initiated with 
work on enzymes from this organism. The genetic organization and the kinetic 
properties of an ACC and a PCC from S. coelicolor have been studied in detail 
(Rodriguez & Gramajo, 1999, Rodriguez, et al., 2001, Diacovich, et al., 2002). The 
two complexes have specific !- and "-subunits (AccB-AccE and PccB-PccE) while 
sharing the same "-subunit, AccA2. The complexes are clearly different in their 
substrate specificities and both require the corresponding "-subunit for maximal 
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enzyme activity (Diacovich, et al., 2002). The crystal structure of hexameric PccB 
(Diacovich, et al., 2004) revealed similarity in structural features to related enzymes 
like the Propionibacterium shermanii 12S transcarboxylase (Hall, et al., 2003) and 
the !-subunit of yeast ACC (Zhang, et al., 2003). Each monomer of PccB has two 
domains (N- and C-domains) with the conventional crotonase fold (Holden, et al., 
2001). The structural analysis, besides highlighting the existence of strong dimeric 
didomain interactions and the presence of 32-fold symmetry with a threefold axis 
perpendicular to a twofold axis, pinpointed for the first time a hydrophobic biotin-
binding pocket (Diacovich, et al., 2004).  
 
 
 
Figure 1-7. Crystal structure of S. coelicolor PccB. (A) The overall structure of PccB 
hexamer, with each monomer in a different colour. (B) The dimeric didomain interaction that 
is crucial for PccB function; the catalytic site (key residues shown as spheres) lies at the 
interface of two monomers (in green and yellow, respectively). (C) Closer view of the 
substrate-binding pocket with the key substrate specificity determinant residue (D422) and 
the two conserved glycines (that provide a catalytically important oxyanion hole) shown in 
‘stick’ mode with carbon, oxygen and nitrogen atoms coloured green, red and blue 
respectively. (PDB ID: 1XNY) 
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The biotin-propionyl-CoA cocrystal structure of PccB showed that biotin and 
propionyl-CoA bind perpendicular to each other at the active site, where two key 
oxyanion holes were identified. Like in previously characterised homologs, the acyl-
CoA binds predominantly to the N-domain of the first monomer, while biotin binds 
predominantly to the C-domain of its dimeric partner. The !-subunit substrate 
specificity code, i.e. how the !-subunits potentially differentiate one substrate from 
another, has been explained with the crystal structures of active site mutants of S. 
coelicolor PccB (Diacovich, et al., 2004, Arabolaza, et al., 2010). These mutational 
analyses have shed light on the key molecular determinant of substrate specificity and 
have further demonstrated that a single mutation in the substrate-binding pocket is 
sufficient to interchange the substrate specificities of S. coelicolor ACC and PCC 
(Arabolaza, et al., 2010).  
 
1.2.2.5 Acyl-CoA carboxylases of Mycobacterium tuberculosis 
The M. tuberculosis genome codes for an unusually high number of YCC subunits; 
some of their properties have been tabulated below (Cole, et al., 1998, Sassetti, et al., 
2003, Portevin, et al., 2005, Gago, et al., 2006). 
 
Table 1-4. The YCC subunits of M. tuberculosis 
Subunit Protein Gene Active 
expression 
Essential? Substrate 
%-subunit AccA1 Rv2501c Late log phase No Biotin 
 AccA2 Rv0973c Late log phase Yes Biotin 
 AccA3 Rv3285 Log phase Yes Biotin 
!-subunit AccD1 Rv2502c Late log phase No Methylcrotonyl-
CoA 
 AccD2 Rv0974c Late log phase No Unknown 
 AccD3 Rv0904c Unknown Unknown Unknown 
 AccD4 Rv3799c Log phase Yes C26-CoA 
 AccD5 Rv3280 Log phase Yes C3-CoA 
 AccD6 Rv2247 Log phase Yes C2-CoA 
"-subunit AccE5 Rv3281 Log phase Yes --- 
 
   Introduction 
 24 
The YCC ‘interactome’ of M. tuberculosis seems to contain fewer YCC complexes 
than the theoretically possible number of combinations (Ehebauer, et al., 
unpublished). In other words, each characterised !-subunit interacts with only one of 
the three %-subunits. Based on genetic organization and data from pull-down 
experiments (Ehebauer, et al., unpublished) in model organisms of M. tuberculosis, it 
is now known that M. tuberculosis YCC complexes are likely five in number: AccA1-
AccD1, AccA2-AccD2, AccA3-AccD4, AccA3-AccD5-AccE5 and AccA3-AccD6. 
YCCs of M. tuberculosis are of very high biological and pharmaceutical interest 
mainly because 50% of M. tuberculosis YCC subunits (namely AccA3, AccD4, 
AccD5, AccD6 and AccE5) are validated drug targets (Mdluli & Spigelman, 2006); 
this study focuses on the characterisation of these subunits. 
 
1.2.2.5.1 M. tuberculosis propionyl-CoA carboxylase 
The M. tuberculosis PCC is an essential complex and is constituted by the subunits 
AccA3, AccD5 and AccE5 (Gago, et al., 2006). The function of this complex was 
predicted based on homology to PccB from S. coelicolor and was confirmed by 
kinetic experiments (Gago, et al., 2006). The most likely physiological role of this 
enzyme is to generate methylmalonyl-CoA for the biosynthesis of branched-chain 
fatty acids because, in vitro, it displays five-fold higher preference to propionyl-CoA 
than to acetyl-CoA (Gago, et al., 2006). The crystal structure of AccD5 has shed light 
on the active site architecture of this enzyme (Holton, et al., 2006, Lin, et al., 2006). 
As in the case of the S. coelicolor counterpart, the M. tuberculosis PCC exhibits 
maximal catalytic activity only in the presence of the "-subunit AccE5 (Gago, et al., 
2006). How the three subunits of M. tuberculosis PCC interact with each other and 
how the #-subunit modulates the activity of the complex remain to be discovered, as 
there has been no clear molecular evidence for the functional role of the #-subunit. 
 
1.2.2.5.2 M. tuberculosis acetyl-CoA carboxylase 
The ACC of M. tuberculosis is composed of the subunits AccA3 and AccD6. The 
physiological role of this complex, the generation of malonyl-CoA for fatty acid and 
mycolic acid biosynthesis, was inferred based on the location of accD6 in the fasII 
operon (fabD-acpM-kasA-kasB-accD6) and confirmed by experiments on a 
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conditional mutant of accD6 in M. smegmatis (Kurth, et al., 2009). The ACC 
complex of M. tuberculosis reconstituted in vitro has been shown to act on both 
acetyl-CoA and propionyl-CoA, with a threefold higher efficiency in carboxylation of 
the former (Daniel, et al., 2007). Unlike in the case of PCC, the "-subunit AccE5 
displayed inhibitory effect on the carboxylase activity of the AccA3-AccD6 complex 
(Daniel, et al., 2007). The essential nature of AccD6 (Sassetti, et al., 2003, Kurth, et 
al., 2009) makes it an attractive target for the design of novel anti-TB therapeutics. 
Based on in vitro inhibitory effects of the hit compounds determined via in silico 
inhibitor screening carried out against the AccD5 active site (Lin, et al., 2006), a 
ligand NCI-172033 capable of potentially inhibiting AccD6 has been identified 
(Kurth, et al., 2009). However, the stoichiometry of the M. tuberculosis AccA3-
AccD6 carboxylase and the structural basis of its function remain unclear. 
 
1.2.2.5.3 M. tuberculosis long-chain acyl-CoA carboxylase 
The relatively poorly characterised long-chain acyl-CoA carboxylase of M. 
tuberculosis is composed of the subunits AccA3 and AccD4. AccD4 is encoded by 
accD4, a genomic neighbour of the genes pks13 (Rv3800c) and fadD32 (Rv3801c), 
whose products are, respectively, a polyketide synthase and an acyl-AMP ligase 
involved in mycolic acid biosynthesis (Trivedi, et al., 2004). The existence of AccD4 
orthologs only in the mycolic acid producing bacteria (Gago, et al., 2011) and the 
presence of accD4 in the vicinity of the mycolic acid synthetic machinery suggested 
that AccD4 is the CT subunit of a long-chain YCC that is responsible for the 
generation of long-chain acyl carboxylic acid involved in the Claisen condensation 
step of mycolic acid biosynthesis. Based on the interaction of AccD4 with AccA3 and 
AccD5 identified by coimmunoprecipitation studies in cell-free extracts of M. 
smegmatis, it was proposed that these three proteins together form an YCC complex 
(Portevin, et al., 2005). This hypothesis, however, has not been substantiated by 
experimental data. Detailed biochemical and structural characterisation of AccD4 is 
requisite to fully comprehend its role in the production of mycolic acids.  
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1.3 Aims of this study 
Given the indispensability of fatty- and complex mycolic-acids for the growth and 
survival of M. tuberculosis, its lipid metabolism is being viewed as a major repertoire 
of potential drug targets. Acyl-CoA carboxylases, being responsible for the catalysis 
of the first rate-limiting step of mycolic-acid biosynthesis, are of special therapeutic 
interest because of two main reasons: (1) these enzymes are encoded by genes known 
to be essential for mycobacterial survival and (2) these enzymes bear limited 
homology (in terms of sequence, domain architecture and presumably three-
dimensional structure) to their counterparts in human beings.  
 
This study was aimed at the biophysical and X-ray crystallography-based structural 
characterisation of lipid-metabolizing acyl-CoA carboxylase complexes (AccA3-
AccD5-AccE5 / AccA3-AccD4 / AccA3-AccD6) of M. tuberculosis. It was expected 
that such structural and complementing biophysical analyses would help address 
questions concerning the stoichiometries and modes of interaction between the 
subunit components, besides providing detailed insights into the molecular basis of 
carboxylase function.  
 
Another objective of the work was to investigate, by X-ray crystallography, the 
molecular determinants of !-subunit substrate specificity. The !-subunits AccD5 and 
AccD6 share moderate levels of sequence identity and are known to possess varying 
strengths of affinity to substrates that are close chemical relatives; AccD4 is the only 
YCC !-subunit that has been implicated to act on long-chain acyl-CoA substrates. A 
part of this study was an attempt to elucidate the molecular reasons for this difference 
in substrate preferences.  
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2 Materials and Methods 
2.1 Materials 
2.1.1 Chemicals 
All chemicals used in this study were of analytical grade and were purchased from 
Carl Roth GmbH, Sigma-Aldrich Corporation, Serva Electrophoresis GmbH and 
Merck Group unless otherwise stated. Microbial growth media components were 
bought from Melford. Crystallisation screens were purchased from Hampton 
Research and Jena Bioscience. 
 
2.1.2 Fine biochemicals 
Molecular biology grade biochemicals like restriction enzymes, DNA polymerases, 
PCR materials, DNA ligases, DNA molecular weight markers, etc. for molecular 
cloning were purchased from New England Biolabs (NEB) and Thermo Fisher 
Scientific Inc. Oligonucleotides were bought from Eurofins MWG Operon in 
lyophilized form with HPSF-purified quality, diluted in double distilled water to a 
final concentration of 10 pmol/µl and frozen until required. Expression vector 
backbones were provided by the EMBL-Hamburg vector collection [Appendix I]. 
Protein molecular weight markers were purchased from Carl Roth, NEB and Thermo 
Fisher Scientific; gel filtration standards were procured from Bio-Rad Laboratories, 
Inc.; DNaseI and protease inhibitor cocktail were obtained from Serva. 
 
2.1.3 Genomic DNA and bacterial strains 
Mycobacterium tuberculosis strain H37Rv and Mycobacterium smegmatis strain 
mc2155 genomic DNA were kind gifts from the Kaufmann group at the Max Planck 
Institute for Infection Biology, Berlin. Bacterial strains for cloning and expression 
were used from the EMBL Hamburg bacterial strain collection [Appendix I]. Owing 
to its fast-growing nature, relative ease of handling and well-established genetics, the 
non-pathogenic mycobacterium M. smegmatis has often been used as a near-native 
expression host for the purification of M. tuberculosis proteins (Goldstone, et al., 
    Materials and Methods 
 28 
2008). However, the major disadvantage of using this expression system to produce 
polyhistidine-tagged recombinant proteins is the undesired co-purification of the 
Hsp60 chaperone GroEL1, which contains an intrinsic histidine-rich C-terminus. The 
strain of M. smegmatis used in this study harbors a mutant version of groEL1 created 
in-house (Noens, et al., 2011) by removing the coding sequence for the histidine-rich 
C-terminus. This novel M. smegmatis expression strain groEL1!C solves the problem 
of GroEL1 contamination and hence increases the efficiency and speed of protein 
purification. 
 
2.1.4 Laboratory consumables 
Table 2-1. List of laboratory consumables used in the study 
 
Consumable Supplier(s) 
Assay plates (96-well) 
Centrifugal ultrafiltration devices 
Chromatography columns (polyprep) 
Crystallisation plates (24-well) 
Dialysis cassettes 
Dialysis membranes from regenerated cellulose 
Disposable plastic cuvettes 
Electroporation cuvettes 
Filtration membranes from cellulose acetate 
Injection needles 
Inoculation loops and needles 
PCR tubes 
Pipette tips 
Plastic Petri dishes 
Plastic syringes 
Plastic tubes 
Serological pipettes 
Siliconized glass cover slides 
Syringe filters 
Vacuum-driven filtration systems 
 
Greiner Bio-One 
Sartorius, Corning 
Bio-Rad 
Nextal, Qiagen, Crystalgen 
Thermo Fisher Scientific 
Roth, Spectrum Laboratories 
Brand 
Biozym Scientific 
GVS Filter Technology 
B. Braun 
Greiner Bio-One 
Brand 
Sarstedt 
Sarstedt 
Henke-Sass Wolf, B. Braun 
Sarstedt, Greiner Bio-One 
Greiner Bio-One 
Hampton Research 
Sartorius, Millipore 
Millipore, Nalgene 
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2.1.5 Molecular cloning kits 
The DNA NucleoSpin Plasmid kit, purchased from Macherey-Nagel, was used for 
plasmid purification. For gel extraction and purification of PCR products, Wizard SV 
Gel and PCR Clean-Up system, purchased from Promega Corporation was used.  
 
2.1.6 Chromatography materials 
Ni-NTA agarose resin for protein purification was purchased from Qiagen. 
Superose™ 6 10/300 GL, HiLoad™ 16/60 Superdex™ 75 prep grade, and HiLoad™ 
16/60 Superdex™ 200 prep grade prepacked Tricorn columns and chromatography 
media were purchased from GE Healthcare Life Sciences.  
 
2.2 Methods 
This section of the thesis provides a general description of the experimental 
procedures used in the study. Protein-specific modifications to the protocols, if any, 
are mentioned in Chapter 3. 
 
2.2.1 Preparation of competent cells 
2.2.1.1 Preparation of chemically competent E. coli cells 
Competence, the ability of bacteria to take up exogenous genetic material from the 
environment, can be artificially induced by causing passive and transient permeability 
of the cell through exposure to suitable chemicals (most commonly, calcium chloride) 
or to an electric field. In this study, high-efficiency chemically competent E. coli for 
cloning and expression purposes was prepared by the Inoue method (Inoue, et al., 
1990). Briefly, an overnight pre-culture (of DH5%-T1R cloning strain or of 
expression strains) grown at 37 °C was used to inoculate a larger volume of SOB 
medium [Appendix II] (containing suitable antibiotic, if required) and incubation was 
carried out overnight at 21 °C. When an OD600 of 0.4 – 0.5 was reached, cells were 
harvested in pre-chilled tubes by centrifugation (2500 rpm, 20 min, 4 °C) and gently 
resuspended in 80 ml ice-cold Transformation Buffer (TB§) [Appendix II]. After a 
brief incubation on ice, cells were collected by centrifugation (2500 rpm, 20 min, 4 
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°C), gently resuspended in 20 ml ice-cold TB§ and treated with 1.5 ml DMSO. 
Aliquots of 100 µl were dispensed into pre-chilled microfuge tubes, flash-frozen with 
liquid nitrogen and stored at -80 °C until further use. All the above steps were carried 
out under sterile conditions. Cells were tested for background and DNA 
contamination and the transformation efficiency was evaluated using a plasmid DNA 
sample of known concentration.  
 
2.2.1.2 Preparation of electrocompetent M. smegmatis cells 
Mycobacterium smegmatis has been classified as a risk group 2 (S2) organism. 
Therefore, in accordance with established laboratory safety guidelines, all open work 
with M. smegmatis cells were carefully performed in a laminar flow hood in a 
biological safety level 2 (S2) laboratory. For preparation of electrocompetent cells, a 
single colony of M. smegmatis groEL1!C cells (Noens, et al., 2011) was used to 
inoculate a small volume (5 ml) of 7H9 complete medium [Appendix II] and 
incubated with shaking at 37 °C for 2 to 3 days. This pre-culture was used to 
inoculate a larger volume (50 ml) of 7H9 complete medium and incubated overnight 
at 37 °C. After cooling the culture on ice for a couple of hours, cells were collected by 
centrifugation (4000 rpm, 10 min, 4 °C). Cells were resuspended in 50 ml ice-cold 
10% (v/v) glycerol and recovered by centrifugation (4000 rpm, 10 min, 4 °C). The 
above step was repeated twice. The resulting pellet was resuspended in 2 ml ice-cold 
10% (v/v) glycerol, aliquoted into 100 µl fractions, flash-frozen in liquid nitrogen and 
stored at -80 °C until future use. The entire preparation was carried out under sterile 
conditions.  
 
2.2.2 Molecular cloning 
2.2.2.1 Ligase-dependent cloning 
Conventional ligase-dependent cloning experiments involve the insertion of a DNA 
fragment into a plasmid vector containing a multiple cloning site, a drug resistance 
gene marker, an inducible promoter to drive protein expression, and if necessary, a 
suitable tag for affinity purification of the expressed protein(s).  
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2.2.2.1.1 Preparation of insert 
DNA fragments to be inserted into the vectors of choice were prepared by PCR. In 
this study, genomic DNA of M. tuberculosis strain H37Rv or a different plasmid 
harboring the gene(s) of interest was used as DNA template for PCR. Each PCR mix 
contained 0.1 – 0.2 µg of template DNA, 0.5 µM of each primer (forward and 
reverse) designed to amplify region of interest and to engineer appropriate restriction 
sites that enable generation of suitable overhangs [Appendix I], 0.2 mM of each of the 
four dNTPs, 1 – 3% DMSO, 1X final concentration of suitable DNA polymerase 
buffer (+MgCl2) and prescribed concentration of the DNA polymerase (Pfu DNA 
polymerase or Phusion& high-fidelity DNA polymerase) in a total reaction volume of 
50 µl made up using nuclease-free H2O. The enzyme was added immediately prior to 
the reaction. Appropriate positive and negative control reactions were included and 
PCR was carried out in a Mastercycler& Personal or a Mastercycler& Gradient 
thermal cycler (Eppendorf) by the following general protocol with minor 
modifications, if necessary: 
 
Initial denaturation 97 °C, 2 - 3 min 
Denaturation  97 °C, 30 s 
Primer annealing 55 °C / 60 °C, 30 s        x 30 cycles 
Primer extension 72 °C, 2 min per 1 kb for Pfu; 
20 s per 1 kb for Phusion 
Final extension 72 °C, 10 min 
Storage  4 °C 
 
The resulting PCR products were mixed with DNA sample buffer [Appendix II] and 
visualized by agarose gel electrophoresis [Appendix II], a technique that separates 
polynucleotides based on size, performed at constant voltage (100 V) using a Consort 
EV243 electrophoresis system (Wolflabs). The size of the polynucleotide of interest 
was verified by comparison with a DNA ladder loaded on the same gel; the PCR 
products were purified, quantified by measuring absorbance at 260 nm using an ND-
1000 NanoDrop spectrophotometer (PEQLAB) and frozen until further use. 
 
2.2.2.1.2 Restriction digestion and ligation 
Vector DNA and purified PCR products were digested with restriction endonucleases, 
using enzyme concentration, incubation temperature and duration as prescribed by the 
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manufacturer. The digested products were electrophoresed and the linearised 
materials were excised and purified. Vector and insert were mixed in a stoichiometric 
ratio of approximately 1:3 and ligated using DNA ligase, according to the 
manufacturer’s instructions.  
 
2.2.2.1.3 Transformation 
2.2.2.1.3.1 Heat-shock transformation of chemically competent E. coli 
For each transformation, a frozen aliquot (100 µl) of competent E. coli cells was 
thawed on ice. One or a few µl of DNA (plasmid DNA/ligation mix) was added to the 
cells, mixed gently and incubated on ice for 20 – 30 min. The cells were administered 
a brief heat shock (42 °C, 90 sec) and immediately placed on ice for a few min. This 
was followed by addition of approx. 500 µl of SOC medium [Appendix II] and 
incubation, with shaking, at 37 °C for 45 – 60 min. The transformation mix was spun 
down (3000 rpm, 2 min); the cell pellet was resuspended in SOC medium (approx. 
150 µl), plated out on an LB-agar plate supplemented with appropriate antibiotic and 
incubated overnight at 37 °C. For co-expression experiments with two different 
plasmids, 1 µl of each plasmid encoding a component of the complex (AccA3-AccD5 
/ AccA3-AccD4 / AccA3-AccD6) was added to an aliquot of competent E. coli cells 
and the transformation protocol was performed as described above. 
 
2.2.2.1.3.2 Transformation of electrocompetent M. smegmatis 
For each transformation, a frozen aliquot (100 µl) of electrocompetent M. smegmatis 
groEL1!C cells was thawed on ice. The expression construct solution (1 µl) was 
pipetted into a pre-chilled tube and added with 80 µl of competent cells and 80 µl of 
10% (v/v) ice-cold glycerol. The suspension was vortexed, centrifuged briefly and 
transferred into an electroporation cuvette. Electroporation was performed thrice at 
2.5 kV using the Electroporator 1000' (Stratagene) without intermediate cooling. 
After the electroporation, the cuvette was immediately cooled on ice. Ice-cold 7H9 
complete medium [Appendix II] (1 ml) was added; the suspension was transferred to 
a 2-ml microfuge tube and incubated, with shaking, at 37 °C for 2 to 4 hours. The 
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suspension (approx. 100 µl) was plated out on 7H10-agar plates [Appendix II] 
containing 50 µg/ml hygromycin. The plate was incubated at 37 °C for 3 to 4 days. 
 
2.2.2.1.4 Confirmation of construct integrity 
Positive transformants from the transformed LB agar plates were identified by colony 
PCR using reaction mixtures as described in section 2.2.2.1.1 and single colonies as 
DNA templates. Bacteria from each colony pool were reserved to inoculate small 
volumes of LB containing suitable antibiotic. Plasmid DNA was isolated from 
cultures corresponding to the positive transformants and incorporation of insert was 
verified by restriction analysis of the plasmids. Sequencing of plasmid DNA samples 
was outsourced to Eurofins MWG Operon. 
 
2.2.2.2 Ligase-independent cloning 
LIC is a simple two-step method to produce expression constructs that makes use of 
3’ to 5’ activity of T4 DNA polymerase to create specific 10-15 base single overhangs 
in the expression vector (Chen, et al., 2000). LIC vectors used in this study contain 
the gene coding for eGFP flanked by two BsaI sites. In step 1 of the method, the 
vector is linearised by restriction using BsaI, thereby removing the eGFP gene. In step 
2, the linearised vector is treated with T4 DNA polymerase in the presence of dTTP. 
As a consequence of 3’ to 5’ activity of the polymerase, bases are removed from both 
3’-ends until the first T base is reached. This protocol results in two specific 
overhangs (of 10 and 12 bases respectively) in the LIC vector, which facilitate 
specific, ligase-independent annealing. 
 
2.2.2.2.1 Preparation of LIC vector and insert 
The LIC vector was linearised by BsaI digestion performed as per the instructions of 
the manufacturer. The linearised vector was gel-purified, treated with T4 DNA 
polymerase in the presence of 2.5 mM dTTP and incubated at room temperature for 
30 min. The polymerase was inactivated by heating at 75 °C for 20 min. The insert 
was obtained by PCR amplification (as explained in section 2.2.2.1.1) using suitable 
LIC primers [Appendix I] designed as follows: 
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Forward primer (5’ to 3’): CAGGGCGCCATG-gene of interest 
Reverse primer (5’ to 3’): GACCCGACGCGGTTA-gene of interest (rev. comp.) 
 
The forward primer contained the complementary overhang (underlined), the start 
codon (in bold) and a reasonably long overlap with the gene of interest. The reverse 
primer contained the complementary overhang (underlined), one or more stop codons 
(in bold) if no C-terminal tag was used and a suitably long overlap with the reverse 
complement of the gene of interest. The PCR product was purified and treated (as 
above) with T4 DNA polymerase in the presence of 2.5 mM deoxyadenosine 
triphosphate.  
 
Table 2-2. List of constructs for protein expression in E. coli / M. smegmatis 
Protein 
(Gene, UniProt ID) 
Construct 
ID Residue range Vector backbone 
AccA3 (Rv 3285, P96890) M02# Full-length pETM-11 
 M03 Full-length pMyNT 
 M17 Full-length pCDF-13 
 M18 Full-length pCDF-11 
 M24 1 – 454 aa pETM-11/LIC 
 M25 1 – 471 aa pETM-11/LIC 
 M26 1 – 480 aa pETM-11/LIC 
AccD5 (Rv3280, P96885) M08 Full-length pETM-11/LIC 
 M15 Full-length pCDF-13 
 M16 Full-length pCDF-11 
 M32 Full-length pnEK 
AccD5-AccE5 (Rv3280-
81, P96885-P96886) M09 Full-length pMyNT 
AccE5 (Rv3281, P96886) M10 Full-length pETZ2-1a/LIC 
 M11 Full-length pETSUMO/LIC 
 M12 1 – 68 aa,  90 – 178 aa   pETSUMO/LIC 
 M19 Full-length pCDF-13 
 M20 Full-length pCDF-11 
 M13§ Full-length pKW08 (N-ter GFP) 
 M14§ Full-length pKW08 (C-ter GFP) 
AccD4 (Rv3799c, 
O53578) M06
# Full-length pETM-11 
 M21 Full-length pCDF-13 
 M22 Full-length pCDF-11 
 M33 Full-length pnEK 
AccD6 (Rv2247, P63407) M27* Full-length pET-28a 
 M34 Full-length pnEK 
#Prepared by Simon Holton. *Provided by collaborators at Lionex GmbH, Braunchsweig. §Provided by 
collaborators at Institute of Biochemistry and Biophysics, Polish Academy of Sciences, Warsaw. 
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2.2.2.2.2 Annealing of LIC vector and insert 
The treated vector and insert DNA were mixed in a molar stoichiometry of 1:3, added 
with 1 µl of 25 mM EDTA and incubated at room temperature for 5 min. The 
annealing mixture was used to transform E. coli DH5% competent cells and construct 
integrity was verified as explained in sections 2.2.2.1.3 and 2.2.2.1.4 respectively.   
 
2.2.3 Heterologous overexpression of proteins 
2.2.3.1 Large-scale expression of proteins in E. coli 
Optimal conditions (inducer concentration, post-induction incubation temperature and 
duration) for soluble overexpression of proteins in E. coli were identified by small-
scale expression trials and later used for large-scale expression. An overnight pre-
culture (grown from a single colony of cells/glycerol stock of cells bearing the 
expression construct) was used to inoculate large volumes (typically 500 or 750 ml in 
baffled 2-litre Erlenmeyer flasks) of Terrific Broth (TB#) [Appendix II] supplemented 
with appropriate antibiotic(s) to select for transformed cells of the relevant expression 
strain. The cultures were incubated at 37 °C, with shaking at 200 rpm, until an OD600 
of 0.8 to 1.0 was reached. The cultures were cooled down and protein expression was 
induced by the addition of IPTG to a suitable final concentration (typically 0.1, 0.25 
or 0.5 mM). The incubation was continued at 200 rpm and a lower temperature 
(typically between 18 °C and 30 °C) for another 12 to 16 hours. The cells were 
harvested by centrifugation at 5500 rpm for 30 min using an Avanti centrifuge J20-
XP (Beckman Coulter) and the cell pellets were stored at -20 °C until further use.  
 
2.2.3.2 Large-scale expression of proteins in M. smegmatis 
A saturated pre-culture (grown, for a couple of days, from a single colony of M. 
smegmatis groEL1!C cells bearing the expression construct) was used to inoculate 
large volumes (typically 500 ml in baffled 2-litre Erlenmeyer flasks) of 7H9 
expression medium [Appendix II] supplemented with 50 µg/ml hygromycin. The 
cultures were incubated at 37 °C, with shaking at 220 rpm, and cell growth was 
followed spectrophotometrically. The generation time for M. smegmatis is about 3 
hours. When an OD600 of approx. 3.0 was reached, protein expression was induced by 
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the addition of 4.55 ml of 220X acetamide solution [Appendix II] per litre of culture. 
The incubation was continued (at 37 °C, 220 rpm) for another 16 hours. The cells 
were harvested by centrifugation for 60 min at 6000 rpm using a JLA-81000 rotor in 
an Avanti centrifuge J20-XP (Beckman Coulter) and the pellets were stored at -20 °C 
until use. 
 
2.2.4 Purification of proteins 
Proteins were purified in two steps:  
(1) Immobilized metal-affinity chromatography (IMAC) is an effective, widely used 
method of protein purification (Porath, et al., 1975). It is based on the property of His 
and Cys side-chains of proteins to interact strongly with divalent transition metal 
cations. Recombinant proteins expressed in tandem with a stretch of His residues (a 
‘polyhistidine tag’) can be separated from the majority of non-tagged proteins in the 
supernatant of the cell lysate by adsorbance on a solid matrix embedded with divalent 
metal cations (e.g., Ni2+ or Co2+ immobilized with nitrolotriacetic acid [NTA] on 
agarose beads). The bound protein can be eluted competitively by application of high 
concentrations of imidazole, by protonation of the polyhistidine tag by pH-change, or 
by detachment of the bound cations from the solid phase using metal chelators like 
EDTA.  
 
(2) Size-exclusion chromatography (SEC) is a method of separation of molecules 
based on differences in their hydrodynamic volume (their “size”) (Porath & Flodin, 
1959). The material from which the protein of interest is to be purified is allowed to 
traverse a bed of porous beads (of particular dimensions) made of material such as 
cross-linked agarose or dextran, usually held in a vertical column. Separation of 
molecules is achieved owing to the fact that molecules of different sizes migrate 
differently through the column: large molecules enter the bead pores with low 
probability and as a result, elute out quickly; whereas smaller molecules can enter the 
bead pores with a higher probability and need to pass a larger volume before eluting 
from the column.  
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2.2.4.1 IMAC purification of polyhistidine-tagged proteins 
Cell pellets were freeze-thawed, resuspended in lysis buffer [Appendix III] (approx. 5 
ml per gram of cell pellet) and treated with DNaseI and protease inhibitor cocktail 
prepared according to the manufacturer’s instructions. The resuspended cells, being 
cooled on ice, were lysed by ultra-sonication. E. coli cells were sonicated by three 3-
min pulse cycles (0.5 sec on + 0.5 sec off), with 2-min pauses between cycles, in a 
Bandelin Sonopuls sonicator equipped with a VS 70T probe operating at 45% power. 
When M. smegmatis was used for protein production, the cell pellets were lysed by 
four 3-min pulse cycles (0.5 sec on + 0.5 sec off), with 2-min pauses between cycles, 
in a Bandelin Sonopuls sonicator equipped with a MS 73 probe operating at a 
maximum of 40% power. To avoid producing aerosols, lysis of M. smegmatis cell 
pellets was performed in closed vessels (50-ml tubes with a hole in the lid that just 
allows the sonicator probe). Cell debris was removed by centrifugation (19000 rpm, 4 
°C, 60 min) using an SS-34 rotor in an RC-26 Plus centrifuge (Sorvall). The soluble 
cellular fraction was passed through a 0.45-µm syringe filter and loaded onto Ni-NTA 
resin pre-equilibrated with binding buffer [Appendix III] in a polyprep 
chromatography tube. The resin was allowed to rock gently on a platform shaker for 
about an hour, to allow efficient binding of the polyhistidine-tagged recombinant 
protein to the Ni-NTA resin. The resin was then washed with several bed volumes of 
binding buffer and wash buffer(s) [Appendix III] to get rid of non-specifically bound 
contaminant proteins. His-tagged protein was eluted using elution buffer [Appendix 
III] containing high concentrations of imidazole. To facilitate conformational stability 
of proteins, purification protocols were carried out at 4ºC (cold room/cold cabinet) 
and proteins were handled carefully on ice.  
 
2.2.4.2 Size-exclusion chromatography 
Final purification, buffer exchange and assessment of the oligomeric status of 
affinity-purified proteins were done by size-exclusion chromatography. Proteins 
purified by affinity chromatography were concentrated and loaded on to a Superose™ 
6 10/300 GL or a HiLoad™ 16/60 Superdex™ 200 prep grade column, pre-
equilibrated with SEC buffer [Appendix III], using an ÄKTA purification system (GE 
Healthcare Life Sciences). Protein loading and elution were performed at constant 
flow rates; eluates were collected as equal-volume fractions in 18-mm collection 
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tubes or in 96-well deep well blocks. The oligomeric states of the proteins of interest 
were inferred by comparison with the elution volumes of gel filtration calibration 
standards run under similar conditions. Whenever required, affinity tags on the 
purified proteins were removed by treatment with TEV protease, an efficient enzyme 
that has a recognition site between the target protein and the affinity tag in the 
constructs used in this study. Typically, protein: TEV protease amount ratio of 50:1 
was used for the cleavage process (a few hours at room temperature or overnight at 4 
ºC). 
 
2.2.4.3 Evaluation of protein biochemical purity 
Electrophoresis is the most widely used technique for the separation and analysis of 
proteins based on their propensity to migrate in an electric field. The commonly used 
method of electrophoresis employs the anionic detergent SDS, which binds uniformly 
to most proteins, about one SDS molecule per two amino acid residues. SDS imparts 
a large net negative charge to the proteins, thereby masking the intrinsic charge of the 
proteins and rendering a similar charge-to-mass ratio to each protein. Additionally, 
binding of SDS and heating of samples prior to electrophoresis help in the 
denaturation of secondary and non–disulfide–linked tertiary structures of proteins and 
hence, most proteins assume a similar shape. Therefore, during SDS-PAGE proteins 
are separated almost exclusively on the basis of molecular weight, with heavier 
proteins migrating slower than lighter ones. The purity of samples is evaluated 
visually and the molecular weights of proteins are estimated by comparison to 
molecular weight standards electrophoresed on the same gel. 
 
In this study, protein samples were tested for purity by SDS-PAGE using the Mini-
Protean III Tetracel vertical protein electrophoresis system (Bio-Rad). Depending on 
the molecular weight of the protein(s) of interest, appropriate concentrations 
(typically 7.5%, 12% or 15%) of acrylamide were used in the preparation of the 
polyacrylamide gels [Appendix II]. Samples were mixed with SDS-PAGE sample 
buffer [Appendix II], heated at 75 ºC for 10 min and electrophoresed at constant 
voltage (180V – 200V). Gels were thoroughly washed with ddH2O to remove SDS, 
stained using the Coomassie blue safe stain [Appendix II] and destained using ddH2O.  
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2.2.4.4 Protein quantification and concentration 
Estimation of protein concentration was performed by measuring light absorption at 
280 nm using an ND-1000 NanoDrop spectrophotometer (PEQLAB), the underlying 
working principle of which is the Beer-Lambert law (Beer, 1852). The Beer-Lambert 
law explains the relationship of protein molar concentration (c, mol.l-1) with the path 
length of light (d, cm), the absorption (A) and the molar extinction coefficient (", 
L.mol-1.cm-1) of the protein. The extinction coefficient (") of the protein is the sum 
total of the extinction coefficients of the absorbing species (Tyr, Trp, disulphides) 
multiplied by their respective number per molecule of the protein.  
 
     c = A / (" . d) 
  where, " = (nTyr . 1280) + (nTrp . 5690) + (ndisulphide . 120) 
 
In this study, proteins were concentrated as required, by centrifugation (at 4000 rpm) 
using centrifugal ultrafiltration tubes of suitable volume (0.5 ml, 6 ml or 20 ml) and 
molecular weight cut-off (10 kDa or 30 kDa) in a refrigerated 5415R or 5810R bench-
top centrifuge (Eppendorf).  
 
2.2.4.5 Verification of protein identity 
Mass spectrometry is a sensitive analytical technique that helps determine the masses 
of molecules by measuring the mass-to-charge (m/z) ratios of the corresponding ions 
(Fenn, et al., 1989). In a typical mass spectrometry experiment, the sample is ionized 
by the effect of an impact of an electron beam or a vaporized ionic solution. These 
ionized particles are sorted by mass in a mass analyzer chamber that supports an 
isotropic electromagnetic field. The sorted ions are monitored by a detector that 
allows the calculation of the intensities of each ‘mass-by-charge’ species present in 
the sample. A useful application of mass spectrometry in protein science is peptide 
finger printing wherein the protein sample, whose identity has to be 
established/verified, is subjected to specific proteolytic cleavage and the resulting 
peptides are analysed by electrospray ionization time-of-flight or matrix-assisted laser 
desorption/ionization time-of-flight (MALDI-TOF) (Pappin, et al., 1993). The 
experimental peptide peak list is then computationally compared with a theoretically 
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generated list of peptides corresponding to protein sequences from a standard 
database (e.g., UniProt); with the help of specialized software, the results of the 
comparison are analysed statistically to arrive at candidate proteins.  
 
Analytical characterisation of molecular weights of purified protein samples in this 
study was done using a Voyager DE-STR MALDI-TOF mass spectrometer (Applied 
Biosystems) at the in-house Sample Preparation and Characterisation (SPC) facility. 
For a MALDI-TOF experiment, protein sample at a concentration of around 1 mg/ml 
in a low-salt buffer (<50 mM salt) was mixed with matrix solution (50% acetonitrile, 
0.1% trifluoroacetic acid, sinapinic acid to saturation) at a ratio of 1:2, 2:1 or 1:1 and 
spotted onto sample plates. The measurement was done after the samples dried out. 
Confirmation of protein identity by peptide mass fingerprinting was done by the 
Proteomics Core Facility at EMBL, Heidelberg. 
 
2.2.5 Reconstitution of protein complexes 
Attempts to reconstitute YCC complexes for crystallography and kinetic studies, were 
made using the following methods: 
 
2.2.5.1 In vitro reconstitution by purification and co-elution 
One of the presumably simplest and most common ways to assemble a protein 
complex in vitro is to purify the constituent proteins individually and to incubate them 
together in appropriate stoichiometric ratios. It has been known that many YCCs exist 
as dodecameric complexes possessing 1:1 molecular stoichiometry with regard to the 
numbers of %- and !-subunit protomers (Haase, et al., 1982, Kimura, et al., 1998, 
Diacovich, et al., 2002, Gago, et al., 2006). Individual components of M. tuberculosis 
YCCs (AccA3 and AccD5 / AccA3 and AccD4) were purified to homogeneity, mixed 
together at equimolar concentrations and incubated overnight at 4ºC to facilitate the 
formation of protein complexes. Formation of a high molecular weight YCC complex 
was verified by subjecting each protein mixture to analytical chromatography on 
Superose™ 6 10/300 GL. 
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2.2.5.2 In vivo reconstitution by co-expression 
Heterologous expression of components of a complex in the same host cell is another 
useful strategy to obtain the holocomplex in a form suitable for structural and/or 
functional characterisation. E. coli is the expression system of choice for co-
expression trials as it has advantages like the possibility of obtaining large quantities 
of protein, the absence of certain post-translational modifications that might hinder 
crystallisation and the availability of well-established high-throughput platforms that 
enable parallel testing of multiple constructs, strains and culture conditions (Berrow, 
et al., 2006, Tolia & Joshua-Tor, 2006, Perrakis & Romier, 2008, Bieniossek, et al., 
2009). Co-expression can also provide means of facilitating proper folding of the 
interacting protein partners, thereby overcoming folding and solubility problems, if 
any, associated with individually expressed proteins (Li, et al., 1997, Romier, et al., 
2006). Co-expression can be achieved using either single or multiple constructs; when 
more than one expression construct is co-transformed into a single host cell, the 
vectors generally harbor different antibiotic resistance selection markers (Perrakis & 
Romier, 2008, Zeng, et al., 2010) and compatible origins of replication (Johnston, et 
al., 2000, Perrakis & Romier, 2008). When a single plasmid is used for co-expression, 
it can be either monocistronic (a separate promoter for each gene that is transcribed in 
a distinct mRNA) or polycistronic (a common promoter for multiple genes that are 
transcribed in the same mRNA). In the present study, a series of constructs for single 
protein expression of binary complexes were created using pET- and pCDF-based 
vectors [Figure 2-1], which harbor different resistance markers (kanamycin and 
spectinomycin) and compatible origins of replication (Busso, et al., 2011).  
 
 
 
Figure 2-1. Representation of vector backbones used in co-expression constructs. 
Ori, origin of replication; pT7-lacOp, T7 promoter-lac operator system; 6-His, region coding 
for the hexahistidine affinity tag; KanR, kanamycin resistance gene; SpecR, spectinomycin 
resistance gene. 
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The constructs were used to co-transform expression strains of E. coli as described in 
section 2.2.2.1.3.1. Following primary growth, overexpression of the two proteins was 
induced by the addition of IPTG; as one of the interacting partners was expressed 
with a polyhistidine tag, the potential binary complex assembled in vivo was purified 
by IMAC followed by SEC, as explained earlier.  
 
2.2.6 Kinetic characterisation 
Complementary to structural studies on enzymes, it is usually of scientific interest to 
examine if the in vitro catalytic activity of the material under study is intact. Some of 
the enzyme complexes reconstituted in this study were tested for their enzymatic 
activity by standard assays. 
2.2.6.1 Michaelis-Menten kinetics 
It is often assumed that biochemical reactions involving a single substrate follow, 
irrespective of conformity to the underlying assumptions, Michaelis-Menten kinetics, 
probably the simplest and most popular model of enzyme kinetics. The Michaelis-
Menten equation of enzyme kinetics is an algebraic expression of the relationship 
between substrate concentration and the velocity of the enzymatic reaction; it is based 
on the hypothesis that the rate-limiting step in enzymatic reactions is the breakdown 
of the enzyme-substrate complex to product and free enzyme and on the Briggs-
Haldane steady state approximation (Michaelis, et al., 2011). The Michaelis-Menten 
equation, the kinetic rate equation for a one-substrate enzymatic reaction is as 
follows:  
V0 = (Vmax [S]) / (Km + [S]) 
where, V0 and Vmax are the initial and the maximum velocity of the enzymatic 
reaction respectively, [S] is the substrate concentration and Km is the Michaelis 
constant, the substrate concentration at which V0 equals half of Vmax. 
 
2.2.6.2 Assay for carboxylase activity 
Carboxylase activity of YCC enzyme complexes (AccA3-AccD5 / AccA3-AccD4) 
was estimated by a coupled enzyme assay that follows the rate of ATP hydrolysis 
spectrophotometrically (Diacovich, et al., 2002).  
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Figure 2-2. Schematic of the coupled enzyme reaction used to measure 
carboxylase activity. YCC (also denoted as ACCase) activity can be assayed by 
spectrophotometrically monitoring the oxidation of NADH, coupled to the consumption of 
ATP. 
 
In the presence of bicarbonate and ATP, the YCC enzyme carboxylated the substrate 
acyl-CoA to produce carboxy acyl-CoA. The production of ADP during the reaction 
was coupled to pyruvate kinase and lactate dehydrogenase, and the oxidation of 
NADH was probed at 340 nm. The optimal enzyme concentration to be used in the 
assay for the establishment of kinetic parameters was determined by preliminary trial 
experiments. The assay mixture contained 7 units of pyruvate kinase, 10 units of 
lactate dehydrogenase, 50 mM NaHCO3, 3 mM ATP, 0.5 mM phosphoenol pyruvate, 
0.2 mM NADH, 0.3 mg/ml BSA, 100 mM K2HPO4 pH 7.6 and 5 mM MgCl2 and 
varying concentrations of substrate. Reactions were initiated by the addition of YCC 
enzyme to the assay mixture and were maintained at 30 °C. Data were acquired using 
a monochromator-based multimode microplate reader (Infinite® M1000 PRO, Tecan). 
The kinetic parameters Km and Vmax were determined by fitting the mean velocities 
versus the substrate concentration to the Michaelis-Menten equation of enzyme 
kinetics using nonlinear regression analysis, executed by the program Prism 5 
(GraphPad Software(). 
 
2.2.7 Biophysical characterisation 
2.2.7.1 Static light scattering 
The phenomenon of static light scattering (SLS) is very useful in the accurate 
experimental determination of the absolute molecular mass of a protein sample in 
solution through exposure of the sample to low intensity laser light (690 nm) (Debye, 
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1947). During an SLS experiment, the intensity of the light scattered by the sample is 
recorded as a function of angle. The molar mass, root mean square radius, and second 
virial coefficient (A2) may be calculated from the measured scattering intensities. 
SLS, in principle, eliminates ambiguities in molecular weight determination using 
SEC elution volumes arising from unusual shapes of analyte molecules. In this study, 
SLS measurements were made in the chromatography mode using a miniDAWN 
Tristar SLS detector (Wyatt Technology) designed to collect scattering data from 
three different angles, placed in the flow path of the Äkta Purifier and pre-
equilibriated with the corresponding SEC buffer. Data analysis was performed using 
the software ASTRA version 5.3.4.11 as per manufacturer instructions.  
 
2.2.7.2 Thermofluor 
Thermofluor is a fluorescence!based thermal stability assay that monitors the effects 
of buffer conditions on temperature!dependent protein unfolding (Pantoliano, et al., 
2001). It presents a valuable method to study protein behaviour (solubility, stability 
and conformational homogeneity) as a function of the chemical environment (pH, salt 
nature and concentration, presence of additives, etc.) and hence to identify 
condition(s) amenable to crystallisation (Ericsson, et al., 2006). Protein was added to 
96 different conditions of a sample stabilization screen (prepared by the in-house SPC 
facility) in a PCR plate; each well contained the following components: 16 µl ddH2O 
+ salt (of varying concentration), 5 µl buffer (of varying chemical nature and 
concentration), 2 µl diluted SYPRO® orange dye (Invitrogen), 2 µl protein sample (20 
– 100 µM). Thermal denaturation analysis was performed in an ICycler thermal 
cycler with a MyIQ optical module (Bio-Rad) using a gradient of 1 °C/min from 5 °C 
to 95 °C. Data was analysed using Prism 5 (GraphPad Software(). 
 
2.2.7.3 Circular dichroism spectroscopy 
Circular dichroism (CD) spectroscopy is a spectroscopic technique wherein the CD 
(i.e., the difference in the absorption of left-handed and right-handed circularly 
polarized light) of chiral molecules measured over a range of wavelengths is used to 
draw inferences on the physiochemical properties of these molecules. CD 
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measurements made in the far-UV range provide information on the secondary 
structure or conformation of proteins and are therefore useful in structural, kinetic and 
thermodynamic studies (Greenfield, 2007). For the assessment of secondary structure 
content by this method, proteins were dialyzed overnight against 20 mM sodium 
phosphate buffer (pH 7.5 or 8.0) and then diluted in the same buffer to final 
concentrations of 0.1 – 0.5 mg/ml. CD spectra between 180 and 260 nm wavelength 
were recorded in 0.5 nm steps on a Chirascan CD spectrometer (Applied 
Photophysics) at room temperature in a quartz cuvette of 0.1 cm path length; raw data 
were converted to molar ellipticity (deg cm2 dmol-1). 
 
2.2.8 Protein crystallisation 
Obtaining crystals of diffraction-quality is often a major bottleneck for 
macromolecular X-ray crystallography, because crystallisation is a complex process 
that involves multiple parameters. Protein crystals can be grown from highly 
concentrated solutions of pure proteins by various methods aimed at forcing the 
protein to a certain level of supersaturation by the controlled addition of precipitants 
or/and changes in ionic strength, protein concentration, etc. 
 
2.2.8.1 Principles 
2.2.8.1.1 The protein crystallisation phase diagram 
The process of crystallisation proceeds in two distinct phases that require different 
conditions: nucleation and growth (Ataka & Asai, 1990, Chayen, 2005). Upon the 
formation of a critical nucleus, spontaneous growth of the crystal follows, provided 
the existence of an amenable environment. As crystallisation involves phase 
transition, it can be illustrated by a phase diagram that shows which state of the 
protein (liquid, crystalline or amorphous precipitate) is stable under a given set of 
crystallisation parameters. A typical phase diagram is produced experimentally by 
testing two parameters at a time, thus representing a two-dimensional slab of the 
multiparametric space of the phenomenon of crystallisation.  
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Figure 2-3. The protein crystallisation phase diagram. The solubility curve 
demarcates conditions that favour spontaneous nucleation (or phase separation or 
precipitation or crystal growth) from those under which the protein remains completely 
soluble. Each of the major crystallisation methods [(i) microbatch (ii) vapour diffusion (iii) 
dialysis (iv) free interface diffusion (FID)] adopts a different route to reach the nucleation 
zone (dashed lines) and the metastable zone (solid arrows). The starting conditions are 
represented by the filled circles. (Reprinted by permission from Macmillan Publishers Ltd: 
(Chayen & Saridakis, 2008)). 
 
A phase diagram consists of four areas: (1) the undersaturation zone, where the 
protein is completely soluble and does not crystallize; (2) the nucleation zone, an area 
of moderate supersaturation where spontaneous formation of crystal nuclei takes 
place; (3) the metastable zone, an area of low supersaturation best suited for well-
ordered crystal growth and stability, but unsuitable for further nucleation; (4) the 
precipitation zone, an area of high supersaturation where the protein precipitates, 
mostly irreversibly (Ataka & Asai, 1990, Chayen, et al., 1996). Phase diagrams 
clearly represent the physical chemistry operating behind crystallisation and are hence 
useful in the design and fine-tuning of crystallisation experiments.  
 
2.2.8.1.2 Protein crystallisation methods 
There are several procedures and devices to cause supersaturation in a protein 
solution, generally by the gradual increase in the concentration of a precipitant such 
as polyethylene glycol (PEG) or salt. In addition to the most common methods 
(microbatch, vapour diffusion, dialysis and free interface diffusion), other methods 
available for attaining a solubility minimum are bulk crystallisation, evaporation, 
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liquid bridge, sequential extraction, pH-induced crystallisation, temperature-induced 
crystallisation and effector addition (McPherson, 1999).  
 
(i) In microbatch experiments, crystallisation trials are maintained under low-density 
paraffin oil, which protects the drops from evaporation, contamination and 
mechanical shock (Chayen, et al., 1990). As samples are set at their final 
concentration right at the start of experiment, unlike in diffusion-based methods, the 
conditions are constant within a normal duration of microbatch crystallisation 
experiment. This method is unsuitable only for crystallisation trials involving small 
volatile organic molecules that dissolve into oil.  
 
(ii) In the most widely used vapour diffusion method, the protein solution is 
maintained as either a sitting or hanging drop that equilibrates against a reservoir of 
mother liquor containing crystallisation agents at known initial concentrations. As 
equilibration between the drop and the reservoir proceeds, conditions keep varying 
and the crystallisation parameter space is sampled. Besides transportation problems, 
this method has a few disadvantages like changes in pH due to volatile ions, and 
indeterminable and uncontrolled changes in drop volume and composition during the 
course of the experiment. 
 
(iii) The dialysis method of crystallisation involves the separation of the protein from 
the crystallisation agent by a semi permeable membrane that selectively allows the 
precipitant molecules to gradually mix with the protein molecules. 
 
(iv) In the FID technique, the protein solution and the precipitant are placed side-by-
side; owing to slow diffusion of one solution into the other, a concentration gradient 
that varies with time is created. The system self-selects the optimal supersaturation 
levels for crystal nucleation and growth. This technique is generally useful as a fine-
tuning strategy rather than an initial screening method (McPherson, 1999). 
 
Each of the above-mentioned methods of crystallisation adopts a different 
mechanistic route to attain the desired level of supersaturation; these routes have been 
indicated by arrows in Figure 2-3. In this study, the vapour diffusion method of 
crystallisation was exclusively used.  
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2.2.8.2 Screening and optimization 
The appropriate concentration of proteins, an important variable for crystallisation 
experiments, was identified using a pre-crystallisation test (PCT, Hampton Research) 
performed in hanging-drop format (1 µl protein + 1 µl PCT solution). Initial screening 
for crystallisation conditions by the sitting-drop vapour diffusion method was 
performed at the high-throughput crystallisation facility at the EMBL Hamburg 
(Mueller-Dieckmann, 2006). Commercially available crystallisation screens (such as 
Classic I and II from Qiagen and JBScreen Classic from Jena Bioscience) were used 
in these experiments. Drops of volume 400 – 600 nl were set, maintained at constant 
temperature (20 °C) and monitored periodically. Conditions that yielded crystalline 
hits were optimized manually by the hanging-drop vapour diffusion method. 
Optimisation experiments involved the variation of parameters like composition of 
the mother liquor (concentration of precipitant, pH, additives), crystallisation 
temperature (20 °C/ 4 °C) and drop volume. Crystallisation protocols of individual 
proteins are described in detail in the results and discussion chapter.  
 
2.2.8.3 Reductive methylation 
Reductive methylation of free amino groups, especially of residues found on the 
surface, has been shown to promote crystallisation of proteins presumably by means 
of immobilization of flexible side chains (Walter, et al., 2006, Kim, et al., 2008). It 
has also been demonstrated that methylation of proteins neither affects their 
biochemical function nor causes significant conformational changes (Rypniewski, et 
al., 1993, Kobayashi, et al., 1999). In an attempt to improve its crystallisability, the 
protein AccD4 was methylated by an adaptation of a standard reductive methylation 
protocol. Briefly, 1 mg of pure protein was dialyzed overnight against a buffer free of 
amino groups or alcohols [Appendix III]. The protein was then added with 20 µl of 
1M dimethylamine-borane complex (ABC) and 40 µl of 1M formaldehyde and the 
reaction mixture was incubated with gentle shaking at 4 °C for 2 h. The above step 
was repeated and the incubation was continued for two hours at 4 °C. The mixture 
was left overnight at 4 °C after the addition of a final aliquot of 10 µl ABC. The 
methylated protein was concentrated and analyzed by SEC using a Tris-based gel 
filtration buffer [Appendix III] that helps quench the methylation reaction while 
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washing out the excessive reagents. The methylated protein was used in 
crystallisation screens after its homogeneity was verified by MALDI-TOF.  
 
2.2.9 X-ray crystallography 
X-ray crystallography, the most powerful means for macromolecular three-
dimensional structure determination, was used for the structural characterisation of 
proteins in this study. The contribution of X-ray crystallography to the field of 
structural biology has been enormous because, as a technique, it is not restricted by 
molecular size limitations (unlike NMR); it enables structural elucidation at a very 
high resolution (unlike cryo-electron microscopy) with only minor destructive effects 
on the integrity of the crystalline sample (unlike electron crystallography). As a 
detailed illustration of the theory behind the tool is beyond the scope of the thesis, a 
limited general explanation (Wlodawer, et al., 2008) of diffraction concepts and of the 
phasing method (molecular replacement) used in the study will be provided in the 
following sections. 
  
2.2.9.1 Theory 
2.2.9.1.1 Diffraction by crystals 
Scattering of X-rays by electrons in the molecules of the investigated sample forms 
the basis of structural crystallography. The symmetric, periodic arrangement of 
molecules in unit cells throughout the entire volume of a crystal allows the crystal to 
act as a three-dimensional diffraction grating that results in enhanced scattering of X-
rays in some directions and annihilated scattering in others. The fate of the scattering 
is determined by the geometry and content of the unit cell of the crystal and by the 
wavelength of the incident radiation. The geometrical conditions that give rise to 
phase agreement in the scattered radiation and hence to constructive interference can 
be described by Bragg’s law (Bragg, 1913): 
 
2dhkl sin)  = n*  
where, dhkl is the interplanar spacing in a lattice, ) is the glancing angle of the 
electromagnetic wave, * is the wavelength of the electromagnetic wave and n is a 
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whole number. The implication from Bragg’s law, that every order of diffraction can 
be considered as reflection in a set of lattice planes (denoted by the reciprocal indices 
hkl), is a central theme of X-ray crystallography.  
 
The characteristics of a wave (i.e., its amplitude and phase) diffracted from a set of 
crystal lattice planes (whose Miller indices are h, k, l) can be described by a 
mathematical function known as the structure factor F(hkl): 
 
F(hkl) = |F(hkl)| exp (i%hkl) = + j fj exp [2,i (hxj + kyj + lzj)] 
where, i is the imaginary number --1, "hkl is the phase of the diffracted wave, fj is the 
scattering factor of the jth atom whose positional coordinates are xj, yj, zj, and the 
summation is over all atoms of the unit cell. The electron density ., the probability of 
existence of an electron at a specific location in three-dimensional space, can be 
obtained by the inverse Fourier transform of the above structure factor equation.  
 
.(xyz) =  V-1 + hkl |F(hkl)| exp (-2, i (hx +  ky +  lz) +  i %hkl) 
where, V is the volume of the unit cell. A diffraction experiment facilitates the 
measurement of only the volume of the unit cell and the reflection intensities I(hkl). 
These measured reflection intensities can be used in the calculation of the structure 
factor amplitudes |F(hkl)|, while also taking into account the absorption correction 
factor and the radiation source-dependent combined geometry and polarization factor. 
However, the phase information of the reflections is missed out during the 
experiment, thereby resulting in a complication known as the crystallographic ‘phase 
problem’ in the calculation of electron density. 
 
The phase problem can be solved by mathematical strategies (molecular replacement, 
difference Fourier synthesis, or direct methods) or by various experimental 
approaches (isomorphous replacement, anomalous dispersion, or their combinations); 
several combinatorial techniques (that utilize a mathematical strategy in addition to an 
experimental approach) have also been developed. Among these, molecular 
replacement was exclusively used as the phase determination method in this study. 
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2.2.9.1.2 Phase determination by molecular replacement 
Molecular replacement (MR) is conceptually the simplest method of phase 
determination. If the target protein shares considerably high sequence homology (at 
least 25% sequence identity) with a protein (probe) of known three-dimensional 
structure, starting phases can normally be derived by computationally placing the 
probe molecule in the correct orientation and position in the unit cell of the target 
protein and calculating its theoretical diffraction pattern using the electron density 
equation. The probe molecule is then oriented and moved until the experimental 
patterns match the theoretical ones. Positioning of the molecule in three-dimensional 
space requires a six-dimensional search with three variables each for rotational and 
translational searches. As six-dimensional searches (three rotation angles and three 
translations) are computationally expensive, the process is normally broken up into 
two segments: a rotation search followed by a translation search.  
 
The most common strategy of searching uses Patterson functions (Patterson, 1935). 
Patterson peaks, the interatomic distance vectors calculated from the target (P’) and 
probe (P) molecules are superimposed in order to identify overlaps. This operation 
can be described by the following equation: 
 
P’ = P[R] + T 
where, [R] is a matrix describing the rotational parameters that bring the probe 
molecule into maximum coincidence with the target, and T is the translation vector 
that maximizes the overlap. 
 
2.2.9.1.2.1 Patterson rotation function 
Three rotational parameters are used to score the agreement between two Patterson 
functions as they are rotated with respect to each other. Only the Patterson function 
relatively close to the origin is considered, in order to enrich for intramolecular 
vectors and to reduce the contribution from the intermolecular counterparts. During 
the rotational search, the model has to be placed in a ‘box’ of appropriate dimensions 
so that all intermolecular vectors are outside the search volume; the box size must be 
at least the largest molecular radius plus the search sphere radius. The match can be 
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evaluated as a correlation coefficient or product function (RF) in Patterson space, or 
as the equivalent to the Patterson product function in reciprocal space.  
 
 
RF is the product of the observed crystal Patterson Pobserved(u) and the rotated model 
Patterson Pmodel(R, u) integrated over all points (u) in Patterson space within a sphere 
of radius rmax centered on the origin and omitting the origin peak out to a radius rmin. 
When a crystal has rotational symmetry operators (i.e., belongs to a space group other 
than the triclinic P1 that lacks symmetry), the search function respects the fact that the 
corresponding Patterson also has ‘cross-vectors’ between atoms belonging to different 
molecules related by symmetry. The variables of the rotation matrix are three angles 
designated by either of two alternative geometrical systems: Eulerian angles and Polar 
angles. 
 
2.2.9.1.2.2 Patterson translation function 
Once the optimal orientation of the model is deduced from the rotation search, the 
model structure factors can be calculated for every possible shift vector ‘t’. The 
translational search function then probes for correlation between the experimentally 
measured intensities and the Patterson cross-vectors of the symmetry-related 
molecules of the probe as it is moved within the cell. When the probe is optimally 
placed, the translation function has peaks at values corresponding to the translation 
vectors between the symmetry related molecules. The Patterson translation function 
for a translation T is defined as the product of the observed and model Pattersons, 
integrated over the whole cell, 
 
 
 
where, Pobserved(u) is the crystal Patterson at point u, Pmodel(u, t) is the model Patterson 
shifted by the search vector ‘t’ and the Pjj terms are the calculated self-vectors. 
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2.2.9.2 Data collection 
X-ray diffraction data corresponding to crystals of the potential AccA3-AccD5 
complex and of AccD6 were collected at synchrotron radiation microfocus beamlines 
at the ESRF (Grenoble, France) and PETRA III, EMBL-DESY (Hamburg, Germany) 
respectively [Table 2-3].  
 
Table 2-3. Beamlines used for diffraction experiments 
Synchrotron Beamline Energy Wavelength Detector 
ESRF ID23-2 14.2 keV 0.8726 Å MarMOSAIC 225 
PETRA III P14 10 keV 1.2395 Å PILATUS 6M 
 
For data collection, the crystal was carefully harvested from the crystallisation drop, 
treated with a suitable cryoprotectant (mother liquor mixed with 10-15% (v/v) 
glycerol), mounted on a nylon crystal loop (Hampton Research) and flash-cooled 
either in liquid nitrogen (for transportation to the ESRF) or directly in the cryo-stream 
at the beamline (diffraction experiment at PETRA III, EMBL-DESY). The main 
purpose of flash-cooling (Haas & Rossmann, 1970) is to overcome the problem of 
radiation damage to the sample by avoiding ice formation that is bound to happen in 
slower cooling methods. The mounted crystal was exposed to X-rays after appropriate 
alignment using the option of ‘three-click centering’. All diffraction experiments were 
performed at a temperature of 100 K using the single axis rotation method.  
 
2.2.9.3 Structure solution and refinement 
On the basis of diffraction spots from a few initial images, the crystal was indexed 
using the program iMOSFLM (Battye, et al., 2011) and an appropriate data collection 
strategy was identified using BEST (Bourenkov & Popov, 2010). The programs XDS 
(Kabsch, 2010) / iMOSFLM (Battye, et al., 2011) and POINTLESS (Collaborative 
Computational Project, 1994) were used in the integration of the diffraction data and 
in the determination of the Laue and space group of the crystal respectively. The 
integrated data were scaled and merged using SCALA (Evans, 2006). Using the scaled 
and merged intensities (in MTZ format) and the molecular weight of a monomer 
calculated from the protein sequence/number of residues, the Matthews coefficient 
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was calculated in order to estimate the number of molecules in the asymmetric unit 
(Collaborative Computational Project, 1994).  
 
Initial phases for the structures were determined by MR using Phaser (McCoy, et al., 
2007) that performs maximum likelihood molecular replacement. The initial models 
were improved by alternative cycles of manual model building with COOT (Emsley 
& Cowtan, 2004) and maximum-likelihood refinement using REFMAC5 (Murshudov, 
et al., 1997). During restrained refinement, non-crystallographic symmetry (NCS) 
restraints were applied and in the later stages of refinement, TLS parameters were 
also employed. The progress of refinement was monitored using Rfree (estimated using 
5% of reflections set aside) and validation tools in COOT (Emsley & Cowtan, 2004, 
Emsley, et al., 2010). The stereochemical qualities of the structural models were 
verified using the program PROCHECK (Laskowski, et al., 1993) integrated in the 
CCP4 suite. Structural analysis and graphical visualization were performed using 
PyMOL (The PyMOL Molecular Graphics System, Version 1.5.0.3 Schrödinger, 
LLC).  
 
2.2.10 Small angle X-ray scattering 
Small angle X-ray scattering is a structural biology method, which, unlike X-ray 
crystallography, is not restricted to elucidating low energy conformations of 
macromolecules within lattice planes of crystals. Although the resolution range of 
SAXS data is low (about 50 Å to 10 Å), it provides complementary information about 
overall molecular shape, conformation, folding, unfolding and aggregation. A key 
merit of SAXS is that it neither requires highly ordered crystalline sample nor is 
associated with size limitations like those inherent in electron microscopy and NMR 
studies. 
 
In this study, synchrotron radiation small angle X-ray scattering data were collected at 
the X33 beamline of EMBL/DESY (Roessle, et al., 2007) using a PILATUS 1M pixel 
detector at a sample-detector distance of 2.7 m and a wavelength of * = 1.5 Å; the 
range of momentum transfer 0.01 < s < 0.6 Å-1 was covered (s = 4$ sin%/&, where 2% 
is the scattering angle). For each sample, several solute concentrations in the range 
16.1 to 0.7 mg/ml were measured. To monitor for possible radiation damage, eight 
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successive 15-second exposures of protein solutions were compared and no 
significant changes were observed. The data were normalized to the intensity of the 
transmitted beam and radially averaged; the scattering of the buffer was subtracted 
and the difference curves were scaled for protein concentration. The low angle data 
measured at lower protein concentrations were extrapolated to infinite dilution and 
merged with the higher concentration data to yield the final composite scattering 
curves. The data processing steps were performed using the program package 
PRIMUS (Konarev, et al., 2003).  
 
The forward scattering I(0) and the radius of gyration Rg were evaluated using the 
Guinier approximation (Guinier, 1939) assuming that at very small angles (s < 1.3/Rg) 
the intensity is represented as I(s) = I(0) exp (-(sRg)2/3). These parameters were also 
computed from the entire scattering patterns using the indirect transform package 
GNOM (Svergun, 1992), providing also the pair distribution function of the particle 
p(r) and the maximum size Dmax. The molecular mass (MM) of the solute was 
evaluated by comparison of the forward scattering with that from reference solution 
of bovine serum albumin (MM = 66 kDa). The excluded volume of the hydrated 
particle was computed from the small angle portion of the data (s < 0.25 Å-1) using 
the equation (Porod, 1982): 
 
Prior to this analysis, an appropriate constant was subtracted from each data point to 
force the s-4 decay of the intensity at higher angles following the Porod's law (Porod, 
1982) for homogeneous particles. For globular proteins, Porod (i.e. hydrated) volumes 
in nm3 are about 1.7 times the MMs in kDa (Petoukhov & Svergun, 2013). 
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3 Results and Discussion 
3.1 Characterisation of components of the propionyl-CoA 
carboxylase (PCC) of Mycobacterium tuberculosis 
 
There have been extensive efforts towards understanding the mechanisms and 
regulation of lipid biosynthesis in M. tuberculosis; however, the enzymes that 
catalyze the formation of the building units of these complex biomolecules have not 
been completely characterised. One of the most important building/extender units is 
methylmalonyl-CoA, which is employed by key biosynthetic enzymes such as 
mycoseric acid synthases (Mathur & Kolattukudy, 1992) and multifunctional 
polyketide synthases (Sirakova, et al., 2001, Gande, et al., 2004) for the iterative 
extension of complex acyl chains. The common products of these enzymes are 
surface-exposed lipids like mycosides and phthiocerols that are unique to pathogenic 
species of mycobacteria and have been shown to play important roles in cell wall 
structure and permeability (Camacho, et al., 2001), virulence and host-pathogen 
interactions (Cox, et al., 1999, Sirakova, et al., 2003). Methylmalonyl-CoA is 
generally produced in the cell either by the methylmalonyl-CoA mutase-driven 
isomerization of succinyl-CoA (Hunaiti & Kolattukudy, 1984) or by the propionyl-
CoA carboxylase-driven carboxylation of propionyl-CoA. The M. tuberculosis 
genome harbors two genes coding for the putative methylmalonyl-CoA mutase 
subunits (Cole, et al., 1998) that are known to be non-essential for mycobacterial 
survival (Sassetti, et al., 2003) although the physiological relevance is not precisely 
known. On the other hand, at least one component of the relatively better-studied 
propionyl-CoA carboxylase (that catalyses the carboxylation of propionyl-CoA to 
methylmalonyl-CoA) is known to be essential for mycobacterial survival (Sassetti, et 
al., 2003). Therefore, PCC is responsible for probably the only available route used 
by M. tuberculosis for the generation of the building blocks of certain essential lipids. 
Surprisingly, a comprehensive understanding of the structural and functional 
properties of this key enzyme is lacking to date.  
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Sub-chapter 3.1 describes the characterisation of AccA3, AccD5 and AccE5 – the 
component subunits of M. tuberculosis propionyl-CoA carboxylase. Various 
strategies tested for the in vitro assembly of the AccA3-AccD5 complex, kinetic 
characterisation, crystallisation experiments, and efforts towards the biophysical 
characterisation of AccE5 are elucidated. 
 
3.1.1 Results 
3.1.1.1 AccA3 and AccD5: formation of a binary complex 
Full-length versions of M. tuberculosis AccA3 and AccD5 proteins could be 
individually overexpressed in moderate amounts (AccA3: 1 – 2 mg per litre of 
culture; AccD5: 2 – 5 mg per litre of culture) in M. smegmatis groEL1!C by 
acetamide-based induction using constructs M03 and M09 respectively [Table 2-2]. 
However, no overexpression of AccE5 could be observed with construct M09, as 
verified by SDS-PAGE and MALDI-TOF. Profiles from SEC experiments indicated 
the existence of AccD5 as a stable hexamer in solution. The %-subunit AccA3, on the 
other hand, eluted as a mixture of oligomers, with trimers possibly being the 
predominantly present species; significant amounts of AccA3 protein were also lost as 
very high-molecular weight aggregates in the void volume during SEC trials with 
Superose™ 6 10/300 GL. 
 
Figure 3-1. Purification of the AccA3-AccD5 complex. SEC elution profiles of 
AccA3, AccD5 and the AccA3-AccD5 complex. Molecular weight standards used and 
respective elution volumes (ml) in brackets: 670 kDa (12.1), 158 kDa (15.5). Inset: Peak 
analysis of (1) AccD5 hexamer, (2) AccA3 trimer and (3) AccA3-AccD5 complex by SDS-
PAGE (12%); lane M: protein marker with standard molecular weights (in kDa). 
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The polyhistidine affinity tag at the N-terminal of AccD5 was cleaved by TEV 
protease treatment. Untagged AccD5 could be pulled down by polyhistidine-tagged 
AccA3 immobilised on Ni-NTA resin, indicating a direct physical interaction between 
the two proteins. Hexameric AccD5 and trimeric AccA3, upon mixing in an 
equimolar ratio, form a high-molecular weight binary complex, as observed by SEC 
[Figure 3-1]. Comparison with molecular weight standards showed that this complex 
is a dodecamer (six monomers each of AccA3 and AccD5) with a total molecular 
weight of approximately 700 kDa.  
 
3.1.1.2 AccA3-AccD5 is an active carboxylase 
The AccA3-AccD5 complex reconstituted in vitro was found to be a catalytically 
active carboxylase based on a spectrophotometric assay that utilizes a coupled 
enzyme reaction and monitors ATP hydrolysis at 340 nm. Preliminary trials identified 
an optimal enzyme concentration of 0.06 mg/ml (i.e., 0.5 µM) for the determination 
of kinetic parameters of the carboxylase reaction of AccA3-AccD5 on the known 
substrate, propionyl-CoA. The Michaelis-Menten kinetic parameters for the 
carboxylase reaction were calculated as: Vmax = 1.33 ± 0.05 mM min-1 mg-1 and KM = 
0.13 ± 0.019 mM. The high efficiency of propionyl-CoA carboxylation of AccA3-
AccD5 was evidenced by the turnover number kcat = 0.045 s-1, calculated based on the 
assumption that the number of molecular active sites is 6, in accordance with the 
hexameric arrangement of the core catalytic subunit AccD5.  
 
Figure 3-2. Carboxylase activity of AccA3-AccD5. AccA3-AccD5 assembled in vitro 
exhibits efficient carboxylase activity on propionyl-CoA (chemical structure shown on the 
right). Mean velocity of the reaction has been plotted as a function of the concentration of 
propionyl-CoA; error bars have been calculated based on data from three independent 
experiments. 
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3.1.1.3 Crystallisation 
Pre-crystallisation tests identified the optimal concentration of AccA3-AccD5 for 
crystallisation as 4 mg/ml. In the crystallisation (sitting-drop vapour diffusion) trials 
that AccA3-AccD5 was subjected to, crystals of different morphologies appeared in 
several conditions in a duration of two to three weeks. 
 
 
Figure 3-3. Crystallisation of the putative AccA3-AccD5 complex. (A) Short 
needles that were grown in 0.2 M ammonium acetate, 0.1 M Bis-Tris pH 6.5, 25% (w/v) PEG 
3350. (B) Long needles that were grown in 0.1 M MES pH 6.5, 30% (w/v) PEG 4000. (C) 
Small cuboidal crystals that appeared with 0.1 M HEPES pH 7.0, 20% (w/v) PEG 8000. (D) 
Rod-shaped crystal that was grown in 0.1 M HEPES-sodium pH 7.5, 1.6 M ammonium 
sulphate, 2% (w/v) PEG 1000. The white bars indicate a length of 50 µm.  
 
Crystals were briefly soaked in suitable cryoprotectants (mother liquor containing 
15% (v/v) glycerol additionally) and flash-cooled in liquid nitrogen until they were 
tested for X-ray diffraction. Crystals of type B [Figure 3-3] were very fragile, so only 
short fragments of the long needles were mounted, cryoprotected and flash-cooled.  
 
3.1.1.4 X-ray data collection, structure solution and refinement 
Crystals of the putative AccA3-AccD5 complex were tested at the ID23-2 beamline 
of the ESRF, Grenoble; only the crystal (D) was of good diffraction quality. 
Diffraction data were collected to a maximum resolution of 2.49 Å at a detector 
distance of 306 mm; the data were indexed, scaled and merged using iMOSFLM 
(Battye, et al., 2011) and SCALA (Evans, 2006) [Table 3-1]. The crystal belonged to 
the orthorhombic space group P212121, with a space group confidence of 0.925, Laue 
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group confidence of 0.987 and systematic absence probability of 0.950, as estimated 
by the program POINTLESS (Collaborative Computational Project, 1994). The 
structure was solved by molecular replacement with Phaser (McCoy, et al., 2007) 
using the crystallographic structure of a monomer of AccD5 (PDB ID: 2BZR) as the 
search model. The emergence of unbiased electron density features indicated a correct 
molecular replacement solution. However, it was observed that the data corresponded 
to protomers of only AccD5; unfortunately, even after several rounds of maximum-
likelihood refinement using REFMAC5 (Murshudov, et al., 1997), positive electron 
density features that could accommodate protomers of AccA3 in the crystal structure 
did not appear.  
 
Table 3-1. Crystallographic statistics of AccD5 
Crystallographic parameter Value 
Data collection and processing  
Wavelength [Å] 0.8726 
Resolution range [Å] 53.53 – 2.49 (2.63 – 2.49) 
Space group P212121 
Unit cell dimensions [Å] 175.8, 218.8, 258.9 
Average mosaicity [°] 0.33 
Number of measured reflections 2164770 (282860) 
Number of unique reflections 329407 (44209) 
Multiplicity 6.6 (6.4) 
Mean I/#(I) 6.7 (1.9) 
Completeness [%] 95.3 (88.4) 
1Rsym 0.06 (0.37) 
Values in parentheses correspond to the highest resolution shell. 
Refinement  
2Rconv / 3Rfree 0.204 / 0.257 
Average B-factor [Å2] 27.93 
Root mean square deviations  
     Bond lengths [Å] 0.016 
     Bond angles [°] 1.719 
Ramachandran plot analysis  
     Favoured [%] 94.8 
     Additionally allowed [%] 5.2 
  
 
1 Rsym = Ih, j ! Ih
j
"
h
" Ih, jj"h" where Ih,j is the intensity of the j
th observation of unique 
reflection h.  
2
! 
Rconv =
h
" Foh # Fch Foh
h
"  where Foh and Fch are the observed and calculated 
structure factor amplitudes for reflection h.  
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3 Rfree is equivalent to Rconv, but is calculated using a 5% disjoint set of reflections excluded 
from the maximum likelihood refinement stages. 
 
3.1.1.5 Crystal structure of AccD5 
The crystal structure of AccD5 (in a space group different from P212121) has 
previously been characterised (Holton, et al., 2006, Lin, et al., 2006); so only a brief 
description of the structure will be provided in the following sub-sections. A more 
detailed comparative analysis of the structural features of AccD5 with those of its 
structural relatives will be presented in sub-chapter 3.3. It is noteworthy that the 
structure of AccD5 determined in this study is either of moderately higher resolution 
or is more complete than each of the AccD5 structural models that have been 
described earlier (Holton, et al., 2006, Lin, et al., 2006).  
 
3.1.1.5.1 Overall molecular architecture 
The asymmetric unit of the crystal consists of 12 monomers of AccD5 related to each 
other by operations of crystallographic and non-crystallographic symmetry. These 
monomers are arranged in the form of two homohexamers related by symmetry 
arising from crystallographic packing. The biological assembly of the protein is a 
350-kDa hexamer, similar to the CT domain of Streptomyces coelicolor (Diacovich, 
et al., 2004) and the core catalytic 12S domain of Propionibacterium shermanii 
transcarboxylase (Hall, et al., 2003). The AccD5 homohexamer is a roughly donut-
shaped structure, made of two layers of tightly stacked trimers A-B-C and D-E-F 
[Figure 3-4], giving rise to 32-fold symmetry with a 3-fold axis perpendicular to a 2-
fold axis.  
 
The structural differences observed among the six monomers are negligible (a root 
mean square deviation of approximately 0.35 Å over 520 equivalent C% atoms in each 
pair). Each monomer measures a length of approximately 80 Å in the longest 
dimension and is composed of two subdomains – the N-terminal and C-terminal 
subdomains – that possess the conventional crotonase fold [Figure 3-4B]. One loop 
region in each monomer (residues 470 to 489) could not be modeled with confidence 
because of the lack of corresponding positive electron density, presumably due to a 
high degree of conformational flexibility.  
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Figure 3-4. The crystal structure of AccD5. (A) The ribbon diagram of the AccD5 
hexamer, arranged as two rings of trimers. The two rings are coloured in shades of orange and 
green respectively. The grey triangle indicates the three-fold axis of symmetry that associates 
monomers A, B and C as well as D, E and F. The hexamer is approximately 145 Å long in its 
largest dimension and the central pore is approximately 20 Å in diameter. (B) The structure of 
one monomer of AccD5, with helices, strands and loops coloured orange, yellow and olive 
respectively. The monomer is composed of N-terminal and C-terminal subdomains that 
interact strongly with the C-terminal and N-terminal subdomains respectively of the 
adjacently placed monomer in the other trimeric ring. 
 
Buried surface area refers to the solvent-accessible surface area (in square Å) of 
monomeric units that becomes solvent-inaccessible upon the corresponding assembly 
formation and is therefore, an indicator of the strength of the association. Three-
dimensional assembly and interface analysis performed using the PDBePISA tool 
(Krissinel & Henrick, 2007) revealed that the fraction of buried surface area resulting 
from the formation of units A-D, B-E and C-F are significantly higher than that in the 
cases of A-B, B-C or C-A [Table 3-2].  
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Table 3-2. Interface analysis of AccD5 protomers 
No. of 
monomers Composition 
Total surface 
area [Å2] 
Buried surface 
area [Å2] 
Fraction 
buried [%] 
6 ABCDEF 98050 44730 45.62 
3 ABC 63390 8250 13.01 
3 DEF 62630 8510 13.59 
2 AD 38820 9270 23.88 
2 BE 37940 9210 24.28 
2 CF 38340 9190 23.97 
2 AB 47821 1378 2.88 
2 BC 47278 1372 2.90 
2 CA 48171 1374 2.85 
2 DE 47425 1403 2.96 
2 EF 47407 1454 3.07 
2 FD 47448 1399 2.95 
 
The intra-dimeric interactions between monomeric members of the dimer pairs A-D, 
B-C and E-F are likely stronger than the inter-dimeric interactions (AD-BE, BE-CF, 
CF-AD) and the intra-trimeric associations within A-B-C and D-E-F. Only values 
corresponding to the A-B-C-D-E-F hexamer have been listed in the table above; 
nevertheless, nearly identical interface characteristics were observed for the G-H-I-J-
K-L hexamer. 
 
3.1.1.5.2 The active site 
The active site of AccD5, as in other CT subunits characterised so far, lies at the 
conserved dimeric interface and is composed of two pairs of oxyanion-stabilizers: Gly 
193 - Gly 194 (of monomer 1) and Gly 434’ - Ala 435’ (of monomer 2) [Figure 3-
5A]. By analogy with other CT subunits (Hall, et al., 2003, Diacovich, et al., 2004), 
the backbone amide groups of the former pair might be responsible for making 
hydrogen bonds with the carbonyl group of the acyl-CoA substrate; the amide groups 
of the latter pair might be involved in forming hydrogen bonds with the carbonyl 
group of the carboxybiotin transported into the !-subunit active site by the BCCP 
domain of the %-subunit. In this way, residues from both the monomers of the !-
subunit contribute to the stable binding of the substrate, the cofactor and probably the 
reaction intermediates, thereby facilitating the catalytic mechanism. Such an 
arrangement emphasizes the indispensability of the formation and maintenance of the 
dimeric interface for successful carboxyl moiety transfer to occur. The conserved 
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residues Gly 433’, Tyr 432’, and Ala 431’ seem to be suitably positioned to allow a 
certain degree of flexibility in order to accommodate the substrate and reaction 
intermediates in the active site of the enzyme. The tentative substrate-binding pocket 
lies at the dimeric interface, adjacent to the catalytic site described above. Major 
contribution to the substrate-binding pocket comes from monomer 1 [Figure 3-5B]. 
Fully/partially conserved residues like Ala 153, Ala 155, Ile 157, Leu 164, Tyr 167, 
and Phe 120 are strategically arranged to give rise to a predominantly hydrophobic 
patch that could bind the acyl-CoA substrate molecule. 
 
 
Figure 3-5. The active site of AccD5. (A) Secondary structural elements of monomers A 
and D are coloured orange and green respectively. Conserved residues that are integral to 
catalytic function are shown in the ‘stick’ mode; carbon, nitrogen and oxygen atoms are 
coloured green, blue and red respectively. (B) Fully/partially conserved residues that are most 
likely to have a role in substrate-binding and stabilization are represented as sticks; carbon, 
nitrogen and oxygen atoms are coloured orange/green, blue and red respectively. The residues 
described in (A) are seen in the top part of the figure.  
 
The partially conserved polar residues Lys 91, Arg 156, and Gln 158 might utilize 
their side chains to stabilize different parts of the substrate molecule. Certain residues 
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from monomer 2 that could potentially be involved in binding of the bisphosphate 
group of the substrate through main-chain as well as side-chain interactions could not 
be modeled with confidence, as they are part of a flexible loop (residues 470 – 489). It 
is highly likely that the conformational mobility of this loop will be relatively 
restricted in the event of substrate-binding. It is interesting to note that Lys 91, that is 
distant from the active site in terms of primary sequence and is closer to the N-
terminal of monomer 1, might get suitably positioned to act in conjunction with 
residues of the C-terminal subdomain of monomer 2 to bring about efficient substrate-
binding and stabilization. The cofactor-binding pocket is located in close vicinity to 
the key catalytic residues. The binding of biotin is expected to be carried out 
predominantly by residues of monomer 2 [Figure 3-6]. The substrate and cofactor 
should therefore reach the catalytic centre via opposite sides of the dimeric interface. 
 
 
Figure 3-6. The cofactor-binding site of AccD5. The residues responsible for cofactor-
binding are predominantly from monomer 2 and are represented here in the ‘stick’ mode with 
carbon, nitrogen, oxygen and sulphur atoms coloured green, blue, red, and yellow 
respectively. The catalytic site residues from both the monomers are shown as spheres with 
colouring scheme as in Figure 3-5. The tentative substrate-binding residues from monomer 1 
are shown as dots for reference. 
 
Similar to the cases of S. coelicolor PccB and P. shermanii transcarboxylase 12S 
domain, the conserved residues Gly 393’, Phe 394’, and Pro 396’ give rise to a 
hydrophobic environment suitable for carboxybiotin-AccD5 interaction. This 
arrangement favours the precise binding of carboxybiotin in such a fashion that the 
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ureido moiety of biotin points directly into the oxyanion hole generated by residues 
Gly 433’ and Gly 434’. The crystal structure of AccD5 and comparison with 
structurally related homologs have helped reiterate that the modes of binding of acyl-
CoA substrate and carboxybiotin should be conserved and ubiquitous among biotin-
dependent carboxyltransferases, wherein the dimeric, di-domain associations are 
essential for activity. 
 
3.1.1.6 Electron microscopy of AccA3-AccD5 
The AccA3-AccD5 complex was subjected to preliminary investigation by negative 
staining electron microscopy (in collaboration with the Sachse group, EMBL 
Heidelberg). At all concentrations of proteins tested, no clear uniformity/pattern was 
observed in the shapes of the particles [Figure 3-7]. The incubation of AccA3-AccD5 
with the substrate analog CoA (at a molar concentration thrice as that of AccA3-
AccD5) did not lead to improvement in sample quality.  
 
 
Figure 3-7. Negative staining electron microscopy of AccA3-AccD5. Negative 
staining electron microscopy images of AccA3-AccD5 in the (A) absence of any ligand (B) 
presence of the substrate analog CoA. The red bars correspond to a length of 0.1 µm. 
 
Acquisition of useful electron microscopy data was complicated by the fact that the 
AccA3-AccD5 complex was conformationally heterogeneous, as observed by visual 
analysis of the images. Large variations in the dimensions of the particles underlined 
the possibilities of sample polydispersity and non-native homotypic interactions 
(facilitated by the inherently flexible BCCP domain) between AccA3 protomers of 
adjacently located complexes. 
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3.1.1.7 Overexpression in E. coli 
It was reasoned that contamination from endogenous host proteins could contribute to 
the biochemical heterogeneity of the AccA3-AccD5 complex. Peptide mass 
fingerprinting analysis (Proteomics Core Facility, EMBL Heidelberg) of the samples 
indeed highlighted the presence of, along with a few host chaperone proteins, the PCC 
%- and !-subunits (with approximately 55% sequence coverage in each case) of M. 
smegmatis in preparations of M. tuberculosis AccA3-AccD5. The amino acid 
sequences of the major M. smegmatis ‘contaminant’ proteins are provided in the 
following box; the peptides identified with confidence by mass spectrometry are 
highlighted in red. 
 
>gi|118471103|ref|YP_890604.1| propionyl-CoA carboxylase 
subunit beta [Mycobacterium smegmatis str. MC2 155] 
 
MTNKTTAELL AELREKLELA KEPGGEKAVA KREKKGIPSA RARINALLDP 
GSFIEIGALA KTPGDPNALY GDGVVTGRGT IDGRPVGVFS HDQTVFQGSV 
GEMFGRKVAR LMEWVAMVGC PIIGINDSAG ARIQDAVTSL AWYAELGRRH 
EMLRGLVPEI SLIFGKCAGG AVYSPIQTDL LVAVRDQGYM FITGPDVIKD 
VTGEDVTFDE LGGADEQAKR GNIHKVVNSE AEAYQYVRDY LSFLPSNHFD 
NPPIVNPGME PEITPHDLEL DSIVPDADNM AYDMHEILLR IFDDGDVFEI 
AEQRGPAMIT AFARVDGHPV GVIANQPMVL SGAIDNEASD KAASFIRFCD 
SYNLPLVFVV DTPGAMPGVA EEKGGIIKRG GRFFNAIVEA DVPKVTVIIR 
KAYGGGYAVM GSKQLSADLN FAWPTARIAV IGAEGAAQLL VKRFPDPNAP 
EVQKIRDDFI EGYNLNMATP WIAAERGYID AVIQPHETRL LLRKSLRLLR 
DKQNGPKVQR KHGLLPL 
 
>gi|118469108|ref|YP_886179.1| acetyl-/propionyl-coenzyme A 
carboxylase subunit alpha [Mycobacterium smegmatis str. MC2 
155] 
 
MANHASSKIS KVLVANRGEI AVRVIRAAKD AGLASVAVYA EPDADAPHVR 
LADEAFALGG QTSAESYLVF EKILDAAEKS GANAIHPGYG FLSENADFAQ 
AVIDAGLIWI GPSPQSIRDL GDKVTARHIA ARAKAPLVPG TPDPVKDADE 
VVAFAKEHGV PVAIKAAFGG GGRGMKVART LEEIPELFES ATREAIAAFG 
RGECFVERYL DKPRHVEAQV IADQHGNVVV AGTRDCSLQR RFQKLVEEAP 
APFLTDAQRK EIHESAKRIC KEAGYYGAGT VEYLVGQDGL ISFLEVNTRL 
QVEHPVTEET SGIDLVRQQF KIANGEPLDI TEDPTPRGHS FEFRINGEDA 
GRGFLPAPGP VTKFVAPTGP GVRMDSGVET GSVIGGQFDS MLAKLIVTGA 
TREEALERSR RALAEFTVEG LATVIPFHRA VVSDPAFIGD GEKFDVHTRW 
IETEWNNTVE PFTGGDPIEE EDTVPRQTVV VEVGGRRLEV SLPGDLAIGG 
GGGAAAPGVV RKKPKPRKRG GGGAKAASGD AVTAPMQGTV VKVAVEEGQE 
VSAGDLVVVL EAMKMENPVT AHKDGTITGL AVEAGAAITQ GTVIAEIK 
 
Sample biochemical heterogeneity resulting from using a strain of M. smegmatis as 
the expression host could be unfavourable for crystallisation of the AccA3-AccD5 
complex. In order to overcome this problem, an expression strain of E. coli (BL21 star 
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(DE3) pRare2) was chosen as a far-native host for the heterologous production of the 
proteins AccA3 and AccD5 using constructs M02 and M08 respectively [Table 2-2]; 
high levels of overexpression could be achieved (AccA3: 5 – 10 mg per litre of 
culture; AccD5: 15 – 20 mg per litre of culture) by induction with IPTG. As observed 
with the M. smegmatis expression system, AccD5 eluted as a single symmetrical peak 
corresponding to a hexameric quaternary structure [Figure 3-8]. AccA3, on the other 
hand, eluted as a mixture of oligomers (hexamers possibly being the predominant 
species), in addition to forming very high-molecular weight aggregates.  
 
 
Figure 3-8. Overexpression in E. coli and purification of AccA3 and AccD5. (A) 
SEC elution profiles of AccA3, AccD5 and the unstable AccA3-AccD5 complex on 
Superose™ 6 10/300 GL. Molecular weight standards and elution volumes (ml) in brackets: 
670 kDa (12.1), 158 kDa (15.5). Inset: Peak analysis of AccA3-AccD5 complex by SDS-
PAGE (12%); lanes 1 – 6: equidistant fractions corresponding to the leading ‘shoulder’ peak 
P1 of the AccA3-AccD5 chromatogram; lane M: protein marker with standard molecular 
weights (in kDa). (B) SEC elution profiles of the AccA3-AccD5 complex following mixing 
of its components in different molar ratios. 
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Incubation of purified samples of hexameric AccA3 and AccD5 together in equimolar 
concentrations resulted in the formation of a high-molecular weight complex 
observed as a broad, asymmetrical peak P1 in the SEC profile [Figure 3-8A]. This 
complex was unstable and composed of more than one oligomeric state in dynamic 
equilibrium with each other. Incubation of AccA3 and AccD5 in different 
stoichiometric ratios also did not favour the formation of a stable complex suitable for 
crystallisation trials [Figure 3-8B].  
 
3.1.1.8 Co-expression 
As purification of individual components and mixing did not result in successful in 
vitro reconstitution, co-expression was attempted as a strategy for the in vivo 
reconstitution of the AccA3-AccD5 complex. For this, a series of monocistronic, 
IPTG-inducible constructs were made using vector backbones with compatible origins 
of replication [Table 3-3]; in each pair tested, one of the components was expressed in 
tandem with a polyhistidine tag that could facilitate isolation of the component 
together with its interacting partner by imidazole elution.  
 
Table 3-3. Constructs used for co-expression of PCC components 
S. No. Construct 1 
(with N-ter His tag) 
Construct 2 
(with no tag) 
1 accD5 in pETM-11 accA3 in pCDF-13 
2 accA3 in pETM-11 accD5 in pCDF-13 
3 accD5 in pETM-11 accE5 in pCDF-13 
4 accA3 in pETM-11 accE5 in pCDF-13 
 
For each pair of constructs, overexpression trials were performed wherein cells from 
induced and uninduced cultures were lysed by sonication and the supernatant and 
pellet fractions of the lysates were sampled. These experiments showed that there 
were unequal levels of overexpression of the PCC components [Figure 3-9]. In the 
cases of construct pairs (1) and (2), the polyhistidine-tagged member was 
preferentially highly expressed, while the non-tagged protein was expressed only in 
lower levels, as observed by SDS-PAGE; protein identity corresponding to the 
labeled bands [Figure 3-9A, B] was confirmed by peptide mass fingerprinting 
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analyses. In the cases of construct pairs (3) and (4), overexpression of the "-subunit 
AccE5 could not be achieved under any conditions (of inducer concentration and 
post-induction incubation temperature) tested; only the proteins AccA3 and AccD5 
were overexpressed.  
 
 
Figure 3-9. Co-expression trials of M. tuberculosis PCC components. In gel images 
(A), (B), (C) and (D), lanes (1) and (2): cell pellet and cell supernatant respectively from non-
induced cultures; lanes (3) and (4): cell pellet and cell supernatant respectively from induced 
cultures; lane M: protein marker with standard molecular weights (in kDa). Approximate 
theoretical molecular weights of non-tagged versions of the proteins are as follows: AccA3: 
64 kDa, AccD5: 59 kDa, AccE5: 19 kDa. The polyhistidine-tagged protein of each pair is 
marked with a (*).  
 
Upon scale-up of the expression and protein purification, a complex of AccA3-AccD5 
could not be observed in the SEC profiles [Figure 3-10]. The elution profiles of 
AccA3-AccD5 co-expressed were similar to those of AccA3 or AccD5 purified 
individually, depending on which of the proteins was polyhistidine-tagged. In other 
words, a high-molecular weight complex suitable for crystallisation could not be 
obtained by the co-expression strategy tested, as comparable levels of overexpression 
of the components could not be accomplished. 
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Figure 3-10. SEC profiles of co-expressed M. tuberculosis PCC components. (A) 
The elution profile (on Superose 6) of co-expressed AccA3-AccD5 (polyhistidine tag on 
AccD5) overlaid with that of AccD5. (B) The elution profile (on Superose 6) of co-expressed 
AccA3-AccD5 (polyhistidine tag on AccA3) superposed with that of AccA3. Elution volumes 
of molecular weight standards are the same as in Figure 3-8. 
 
3.1.1.9 Attempts to improve AccA3 behaviour 
The inability of AccA3 and AccD5 to assemble into a stable complex could have 
stemmed from the fact that the preparation of AccA3 was a heterogeneous mixture of 
several oligomeric states that existed in dynamic equilibrium with each other, 
presumably because of the inherent conformational flexibility of its BCCP domain. 
Several attempts were made to obtain full-length AccA3 in a stable, monodisperse 
form. Repeated thermofluor experiments aimed at the identification of optimal buffer 
conditions for stable AccA3 preparation did not provide interpretable melting curve 
data. So, a number of AccA3 purification trials (using construct M02) were performed 
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with varying buffer conditions, in a low-throughput fashion. The effects of different 
pH conditions (pH 6.5, 7.0, 7.5, 8.0 and 8.5, at a fixed salt concentration of 200 mM) 
and different concentrations of salt (100 mM, 300 mM) on the oligomerisation 
behaviour of AccA3 were analysed. However, these experiments did not help arrive at 
an absolutely optimal buffer condition for AccA3 monodispersity [Figure 3-11]. At 
pH 6.5 and 8.5, the protein formed dense, cloudy precipitate in the initial stages of the 
purification. In all other conditions tested, AccA3 existed in multiple oligomeric 
states in dynamic equilibrium with each other, in addition to forming heavy 
aggregates that were lost in the void volume.  
 
 
Figure 3-11. Purification of AccA3 under different buffer conditions. (A) The 
elution profiles of AccA3 purified under different conditions of pH. (B) The elution profiles 
of AccA3 purified under different conditions of ionic strength; high salt: 300 mM KCl, low 
salt: 100 mM KCl). The black dotted chromatogram corresponds to the dominant peak 
fraction of the ‘high salt buffer’ trial reloaded on Superose 6; multiple oligomeric states 
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existed in dynamic equilibrium with each other. Elution volumes of molecular weight 
standards are the same as in previous figures. 
 
Truncated versions of AccA3, with the putative BCCP domain deleted, were sub-
cloned to obtain AccA3 in a form devoid of the ability to make undesirable 
homotypic interactions that were presumably unfavourable for complex formation. In 
order not to disrupt secondary structural elements, three /BCCP variants – AccA3 
/BCCP1, /BCCP2 and /BCCP3 (constructs M24, M25 and M26 respectively, Table 
2-2) of different lengths (1 – 454 aa, 1 – 471 aa and 1 – 480 aa) were made based on 
multiple sequence alignment analysis and a homology model of AccA3 constructed 
by an automated process (SWISS-MODEL, (Arnold, et al., 2006)) using the crystal 
structure of the %-subunit of an unnatural chimeric PCC (PDB ID: 3N6R) as template. 
 
 
Figure 3-12. Overexpression of AccA3 /BCCP. (A) Ribbon representation of the 
crystal structure of the %-subunit of Ruegeria pomeroyi (PDB ID: 3N6R-A) used as a 
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template for AccA3 homology modeling. The core BC domain, the BCCP domain and the 
unique BT domain (BC-CT interaction domain, absent in the model of AccA3) are coloured 
grey, green and cyan respectively. Biotin (BTN) and the key lysine residue to which it is 
covalently linked are shown in ‘stick’ representation with carbon, nitrogen and oxygen atoms 
coloured green/cyan, blue and red respectively. The N- and C-termini of the protein are 
indicated. (B) The homology model of AccA3 with the putative core BC domain and BCCP 
domain coloured orange and green respectively. The region highlighted in red is a part of the 
BC domain whose counterpart is unmodeled in the R. pomeroyi structure, presumably 
because of lack of conformational order. The conserved lysine that is expected to act as the 
site of biotinylation is shown as sticks with colouring scheme as in (A). The C-termini of the 
constructs AccA3 /BCCP1, /BCCP2, and /BCCP3 are indicated as black ovals /1, /2, and 
/3 respectively. (C), (D) and (F) Overexpression trials with constructs AccA3 /BCCP1, 
/BCCP2, and /BCCP3 respectively. S1, S2 and S3 refer to expression trials in the expression 
strains E. coli BL21 (DE3) CodonPlus-RP, BL21 star (DE3), and BL21 star (DE3) pRare2 
respectively (Appendix I). Lanes 1 and 2: supernatant and cell pellet respectively of non-
induced cultures; lanes 3 and 4: supernatant and cell pellet respectively of induced cultures; 
lanes M: protein marker with standard molecular weights (in kDa). 
 
A number of conditions (concentration of inducer, post-induction incubation 
temperature and duration, expression strains) were tested for the overexpression of the 
/BCCP constructs. Although high levels of overexpression were achieved with all the 
constructs, the proteins were present in the insoluble pellet fraction of the cells 
[Figure 3-12]; optimal conditions for obtaining the proteins in soluble form for further 
analyses could not be identified. 
 
3.1.1.10 The epsilon subunit AccE5 
The "-subunit AccE5 of M. tuberculosis PCC has been proposed to be responsible for 
the modulation of the catalytic activity of the complex (Gago, et al., 2006, Oh, et al., 
2006). However, the mode and stoichiometry of interaction and the functional basis of 
the role of AccE5 in activity modulation are not known. In this study, attempts were 
made to express, purify and perform preliminary biophysical characterisation of 
AccE5.  
 
3.1.1.10.1 Purification of AccE5 
Efforts to overexpress AccE5 in E. coli with routinely used pET vectors and M. 
tuberculosis H37Rv genomic DNA as template were not successful. After repeated 
trials, AccE5 could be successfully overexpressed as a fusion protein, in combination 
with a solubility enhancer tag – the Z-tag or small ubiquitin-like modifier (SUMO-) 
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tag – in addition to a polyhistidine tag, using constructs M10 and M11 respectively 
[Table 2-2]. These constructs were prepared using a synthetic accE5 gene in a 
commercial vector backbone (GeneArt) as the DNA template. In the synthetic gene, 
the codon usage had been adapted to the codon bias of E. coli genes and further 
optimization measures (removal of negative cis-acting sites such as splice sites, poly 
(A) signals, TATA-boxes, etc. that might adversely influence protein expression, 
adjustment of GC content to prolong mRNA life) to allow high and stable expression 
rates in E. coli had been undertaken.  
 
Protocols for the affinity purification of AccE5-His6-Z-tag and AccE5-His6-SUMO-
tag fusion proteins by imidazole-based elution were optimized [Figure 3-13]. AccE5 
was separated from the respective solubility tag by site-specific cleavage using TEV 
protease. During the cleavage of the Z-tag, AccE5 formed a dense, insoluble 
precipitate; however, in the case of the SUMO-tag, the protein remained soluble after 
the removal of the tag and was used for further experiments. SEC experiments using 
Superdex 75 prep grade chromatography media indicated that AccE5 exists as a dimer 
in solution. However, the protein was very unstable and generally underwent 
degradation/precipitation (at room temperature and at 4 °C) in a few hours after 
preparation.  
 
 
Figure 3-13. Purification of AccE5. SDS-PAGE (15%) analysis of (A) fractions from the 
affinity purification of AccE5-His6-Z-tag fusion protein. (B) fractions from the affinity 
purification of AccE5-His6-SUMO-tag fusion protein. (C) pure eluate of untagged AccE5 
from an SEC experiment. Lanes M: protein marker with standard molecular weights (in kDa); 
lanes S: supernatant of cell lysate; lanes P: insoluble pellet of cell lysate; lanes FT: flow-
through during loading of supernatant of cell lysate onto Ni-NTA resin. 
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3.1.1.10.2 AccE5 lacks secondary structure 
In silico analysis of the primary structure of AccE5 indicated that more than 70% of 
the protein is prone to be intrinsically disordered [Figure 3-14 inset]. This prediction 
was indeed verified by circular dichroism (CD) spectroscopy measurements [Figure 
3-14] performed on AccE5 at different concentrations and at two different 
temperatures (4 ºC and 20 ºC). In all cases tested, AccE5 exhibited CD spectra typical 
of randomly coiled proteins. A concentration-dependent effect on the values of molar 
ellipticity was observed; varying values of molar ellipticities at different 
concentrations suggested the possibility of protein aggregation under the experimental 
conditions. These experiments, nevertheless, indicated that the lack of secondary 
structure was protein concentration- and temperature-independent.  
 
 
Figure 3-14. AccE5 is an intrinsically disordered protein. CD spectra of AccE5 
(measured at 4 ºC and 20 ºC) at three different concentrations: 10 µM, 5 µM, and 2.5 µM. 
Mol. ellipticity*: Molar ellipticity in deg cm2 dmol-1. Top right: Intrinsic disorder propensity 
of AccE5, as predicted by the GlobPlot 2 web service (Linding, et al., 2003). 
 
The intrinsically disordered nature of AccE5 explained the difficulties experienced in 
the overexpression, purification and handling of the protein. As a consequence of 
these technical constraints, AccE5 could not be subjected to further structural or 
functional characterisation during the study. 
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3.1.2  Discussion 
In this part of the study, a dodecameric complex of the M. tuberculosis essential 
propionyl-CoA carboxylase components AccA3 and AccD5 was successfully 
reconstituted by overexpression in a suitably engineered expression strain of the near-
native non-pathogenic host M. smegmatis (Noens, et al., 2011). Unlike in the case of 
the S. coelicolor acetyl-CoA carboxylase enzyme, where interaction between the %-
subunit AccA2 and !-subunit AccB occurs only in the presence of the "-subunit AccE 
(Diacovich, et al., 2002), the M. tuberculosis PCC components AccA3 and AccD5 are 
able to interact even in the absence of the "-subunit AccE5. 
 
Interestingly, the activity of M. tuberculosis AccA3-AccD5 (reconstituted as above) 
was found to be multiple folds higher than that of the M. tuberculosis AccA3-AccD5-
AccE5 complex (reconstituted after overexpression in and purification from E. coli) 
studied earlier, wherein KM = 0.24 ± 0.035 mM for propionyl-CoA (Gago, et al., 
2006). Based on the data published by Gago et al., the Vmax and kcat of the E. coli-
derived complex could be calculated to be as low as 1.38 µM min-1 mg-1 and 4.7x10-5 
s-1 respectively, whereas the corresponding values for the M. smegmatis-derived 
complex reconstituted in this study are Vmax = 1.33 ± 0.05 mM min-1 mg-1 and kcat = 
0.045 s-1. In the study by Gago et al., the presence of AccE5 at a 5:1 ratio with respect 
to the concentrations of AccA3 or AccD5 was shown to enhance the catalytic activity 
at least 20-fold; hence the "-subunit AccE5 was reported to be essential for maximal 
carboxylase activity of the enzyme and has been proposed to be responsible for 
inducing an enzyme conformational change that enhances the substrate’s access to the 
active site or for altering the oligomeric composition of the AccA3-AccD5 complex 
to make it more functional (Gago, et al., 2006). It is interesting to note that the 
complex reconstituted in this study could achieve such high level of activity even in 
the absence of AccE5. The only explanation that could be attributed to this high 
activity is that the usage of the near-native expression host ensures proper protein 
folding and processing, thereby leading to optimal catalytic efficiency. These results 
can be considered to serve as proof of principle that near-native expression hosts are 
usually most optimal for functional studies on proteins. 
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Crystallisation experiments using the AccA3-AccD5 complex, however, did not result 
in structural data of the complex; during the process of crystallisation, the core 
catalytic !-subunit AccD5, being an apparently more compactly packed component, 
had crystallized preferentially over molecules of AccA3-AccD5 or AccA3 alone. This 
result points to the possibility that the interaction between AccA3 and AccD5 is too 
weak and/or transient to give rise to a symmetrical crystal lattice arrangement. Given 
the molecular weight and the expected dimensions of the PCC complex and the 
predicted conformational flexibility of the %-subunit, the inability of AccA3-AccD5 
to readily crystallize was not totally unexpected. During this study, C.S. Huang and 
co-workers solved the first crystal structure of an %6!6 holoenzyme of PCC (Huang, et 
al., 2010); this structure corresponds to an unnatural chimeric PCC composed of the 
PCC %-subunit from Ruegeria pomeroyi and the PCC !-subunit from Roseobacter 
denitrificans. The structure solution of this chimeric PCC was reportedly preceded by 
several technical hurdles like difficulties in native complex reconstitution, crystals 
with poor diffraction properties and/or perfect twinning (Huang, et al., 2010), 
suggesting that these enzymes, in general, are problematic candidates for 
crystallography. 
 
Members of the YCC family are generally conserved, with moderate to high levels of 
sequence and presumable structural homology, among mycobacterial species (Cole, et 
al., 1998, Kapopoulou, et al., 2011). As a direct consequence, samples of the M. 
tuberculosis PCC components were ‘contaminated’ with the endogenously expressed 
M. smegmatis counterparts of their interacting partners. Hence, crystallisation/electron 
microscopy analysis of the complex was further complicated by biochemical 
heterogeneity stemming from the usage of M. smegmatis as the expression host. The 
possibility of tackling this problem by means of using M. smegmatis knockout 
versions of the accA3/accD5/accA3-accD5 genes as expression hosts was ruled out, 
as these genes are essential for mycobacterial viability (Sassetti, et al., 2003), Elke 
Noens, personal communication). 
 
Expression in E. coli, purification and mixing of proteins did not lead to effective 
reconstitution of the AccA3-AccD5 complex, primarily because of the inherent 
tendency of AccA3 to exist in multiple oligomeric forms. It is known that the 
Results and Discussion 
 79 
assembly of a carboxylase complex in a stable, monodisperse form could be highly 
dependent on pH (Ehebauer, et al., unpublished). Various standardization trials could 
not decisively identify conditions for the preparation of full-length AccA3 in a 
satisfactory form for crystallisation experiments. The core BC domain of the %-
subunit might form a compact structure, but the BCCP domain is expected to be 
conformationally flexible as its role is to transport carboxybiotin and biotin to and 
back from the active site of the !-subunit. The structure of the R. pomeroyi – R. 
denitrificans PCC revealed that the distance between the active sites of the %- and !-
subunits is approximately 55 Å, necessitating the translocation of the entire BCCP 
domain during catalysis (Huang, et al., 2010). In an endeavour to obtain AccA3 with 
potentially restricted conformational flexibility, AccA3 /BCCP versions were 
constructed; however, conditions for overexpression in soluble forms remained 
elusive.  
 
The third component of PCC - the "-subunit - is unique to acyl-CoA carboxylases of 
actinobacteria, suggesting that this subunit was present in the common ancestor of all 
actinobacteria. The M. tuberculosis genome codes for only a single "-subunit 
(AccE5), which is known to be essential for survival (Cole, et al., 1998, Sassetti, et 
al., 2003). The corresponding open reading frame has been placed in the list of genes 
(Marmiesse, et al., 2004) that have been conserved by all mycobacterial species, 
including M. leprae, a subject of severe reductive evolution. Though these studies 
emphasize that AccE5 is responsible for an indispensable function, very little is 
known about the function and biophysical aspects of AccE5, a ‘conserved 
hypothetical protein’. A couple of studies have shown that AccE5 is involved in the 
enhancement of the activity of the PCC complex (Gago, et al., 2006, Oh, et al., 2006). 
But the production of the protein, the stoichiometry of binding to AccA3 and AccD5, 
and the mechanism of activity enhancement have not been unambiguously described. 
In this study, considerable effort was invested in the overexpression and purification 
of AccE5. GlobPlot analysis suggested that over 70% of AccE5 could be intrinsically 
disordered. Furthermore, based on sequence, the instability index of AccE5 was 
calculated to be above 45.0 (Guruprasad, et al., 1990) indicating a high level of in 
vitro instability. CD spectroscopy experiments confirmed the sequence-based 
prediction that AccE5 is an intrinsically disordered protein. Preliminary attempts to 
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characterise AccE5 by nuclear magnetic resonance (NMR) spectroscopy (in 
collaboration with Bernd Simon, EMBL Heidelberg) failed. This was because AccE5 
required the presence of at least 5% (v/v) glycerol for its short-lived stability and such 
a buffer environment is inappropriate for NMR measurements. Initiatives were taken 
to overexpress AccE5 as a fusion protein with a green fluorescent protein (GFP) tag 
in M. smegmatis; but under standard conditions of culture density and at various 
concentrations of tetracycline inducer, overexpression of the fusion protein could not 
be achieved. In conclusion, detailed characterisation of AccE5 was hampered by 
serious difficulties in the production and handling of the protein. 
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3.2 Characterisation of the carboxyltransferase subunit of 
the long-chain acyl-CoA carboxylase of Mycobacterium 
tuberculosis 
 
Mycolic acids, long-chain 2-alkyl, 3-hydroxy fatty acids present as esters of either 
trehalose (role in virulence) or arabinogalactan (role in lowering cell wall 
permeability) in the mycobacterial cell wall, are synthesized by the concerted action 
of two multi-component enzyme systems: fatty acid synthase I and fatty acid synthase 
II (Barry, et al., 1998, Asselineau, et al., 2002). Mycolic acids are of significant 
scientific interest, because they are unique to mycobacteria and mycolic acid 
metabolism is the only well-known target of the first-line antitubercular drug 
isoniazid (Barry, et al., 1998, Daffe & Draper, 1998). Despite the importance of these 
complex biomolecules in virulence and antibiotic resistance and extensive 
biochemical and molecular genetic studies, the pathways of mycolic acid 
biosynthesis, maturation and transport are not completely understood. Based on 
genomic location and studies on homologous proteins from M. smegmatis and 
Corynebacterium glutamicum, the protein encoded by the accD4 gene (Rv3799c) of 
M. tuberculosis is believed to be the carboxyltransferase subunit of an acyl-CoA 
carboxylase crucial for mycolic acid biosynthesis in M. tuberculosis (Trivedi, et al., 
2004, Portevin, et al., 2005, Gago, et al., 2011). This section of the chapter reports the 
characterisation of AccD4, the less-studied carboxyltransferase subunit of the M. 
tuberculosis long-chain acyl-CoA carboxylase. Efforts towards the reconstitution of 
the AccA3-AccD4 complex and towards the structural characterisation of AccD4 by 
X-ray crystallography and small angle scattering are described. 
 
3.2.1 Results 
3.2.1.1 Reconstitution of the AccA3-AccD4 complex 
3.2.1.1.1 In vitro reconstitution 
Using constructs M02 and M06 [Table 2-2], the proteins AccA3 and AccD4 could be 
overexpressed individually in expression strains of E. coli (BL21 star (DE3) pRare2 
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and BL21 (DE3) respectively). Typical overexpression experiments resulted in yields 
of 5 – 10 mg of AccA3 and 12 – 15 mg of AccD4 per litre of expression culture. 
During SEC experiments, AccA3 eluted as a mixture of oligomers, hexamers likely 
being the principal species, as was described in section 3.1.1.7. Surprisingly, AccD4 
eluted as a homotrimer unlike other homohexameric actinobacterial CT subunits, 
including AccD5, described so far. Static light scattering analyses indicated a 
molecular weight of approximately 160 kDa [Figure 3-15B] that corresponds to a 
trimeric form of AccD4 (MW of a monomer: 56 kDa). The incubation of AccA3 and 
AccD4 together in equal stoichiometry resulted in the formation of a high-molecular 
weight AccA3-AccD4 complex that eluted as a broad, asymmetrical peak from 
Superose™ 6 10/300 GL in an SEC experiment [Figure 3-15]; the complex was 
unstable and hence could not be forwarded to crystallisation trials.  
 
 
Figure 3-15. In vitro reconstitution of AccA3-AccD4. Size exclusion chromatography 
profiles of M. tuberculosis AccA3 and AccD4 (expressed individually in E. coli) overlaid 
with that of the AccA3-AccD4 complex obtained by mixing the subunits in equimolar 
concentrations. Molecular weight standards and elution volumes (ml) on Superose™ 6 10/300 
GL in brackets: 670 kDa (12.1), 158 kDa (15.5). Inset A: SDS-PAGE analysis of fractions of 
the AccA3-AccD4 complex indicated by black arrows along the x-axis (in the same left-to-
right order). Inset B: Mass distribution (molar mass as a function of elution volume) of 
AccD4 peak fractions, as determined by SLS. 
 
3.2.1.1.2 Co-expression of AccA3-AccD4 
Construct pairs M06-M17 and M02-M21 [Table 2-2], based on the compatible 
pETM11-pCDF13 vector backbones, were used for co-expression of AccA3-AccD4. 
In each pair, one of the members was expressed in tandem with a polyhistidine 
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affinity tag while the interacting partner was expressed in a non-tagged form, to 
enable imidazole-based elution of the complex putatively assembled in vivo. In either 
trial, AccD4 was overexpressed at high levels in the insoluble pellet fractions whereas 
AccA3 was expressed only at low levels in both cell supernatant and cell pellet 
(confirmed by peptide mass fingerprinting) [Figures 3-16A, B]. Upon scale-up of the 
overexpression and purification, the formation of a binary complex could not be 
observed. Another version of co-expressed AccA3-AccD4 material (AccA3 expressed 
together with a Strep-tag® and AccD4 expressed together with a polyhistidine tag) 
was prepared in collaboration with Lionex GmbH. However, in this preparation, the 
AccA3-AccD4 complex existed in several oligomeric states in dynamic equilibrium 
with each other [Figure 3-16C] and hence was not subjected to crystallisation screens.  
 
 
Figure 3-16. Co-expression of AccA3-AccD4. In gel images (A) and (B), lanes (1) and 
(2): cell supernatant and cell pellet respectively from non-induced cultures; lanes (3) and (4): 
cell supernatant and cell pellet respectively from induced cultures; lane M: protein marker 
with standard molecular weights (in kDa). Protein bands of the expected molecular weights 
and whose identities were confirmed by peptide mass fingerprinting have been marked with 
red boxes. The polyhistidine-tagged protein of each pair has been marked with a (*). (C) 
Solid curve: SEC profile of the AccA3-AccD4 complex produced by co-expression (in 
collaboration with Lionex GmbH). Dashed curve: SEC profile of the 10-12 ml peak (from 
above) re-analysed on Superose™ 6 10/300 GL, indicating the existence of dynamic 
equilibrium among the different oligomeric states. Molecular weight standards and elution 
volumes (ml) in brackets: 670 kDa (12.1), 158 kDa (15.5); Void volume: 8.0 ml. Inset: SDS-
PAGE analysis of fractions of the AccA3-AccD4 complex indicated by black arrows along 
the x-axis (in the same left-to-right order). Theoretical MW: AccD4: 56.6 kDa, AccD4+His 
tag: 59.9 kDa, AccA3: 63.7 kDa, AccA3+His tag: 67 kDa, AccA3+Strep tag: 65 kDa. 
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3.2.1.2 Carboxylase activity of AccA3-AccD4 
The carboxylase activity of the AccA3-AccD4 reconstituted in vitro was tested on 
several acyl-CoA substrates of different acyl-chain lengths (butyryl-CoA [C4], 
lauroyl-CoA [C12], myristoyl-CoA [C14], and palmitoyl-CoA [C16]) by a coupled-
enzymatic reaction-based assay that probes ATP hydrolysis spectrophotometrically at 
340 nm (Diacovich, et al., 2002). The activity of the enzyme at different 
concentrations (approximately 0.2 µM – 2 µM) on a given concentration of butyryl-
CoA (0.5 mM) is depicted in Figure 3-17; an enzyme concentration-dependent 
consumption of the substrate was evident.  
 
Figure 3-17. AccA3-AccD4 is an active carboxylase in vitro. The OD340 nm of the 
carboxylase assay mixture, an indicator of the consumption of NADH (and hence of the acyl-
CoA substrate, i.e., butyryl-CoA), plotted as a function of time. Concentration of butyryl-CoA 
in each reaction: 0.5 mM. Concentrations of AccA3-AccD4 enzyme used are mentioned in 
the legend above. 
 
Similar enzyme-concentration dependent carboxylase effects were observed with 
other substrates (lauroyl-CoA, myristoyl-CoA and palmitoyl-CoA) of different acyl-
CoA chain lengths. Therefore, these preliminary kinetic analyses, aimed at checking 
if the AccA3-AccD4 assembled in vitro is a catalytically active acyl-CoA 
carboxylase, were indeed affirmative.  
 
3.2.1.3 AccD4: Crystallisation trials 
Stable AccA3-AccD4 material suitable for crystallisation trials could not be obtained 
by the co-purification and co-expression options tested. However, given that stable 
and monodisperse AccD4 protein could be produced and it was of interest to generate 
high-resolution structural data on individual !-subunits to probe into the molecular 
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determinants of substrate specificity, AccD4 was subjected to screening for 
crystallisation hits. Extensive efforts were undertaken to accomplish the 
crystallisation of AccD4 for structural studies. The crystallisation parametric space 
was explored by varying a number of parameters like protein concentration, 
crystallisation drop volume, and the presence of biotin and/or CoA (a substrate 
analog) in various stoichiometric proportions. Routine crystal screening and 
expansion experiments resulted in crystals in a few conditions; unfortunately, these 
crystals were not of diffraction quality [Figure 3-18D].  
 
 
 
Figure 3-18. AccD4 crystallisation trials. (A) SEC profiles of AccD4 and methylated 
AccD4 on Superose™ 6 10/300 GL. Inset: SDS-PAGE analysis of peak fractions of purified 
AccD4 (lanes 1 and 2) and methylated AccD4 (lanes 3 and 4); lane M: protein marker with 
standard molecular weights (in kDa). (B) CD spectra (molar ellipticity in M deg cm2 dmol-1 
plotted against wavelength in nm) of AccD4 and methylated AccD4 measured between 180 
and 260 nm wavelength with settings as follows: 0.1 cm cell length, 1 nm band width, 0.5 nm 
step size and 0.5 sec response duration. (C) Thermofluor assay on AccD4 pointed to a 
number of potentially favourable acidic buffer conditions for increased thermostability: citric 
acid (pH 5.0); succinic acid/phosphate/glycine (pH 5.6); potassium phosphate (pH 6.0); bis-
tris (pH 6.5); bis-tris (pH 6.5) + 0.25 M sodium chloride; thermostability was relatively lower 
at conditions of basic pH: ammonium acetate (pH 7.3); HEPES (pH 7.5); citric 
acid/CHES/HEPES (pH 8.75); bicine (pH 9.0) + 0.25 M sodium chloride. (D) (i) Bipyrimidal 
and (ii) Short-rod shaped crystals of AccD4 obtained using 0.2 M magnesium acetate, 0.1 M 
sodium cacodylate (pH 6.5), 30% (v/v) MPD. The black bar corresponds to a length of 50 
µm. (iii) Microcrystals of AccD4 (with CoA, 1:5) obtained with 0.1 M bicine (pH 9.0), 5% 
(w/v) PEG 6000. 
Results and Discussion 
 86 
 
Data from thermal denaturation experiments on AccD4 suggested that the 
thermostability (an usually critical criterion for successful crystallisation) of AccD4 
could be enhanced in an acidic environment [Figure 3-18C]. However, attempts to 
purify or ‘exchange’ the protein into such buffer conditions were not successful 
because of the problem of excessive precipitation. 
 
It has been known that protein motions due to solvent-exposed, flexible amino acid 
side chains can be disruptive to an ordered three-dimensional crystal lattice. In such 
cases, surface entropy reduction mutagenesis techniques like lysine methylation have 
been used as rescue strategies for effective protein crystallisation (Walter, et al., 
2006). The primary structure of AccD4 contains about 4% lysine, an amino acid with 
a flexible side chain. In an attempt to restrict overall protein mobility, AccD4 was 
modified by a standard methylation protocol; complete methylation of all Lys 
residues was ensured by MALDI-TOF (0.88 kDa increase in molecular weight, 
corresponding to the trimethylation of 21 Lys). In SEC experiments, methylated 
AccD4 eluted as a higher oligomeric form than AccD4 [Figure 3-18A]; based on 
static light scattering data, methylated AccD4 could be a 9-mer in solution. The 
secondary structural content of methylated AccD4, however, was identical to that of 
AccD4, as verified by CD spectroscopy [Figure 3-18B]. Initial crystallisation trials 
with methylated AccD4 (of unusual oligomeric status) were unsuccessful and hence, 
work with this protein was discontinued. Effort was invested in the characterisation of 
AccD4 by small angle X-ray scattering, a biophysical method widely considered to be 
complementary to X-ray crystallography. 
 
3.2.1.4 SAXS analysis 
AccD4 was subjected to preliminary structural investigation by small angle X-ray 
scattering in collaboration with Anne Tuukkanen, Svergun group, EMBL Hamburg. 
Scattering data of usable quality could not be obtained at protein concentrations 
higher than 1 mg/ml because of the formation of high-molecular weight aggregates at 
these concentrations. Molecular dimensions obtained from the investigation of 
samples at concentrations lower than 1 mg/ml supported the possibility of the trimeric 
quaternary structure of AccD4 [Table 3-4]. To enable comparative analysis, AccD5 
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and AccD6 samples were also included in the SAXS investigation; molecular 
dimensions obtained from these experiments verified the homohexameric state of 
AccD5 and the homodimeric existence of AccD6 (discussed in sub-chapter 3.3).  
 
Table 3-4. Dimensions of YCC !-subunits from SAXS analysis  
Protein Rg (nm) Dmax (nm) 
Volume 
(nm
3
) 
MW 
(kDa) 
Oligomeric 
state 
Quality 
(%) 
AccD4 5.08 ± 3% 17.78 522 170 Trimer 84 
AccD5 5.31 ± 1% 18.2 720 319 Hexamer 94 
AccD6 4.98 ± 1% 17.5 355 129 Dimer 89 
 
 
 
Figure 3-19. SAXS analysis of AccD4. (A) Mesh representation of the rigid body model 
of AccD4 generated by SASREF. (B) Experimental scattering data (green) from AccD4 and 
the calculated scattering curve (red) from the rigid body model plotted as the logarithm of 
scattered intensity against the momentum transfer. (C) For comparison, experimental 
scattering data (green) from AccD5 and the scattering curve (red) calculated from the crystal 
structure of AccD5, plotted as the logarithm of scattered intensity against the momentum 
transfer. 
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Rigid body modeling of AccD4 based on SAXS measurements generated a model 
with an unexpected arrangement of AccD4 protomers; the model that best fits 
(goodness of fit: approximately 2.0; Figure 3-19B) the observed data supports the 
arrangement of three AccD4 monomers in a fan-like fashion around a central axis 
[Figure 3-19A], unlike the compact trimeric ring organization found in other 
actinobacterial YCC !-subunits (Diacovich, et al., 2004, Holton, et al., 2006). In the 
SAXS-generated model, that measures approximately 180 Å at the longest dimension, 
the C-terminal subdomains of AccD4 form interactions at the central core of the 
homotrimer while the N-terminal subdomains are located at the periphery of the ring, 
away from the N-terminal or C-terminal subdomains of adjacent protomers. Efforts to 
confirm this model, by means of collecting data of finer quality so as to accomplish 
better goodness of fit, are underway. 
  
3.2.2 Discussion 
In this part of the study, the structural and biophysical characterisation of AccD4, and 
its reconstitution in the form of a holo-complex together with its interacting partner 
AccA3, were attempted. The YCC components AccA3 and AccD4 did not assemble 
into a stable complex appropriate for crystallographic studies. As with the case of 
AccA3-AccD5 discussed in the previous sub-chapter, the inability of AccA3-AccD4 
to form a stable complex can be attributed to the likely absence of strong interactions 
between the two subunits. It is also possible that the subunits AccA3 and AccD4 
might assemble into a stable entity only in the presence of/by the action of a third (or 
more) interacting partner(s). On the basis of co-immunoprecipitation studies using M. 
smegmatis AccD4, it has earlier been proposed that the proteins AccA3 and AccD5 
are the other subunits of the AccD4-containing acyl-CoA carboxylase involved in 
mycolic acid biosynthesis (Portevin, et al., 2005), but the existence of such a ternary 
complex has not been conclusively proven. The observation that AccA3 and AccD5 
co-immunoprecipitate with AccD4-myc (Portevin, et al., 2005), is not direct evidence 
that the three components arrange in the form of a multi-subunit complex, but could 
be a result of AccA3 being the common biotin-carboxylating partner of the !-subunits 
AccD4 and AccD5 individually. Furthermore, each structurally characterised holo-
YCC complex has been shown to contain a core catalytic !-subunit composed of 
Results and Discussion 
 89 
protomers of only one protein (Huang, et al., 2010, Huang, et al., 2011). Based on 
existing literature, it is unlikely that an acyl-CoA carboxylase complex would contain 
a heteromeric !-subunit capable of carboxylating more than one acyl-CoA substrate. 
 
The function of the AccD4-containing carboxylase (i.e., the carboxylation of the fatty 
acid that will serve as the %-chain of the mycolic acid, whose meromycolate part will 
be activated and provided by FadD32) was deduced based on gene knockout and 
lipidomic studies in C. glutamicum (Portevin, et al., 2005). The understanding that 
AccD4 is responsible for the carboxylation of C16 fatty acids was on the basis of two 
observations: (1) the presence of an alkylmalonate species (whose mass spectrum 
corresponded to that of an activated C16 fatty acid derivative) in wild-type C. 
glutamicum, but not in the !accD4 mutant; (2) the accumulation of tetradecylmalonic 
acid in the !fadD32 mutant, but not in the !accD4 mutant. Nevertheless, a 
comprehensive understanding of the enzyme kinetics of the AccD4-containing YCC 
is lacking. A surprising finding from the current study has been the fact that AccD4 
exists as a trimer in solution, unlike the other hexameric !-subunits found in 
literature. Preliminary kinetic analyses, aimed at checking if the AccD4 trimer is a 
catalytically active carboxyltransferase, were indeed affirmative, hence suggesting 
that a hexameric arrangement of protomers is not necessary for carboxylase activity.  
 
 
Figure 3-20. SAXS model of AccD4. The rigid-body model of AccD4 (left) based on 
SAXS measurements compared with the crystal structure of AccD5 (right). For clarity, only 
one trimeric ring of the AccD5 hexamer is shown. The monomers of each model are coloured 
green, magenta and purple. The structural elements important for hexameric arrangement and 
catalytic activity in AccD5 and the corresponding features mapped on the AccD4 model are 
shown in golden colour. 
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Preliminary SAXS experiments also indicated molecular dimensions of AccD4 that 
correspond to a trimeric quaternary arrangement. Rigid body modeling based on 
SAXS measurements generated a preliminary model that describes relative 
positioning of the AccD4 protomers in a fashion different from that of the other YCC 
!-subunits described so far. It has been known that conserved didomain dimeric 
interactions are crucial for carboxylase activity; in all the CT subunits characterised 
so far, it has been shown that the juxtaposition of members of the dimeric pair gives 
rise to conserved oxyanion holes, strategically located for the stabilization of the acyl-
CoA substrate, the carboxybiotin (translocated to the active site of the !-subunit by 
the BCCP domain of the %-subunit) and the reaction intermediates. The possibility of 
such an arrangement is not supported by the current model of AccD4 [Figure 3-20]; 
therefore, it remains to be verified if such an arrangement is biologically relevant. The 
unsatisfactory goodness of fit between the observed data and the expected model 
could be arising due to possible oligomeric heterogeneity; the implementation of 
measures (such as in-line purification and biophysical characterisation steps coupled 
to small angle scattering measurements) potentially capable of overcoming the 
problem of sample heterogeneity will be required to validate/verify the current model 
and to thereby derive better insights into the structure and function of AccD4. 
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3.3 Structural study of the carboxyltransferase subunit of 
acetyl-CoA carboxylase 
 
Acetyl-CoA carboxylase is one of the most fundamental metabolic enzymes in the 
majority of life forms as it catalyses the generation of malonyl-CoA, a key lipid 
metabolite. The two fatty acid synthase systems (FAS-I and FAS-II) of 
Mycobacterium species rely on the supply of malonyl-CoA as substrate for the 
biosynthesis of the complex lipids that constitute the cell wall, such as the phthiocerol 
dimycocerosates (Trivedi, et al., 2005), sulpholipids (Jackson, et al., 2007), and long-
chain %-alkyl, !-hydroxymycolic acids (Bhatt, et al., 2007). An acyl-CoA 
carboxylase of M. tuberculosis, reconstituted from components AccA3 and AccD6, 
was shown to be active on acetyl-CoA and propionyl-CoA with comparable 
efficiency (Daniel, et al., 2007). On the basis of the location of accD6 (Rv2247) in a 
genetic locus together with members of the FAS-II system and the characterisation of 
an accD6 M. smegmatis conditional mutant (Kurth, et al., 2009), the physiological 
role of M. tuberculosis AccA3-AccD6 is known to be the carboxylation of acetyl-
CoA. Although the function of AccD6 is known, its biophysical properties and the 
structural basis of its catalytic activity and substrate preference are not completely 
understood. Sub-chapter 3.3 reports the crystallisation, structure determination and 
analysis of AccD6.  
 
3.3.1 Results 
3.3.1.1 Purification of AccD6 
Using construct M27 [Table 2-2], the protein AccD6 could be overexpressed in the 
BL21 (DE3) expression strain of E. coli. Typical overexpression and purification 
experiments resulted in a final yield of 10 – 15 mg of AccD6 protein per litre of 
culture. During SEC experiments using Superose™ 6 10/300 GL, AccD6 eluted as a 
single symmetrical peak whose elution volume corresponded to the dimeric state. 
Static light scattering experiments indicated a molecular mass of approximately 123 
kDa (monomer MW: 53 kDa), confirming the existence of AccD6 as a homodimer. 
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Figure 3-21. Purification of AccD6. SEC elution profile of AccD6 on Superose™ 6 
10/300 GL. Molecular weight standards used and respective elution volumes (ml) in brackets: 
670 kDa (12.1), 158 kDa (15.5). Inset A: SDS-PAGE analysis of supernatant (S) and 
insoluble pellet (P) of cell lysate, wash (1) and eluate (2) of IMAC purification, and peak 
fraction (3) of SEC purification; lane M: protein marker with standard molecular weights (in 
kDa). Inset B: Mass distribution (molar mass as a function of elution volume) of SEC peak 
fractions, as determined by SLS. 
 
3.3.1.2 Crystallisation of AccD6 
AccD6, in apo-form and in combination with CoA (substrate analog) and/or biotin 
(cofactor analog) at varying stoichiometries, was used in crystallisation trials by the 
sitting-drop and hanging-drop vapour diffusion methods. Crystals of two different 
morphologies were obtained [Figure 3-22]. The crystallisation conditions 
corresponding to both crystal forms were similar to those observed in a structural 
genomics consortium study conducted elsewhere during the course of this work (Niu, 
et al., 2011). Crystals of type I were roughly rod-shaped and generally, either 
possessed weak diffraction properties or resulted in X-ray diffraction data marred by 
very high degrees of mosaicity; the more robust type II crystals, on the other hand, 
had a trigonal bipyramidal morphology and generally diffracted X-rays to high 
resolution. Crystals were treated with a suitable cryoprotectant (10 – 15% (v/v) 
glycerol, in addition to the mother liquor) and flash-cooled in a stream of liquid 
nitrogen immediately prior to exposure to X-rays; the diffraction experiments were 
performed at the P14 beamline of PETRA III, DESY. 
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Figure 3-22. Crystallisation of AccD6. (A) Type I crystals of AccD6 obtained with 2.6 
M sodium formate (pH 7.0). (B) Type I crystals of AccD6 + biotin + CoA (molar ratio 1:3:3) 
obtained with 2.75 M sodium formate (pH 7.5). (C) Type II crystals of AccD6 obtained with 
27% (w/v) PEG 3350, 0.1 M Tris (pH 8.5) and 0.3 M ammonium sulphate. The white bars 
represent a length of 100 µm.  
 
3.3.1.3 X-ray data collection, structure solution and refinement 
Diffraction data from a crystal of type II were collected to a maximum resolution of 
1.95 Å at a detector distance of 270 mm; the data were indexed, scaled and merged 
using XDS (Kabsch, 2010) and SCALA (Evans, 2006). The crystal belonged to the 
common orthorhombic space group P212121, with a space group confidence of 0.973, 
Laue group confidence of 0.993 and systematic absence probability of 0.983, as 
estimated by the program POINTLESS (Collaborative Computational Project, 1994). 
Solvent content analysis based on Matthew’s coefficient indicated the presence of two 
monomers in the asymmetric unit. The structure of AccD6 was solved by molecular 
replacement with Phaser (McCoy, et al., 2007) using the crystallographic structure of 
a monomer of AccD5 as the search model. The parameters Rconv and Rfree and 
adherence to allowed peptide bond geometry were used to monitor the progress of the 
alternating, iterative cycles of manual model building with COOT (Emsley & Cowtan, 
2004) and maximum-likelihood refinement with REFMAC (Murshudov, et al., 1997). 
The crystallographic data collection and refinement statistics were as in Table 3-5. 
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Table 3-5. Crystallographic statistics of AccD6 
Crystallographic parameter Value 
Data collection and processing  
Wavelength [Å] 1.24 
Resolution range [Å] 76.94 – 1.95 (2.05 – 1.95) 
Space group P212121 
Unit cell dimensions [Å] 76.94, 90.31, 154.56 
Average mosaicity [°] 0.01 
Number of measured reflections 1021845 (145681) 
Number of unique reflections 79385 (11309) 
Multiplicity 12.9 (12.9) 
Mean I/#(I) 34.4 (5.5) 
Completeness [%] 99.8 (98.5) 
1Rsym 0.04 (0.50) 
Values in parentheses correspond to the highest resolution shell. 
Refinement  
2Rconv / 3Rfree 0.181 / 0.241 
Average B-factor [Å2] 30.17 
Root mean square deviations  
     Bond lengths [Å] 0.019 
     Bond angles [°] 1.970 
Ramachandran plot analysis  
     Favoured [%] 97.1 
     Additionally allowed [%] 2.9 
 
1 Rsym = Ih, j ! Ih
j
"
h
" Ih, jj"h" where Ih,j is the intensity of the j
th observation of unique 
reflection h.  
2
! 
Rconv =
h
" Foh # Fch Foh
h
"  where Foh and Fch are the observed and calculated 
structure factor amplitudes for reflection h.  
3 Rfree is equivalent to Rconv, but is calculated using a 5% disjoint set of reflections excluded 
from the maximum likelihood refinement stages. 
 
3.3.1.4 Overall architecture of AccD6 
Consistent with size exclusion chromatographic and static light scattering data, the 
crystal structure of AccD6 is a homodimer [Figure 3-23A]; each of the two monomers 
(A and B) is made of two structural subdomains - the N- and C-terminal subdomains - 
and assumes a variant of the conventional crotonase fold. The monomers are 
structurally similar, as evidenced by an RMSD value of 0.475 Å for an alignment of 
about 400 equivalent main-chain carbon atoms. Residues 328 to 333 and 400 to 430 
of monomer A and residues 156 to 187 of monomer B could not be modeled with 
confidence, presumably due to high conformational flexibility. Residues 400 to 430 of 
monomer B could be modeled on the basis unbiased electron density features, though 
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the corresponding region could not be modeled in monomer A; this was most 
probably because of relatively reduced conformational flexibility of this region (in 
monomer B) due to close crystal contacts (generated by the effect of molecular 
packing) with a neighbouring symmetrical partner in the unit cell. This region 
contains a few residues that are putatively involved in substrate-binding and will be 
discussed in section 3.3.1.7. 
 
 
Figure 3-23. The crystal structure of AccD6. (A) The two monomers of AccD6 are 
coloured green and cyan respectively. (B) A reoriented, closer view of the dimeric interface at 
the central core of the homodimer. Residues that make strong interactions at the dimeric 
interface are shown in ‘stick’ mode with carbon, nitrogen and oxygen atoms coloured 
cyan/green, blue and red respectively.  
 
As in the case of the A-D dimeric pair in the crystal structure of AccD5 (section 
3.1.1.5.1), the N-terminal subdomain of one monomer of AccD6 makes extensive 
atomic interactions with the C-terminal subdomain of its counterpart. About 20% 
(5350 Å2) of the total surface area of the protein (29800 Å2) is buried and solvent-
inaccessible, implying the formation of a very strong and compact dimeric interface. 
Several salt bridges and hydrogen bond-mediated interactions [Table 3-6] between 
fully- or functionally-conserved residues of the two monomers contribute to the 
maintenance of this intact dimeric interface. The details of these interactions were 
verified by interface and assembly analyses using the PDBePISA tool (Krissinel & 
Henrick, 2007). 
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Table 3-6. Interactions at the AccD6 dimeric interface 
Monomer A Monomer B Distance (Å) 
Salt bridges   
Glu 301 (OE1) Arg 339 (NH2) 3.88 
Glu 301 (OE2) Arg 339 (NE) 3.31 
Glu 301 (OE2) Arg 339 (NH2) 3.28 
Arg 340 (NH2) Glu 301 (OE1) 3.45 
Arg 340 (NH2) Glu 301 (OE2) 3.12 
Hydrogen bonds   
Ser 122 (OG) His 346 (NE2) 3.17 
Ser 177 (O) Trp 334 (NE1) 2.96 
Ser 188 (O) Arg 339 (NH1) 2.80 
Glu 301 (OE2) Arg 339 (NE) 3.31 
Glu 301 (OE2) Arg 339 (NH2) 3.28 
Val 337 (O) Tyr 141 (OH) 3.51 
His 346 (NE2) Ser 122 (OG) 3.18 
Arg 340 (NH2) Glu 301 (OE2) 3.12 
Val 159 (N) Glu 333 (OE2) 2.96 
Thr 160 (N) Glu 333 (OE2) 3.74 
 
Re
su
lts
 a
nd
 D
is
cu
ss
io
n 
 
97
 
T
ab
le
 3
-7
. T
op
 st
ru
ct
ur
al
 h
om
ol
og
s o
f A
cc
D
6 
 Th
e 
th
re
e-
di
m
en
si
on
al
 s
tru
ct
ur
e 
of
 A
cc
D
6 
sh
ar
es
 h
ig
h 
de
gr
ee
s 
of
 s
tru
ct
ur
al
 h
om
ol
og
y 
w
ith
 s
ev
er
al
 c
ar
bo
xy
ltr
an
sf
er
as
e 
pr
ot
ei
ns
 [T
ab
le
 3
-7
], 
as
 id
en
tif
ie
d 
by
 P
D
Be
Fo
ld
 a
na
ly
si
s (
K
ris
si
ne
l &
 H
en
ric
k,
 2
00
7)
. I
n 
th
e 
ab
ov
e 
ta
bl
e,
 P
D
B
 e
nt
rie
s t
ha
t w
er
e 
id
en
tif
ie
d 
as
 ‘h
its
’ m
or
e 
th
an
 o
nc
e 
ar
e 
lis
te
d 
on
ly
 o
nc
e.
 F
or
 th
es
e 
st
ru
ct
ur
es
, v
al
ue
s 
fo
r t
he
 c
ha
in
 w
ith
 th
e 
cl
os
es
t s
tru
ct
ur
al
 h
om
ol
og
y 
to
 A
cc
D
6 
ar
e 
sh
ow
n.
 E
nt
rie
s 
ha
ve
 b
ee
n 
so
rte
d 
by
 th
e 
Q
-s
co
re
, w
hi
ch
 is
 a
n 
in
di
ca
to
r 
of
 th
e 
qu
al
ity
 f
un
ct
io
n 
of
 th
e 
C
! 
al
ig
nm
en
t, 
as
 m
ax
im
iz
ed
 b
y 
th
e 
SS
M
 a
lig
nm
en
t a
lg
or
ith
m
 
(K
ris
si
ne
l &
 H
en
ric
k,
 2
00
7)
. T
he
 Z
-s
co
re
 re
pr
es
en
ts
 th
e 
st
at
is
tic
al
 s
ig
ni
fic
an
ce
 o
f a
 m
at
ch
 in
 te
rm
s 
of
 G
au
ss
ia
n 
st
at
is
tic
s;
 N
al
ig
n i
s 
th
e 
le
ng
th
 
of
 a
lig
nm
en
t, 
or
 n
um
be
r o
f m
at
ch
ed
 re
si
du
es
, c
al
cu
la
te
d 
at
 b
es
t 3
D
 su
pe
rp
os
iti
on
 o
f t
he
 q
ue
ry
 a
nd
 ta
rg
et
 st
ru
ct
ur
es
.  
 
T
ar
ge
t (
PD
B
 e
nt
ry
) 
Sc
or
in
g 
St
ru
ct
ur
al
/s
eq
ue
nc
e 
si
m
ila
ri
ty
 
 
PD
B
 ID
 
O
rg
an
is
m
 
Pr
ot
ei
n 
Q
 
Z
 
Se
qu
en
ce
 
id
en
tit
y 
(%
) 
rm
sd
  
(Å
) 
N
al
ig
n 
1 
3N
6R
 
Ro
se
ob
ac
te
r d
en
itr
ifi
ca
ns
 
PC
C
 "
-s
ub
un
it 
0.
64
 
21
.1
 
44
 
1.
26
 
39
7 
2 
2B
ZR
 
M
yc
ob
ac
te
ri
um
 tu
be
rc
ul
os
is
 
PC
C
 "
-s
ub
un
it 
(A
cc
D
5)
 
0.
64
 
21
.7
 
45
 
1.
31
 
39
7 
3 
1O
N
9 
Pr
op
io
ni
ba
ct
er
iu
m
 fr
eu
de
nr
ei
ch
ii 
su
bs
p.
 sh
er
m
an
ii 
Tr
an
sc
ar
bo
xy
la
se
 1
2S
 
do
m
ai
n 
0.
63
 
21
.4
 
41
 
1.
27
 
39
2 
4 
1X
N
Y
 
St
re
pt
om
yc
es
 c
oe
lic
ol
or
 
PC
C
 "
-s
ub
un
it 
0.
62
 
21
.9
 
42
 
1.
28
 
39
5 
5 
1X
0U
 
Su
lfo
lo
bu
s t
ok
od
ai
i 
Pu
ta
tiv
e 
PC
C
 "
-s
ub
un
it 
0.
61
 
20
.8
 
42
 
1.
35
 
39
6 
    Results and Discussion 
 98 
3.3.1.5 Dimer versus hexamer 
Unlike the M. tuberculosis PCC !-subunit AccD5 (this study, Holton, et al., 2006, 
Lin, et al., 2006), the S. coelicolor PccB (Diacovich, et al., 2004), and the 12S 
domain of P. shermanii transcarboxylase (Hall, et al., 2003) that have been 
investigated structurally, the carboxyltransferase AccD6 of M. tuberculosis ACC 
assumes a dimeric quaternary arrangement. The AccD6 homodimer is structurally 
homologous to and superposes well with the A-D (or B-E / C-F) dimer of AccD5 
[Figure 3-24A], as evidenced by an RMSD value as low as 1.3 Å for an alignment of 
approximately 400 equivalent C" atoms. 
 
 
Figure 3-24. AccD6 lacks structural features that favour hexamer formation. (A) 
Superposition of the crystal structure of AccD6 (monomers in cyan and green) with that of 
AccD5 represented as a grey mesh. (B) Structural superposition as in (A), but only one layer 
of each structure (one trimeric ring of AccD5 and one monomer of AccD6) are shown, for 
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clarity. The secondary structural elements that predominantly favour hexameric arrangement 
in AccD5 are coloured orange; the corresponding elements of adjacent monomers on either 
side are coloured yellow and magenta respectively. (C) Closer view of the region marked by 
the box in (B). The monomers of AccD5 are coloured orange and magenta respectively. 
Residues involved in interactions that most likely establish hexameric arrangement are 
represented in the ‘stick mode’ with carbon, nitrogen and oxygen atoms coloured 
orange/magenta, blue, and red, respectively. The details of the interactions labeled 1 to 6 are 
listed in Table 3-8. 
 
Comparative structural and sequence analyses revealed that AccD6 lacks certain 
secondary structural elements that are crucial for interactions between protomers in 
order to result in a hexameric ring arrangement [Figure 3-24C, 3-25]. A !-subunit that 
forms homohexamers, AccD5 for instance, possesses a short loop and an 
approximately 15-residue-long helix at the N-terminal of one protomer (say, 
monomer A). These elements are predominantly responsible for the formation of 
atomic interactions [Table 3-8], in the form of salt bridges and hydrogen bonds, with 
regions close to the C-terminal of a neighbouring protomer (say, monomer B) in the 
trimeric ring of the protein structure. These interactions are identical between the 
pairs B-C and C-A as well, and thus contribute to the maintenance of the trimeric ring 
structure. The existence of these interactions, in addition to the strong dimeric 
interactions between pairs A-D, B-E, and C-F, forms the basis of the hexameric 
architecture of most !-subunits. 
 
Table 3-8. Interactions that favour hexamer formation in AccD5 
No. Monomer A Monomer B Distance (Å) 
 Salt bridges   
1 His 23 (NE2) Asp 497 (OD1) 3.61 
 His 23 (NE2) Asp 497 (OD2) 3.22 
 His 23 (ND1) Asp 497 (OD2) 3.91 
2 Arg 92 (NH2) Glu 507 (OE1) 3.75 
3 Asp 109 (OD1) Arg 533 (NH2) 3.56 
4 Lys 134 (NZ) Asp 512 (OD1) 2.66 
5 Lys 141 (NZ) Asp 447 (OD1) 3.32 
 Hydrogen bonds   
6 Thr 25 (OG1) Ile 304 (O) 2.61 
 Thr 25 (OG1) Pro 305 (O) 2.74 
 Thr 25 (N) Asp 306 (OD2) 2.95 
 
It is most likely that AccD6 forms neither homotrimers nor homohexamers, because 
of the absence of such interactions. The residues His 23 and Thr 25 of AccD5 are part 
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of the N-terminal loop and "-helix respectively and facilitate a strong molecular 
‘hand shake’ of the N-terminal subdomain of one monomer with the C-terminal 
subdomain of the neighbouring monomer. These two amino acids do not have 
equivalent residues in the AccD6 primary structure [Figure 3-25], thus ruling out the 
possibility of such an anchoring set of interactions in AccD6.  
 
In the AccD5 structure, Arg 92 (that forms electrostatic interactions with Glu 507) is 
part of a 30-residue-long loop region between the third "-helix and the first !-strand 
of the canonical crotonase topology. The corresponding loop in the AccD6 structure is 
significantly shorter (17 residues long) and is in close proximity to the N-terminal end 
of the protein due to the absence of the N-terminal loop and "-helix, as mentioned 
earlier [Figure 3-24C]. The positively charged residues in this short loop that might 
contribute to a potential salt bridge are Arg 37 and Arg 39, but the side chains of these 
residues point farther away, in the opposite direction of the Arg 92 side chain of 
AccD5. Additionally, the conserved Glu 507 (AccD5 numbering) of hexameric !-
subunits has been replaced by the shorter Asp 437 in AccD6, causing a further 
reduction in the possibility of establishment of a charge-based interaction in this 
region of the protomers.  
 
Asp 109 and Arg 533 of AccD5 make up another pair of interacting residues and lie 
close to the central core of the hexameric ring. These residues have been substituted 
in AccD6 by the oppositely charged Arg 53 and the non-polar Ala 463, respectively, 
thereby precluding the establishment of a charge-based interaction, in this region, 
between protomers. Similarly, the conserved residues Lys 134 and Lys 141 (AccD5 
numbering), which are involved in key electrostatic interactions along the 
intratrimeric interface in hexameric !-subunits, have been replaced in AccD6 by the 
negatively charged Asn 78 and Glu 85, respectively [Figure 3-25]. The structural data 
indicates that it is highly probable that all these amino acid differences together form 
the basis of the nonexistence of homotrimeric or homohexameric arrangement in 
AccD6. 
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Figure 3-25. Sequence alignment of AccD6 with structural relatives. Sequence 
alignment of the M. tuberculosis carboxyltransferases AccD6, AccD5, and AccD4, the PCC 
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!-subunit of R. denitificans (PccB_Rd), and the PCC !-subunit of S. coelicolor (PccB_Sc). 
Residue numbering and secondary structure assignment (arrow marks for strands and helical 
symbols for helices) shown on the first row of each block of the alignment are based on the 
AccD6 structure. Conserved blocks of residues are shown in blue rectangular frames, with 
partially- and fully-conserved residues represented in a white and red background 
respectively. Legend: red star, putative substrate specificity determinant residue; green star, 
conserved active site residues that favour oxyanion hole formation; black triangle, residues 
contributing to the dimeric interface; pink triangle, putative carboxybiotin-binding residues; 
circle, putative substrate-binding residues that might interact with the adenine and 
biphosphate (dark blue), ribose (cyan), pantotheine (orange), and acetyl (red) moieties 
respectively; $ and !, conserved hydrophobic amino acids; %, conserved aromatic residues; #, 
conserved hydrophilic residues. The figure was generated using the ESPript 2.2 program 
(Gouet, et al., 2003). 
 
Some non-actinobacterial !-subunits have been reported to exist and function as 
homodimers (Wendt, et al., 2003, Zhang, et al., 2003). The CT subunit of yeast ACC 
is known to feature dimeric didomain interactions that are ubiquitous to all 
carboxyltransferase proteins (Zhang, et al., 2003). The unique feature of the 
homodimeric yeast protein, however, is the presence of structural attributes (a large !-
insertion at its N-terminal subdomain, one !-insertion and one "-helical insertion at 
its C-terminal subdomain, and an additional four-helix stretch at its C-terminus) that 
have been implicated in the prevention of hexamer formation (Zhang, et al., 2003). 
Interestingly, AccD6 does not form hexamers even in the absence of such additional 
structural features.  
 
3.3.1.6 Putative cofactor-binding site 
Attempts to obtain the crystal structure of AccD6 in complex with a cofactor analog 
and/or a substrate analog by means of co-crystallisation were unsuccessful. The 
absence of electron density corresponding to the cofactor or substrate analog could be 
a result of the hydrolysis of the analogs in the course of the crystallisation process or 
could reflect a lack of specific contacts between the protein and the analogs under the 
crystallisation conditions tested. Nevertheless, the apo-AccD6 structure provided 
snapshots of the putative cofactor- and substrate-binding sites of the protein. Based on 
structural homology to previously characterised !-subunits, the substrate (acetyl-
CoA) and cofactor (carboxybiotin) are expected to bind at the interface between the 
N-terminal subdomain of one AccD6 monomer and the C-terminal subdomain of its 
dimeric partner [Figure 3-26]. 
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Figure 3-26. The putative cofactor-binding site. Top panel: The putative active site of 
AccD6 lies at the dimeric di-domain interface; the two monomers are coloured green and 
cyan respectively. Models of biotin and propionyl-CoA (based on their location in the crystal 
structure of S. coelicolor PccB; PDB ID: 1XNY) are shown in ‘stick mode’ with carbon, 
nitrogen, oxygen, phosphorus, and sulphur atoms coloured grey, blue, red, orange, and 
yellow, respectively. In the surface representation of AccD6, carbon, nitrogen, oxygen, and 
sulphur atoms have been coloured green/cyan, blue, red, and yellow, respectively; the 
surfaces of the monomers have been rendered partially transparent for the sake of clarity. 
Bottom panel: Closer view of the putative cofactor-binding site. Residues that could 
potentially be involved in cofactor binding are shown as ‘lines’ with colouring scheme as in 
the top panel.  
 
The putative pocket for cofactor-binding is defined by the short loops between N-!5 
and N-"4 of monomer A, C-!12’ and C-"11’, and the relatively longer loop between 
C-!11’ and C-"9’ of monomer B [Figure 3-25]. The biotin-streptavidin interaction is 
known to be predominantly van der Waals and hydrophobic in nature, involving the 
participation of many aromatic residues (Lindqvist & Schneider, 1996). The crystal 
structure of AccD6 revealed that the potential carboxybiotin-AccD6 interaction would 
also be predominantly hydrophobic, carried out by fully or functionally conserved 
residues that line the carboxybiotin-binding pocket. Residues Val 159, Val 164, and 
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Val 168 of monomer A and residues Leu 291’, Pro 324’, Gly 325’, Tyr 326’, Leu 
327’, and Pro 328’ contribute to the hydrophobic environment suitable for cofactor-
binding [Figure 3-26]. Furthermore, the putative cofactor-binding pocket of AccD6 is 
appropriately shaped to allow the ureido moiety of the cofactor to point to two 
possible oxyanion-holes that, in homologs, have been implicated to be essential for 
catalysis (Diacovich, et al., 2004).  
 
3.3.1.7 Putative substrate-binding pocket 
The probable pocket for substrate-binding is located perpendicular to the cofactor-
binding pocket and the two pockets intersect at the junction of the L-shaped active 
site [Figure 3-27]. The crystal structure of AccD6 bears a high degree of homology to 
that of S. coelicolor PccB [Table 3-7]; it is hence reasonable to believe that the 
substrate of AccD6 would bind in a conformation similar to that of propionyl-CoA in 
the PccB-propionyl-CoA-biotin cocrystal structure (Diacovich, et al., 2004). The 
substrate analog modeled, in such a conformation, into the active site of AccD6 does 
not face clashes due to steric effects. This conformation is indeed very similar to those 
observed for the 12S domain of transcarboxylase (Hall, et al., 2003) and the CT 
subunit of yeast ACC (Zhang, et al., 2003). 
 
 
Figure 3-27. The putative substrate-binding pocket. The putative substrate-binding 
pocket of AccD6 lies perpendicular to the cofactor-binding site and is lined by fully- or 
partially-conserved residues placed strategically to interact with the different chemical groups 
of the substrate. In the surface representation of AccD6, carbon, nitrogen, oxygen, and 
sulphur atoms have been coloured green/cyan, blue, red, and yellow respectively; the surfaces 
of the monomers have been rendered partially transparent for the sake of clarity. Residues 
that could potentially be responsible for substrate-binding are shown as ‘lines’ with the same 
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colouring scheme. Models of biotin and propionyl-CoA (based on their location in the crystal 
structure of S. coelicolor PccB; PDB ID: 1XNY) are shown in ‘stick mode’ with carbon, 
nitrogen, oxygen, phosphorus, and sulphur atoms coloured grey, blue, red, orange, and yellow 
respectively.  
 
Substrate-binding could be brought about by the concerted action of both the 
monomers of AccD6, with the N-terminal subdomain contributing most interactions. 
The partially-conserved residues Val 398’, Gly 399’, and Ile 400’ of the C-terminal 
subdomain are placed suitably to generate a hydrophobic patch to accommodate the 
adenine ring of the substrate molecule. The partially conserved, positively charged 
residues Lys 403’ and Lys 404’ might be involved in stabilizing the biphosphate 
moiety of the substrate [Figure 3-27]. These residues are respectively Arg and Gln in 
AccD5 and Arg and Arg in the S. coelicolor homolog PccB [Figure 3-25]. Although 
these positions are functionally conserved and may contribute equally to the charge-
based anchorage of the biphosphate, the differing sizes of the side chains indicate a 
possibility of subtle variations in the recognition and stabilization of this part of the 
substrate. As explained in section 3.3.1.4, this region (residues 400 to 430) of the 
AccD6 protein could not be modeled with confidence in one of the two monomers, 
presumably because of a high degree of conformational flexibility. This 
conformational flexibility could potentially be restricted in the presence of the 
substrate or an analog as well as by the establishment of crystal contacts with adjacent 
symmetry-related molecules.  
 
The AccD6 structure contains a flexible, conserved patch of mainly non-polar 
residues that could accommodate the ribose part of the substrate; this patch is 
composed of the residues Gly 65, Gly 66, Gly 97, Gly 98, Ala 99, Ala 396’, and Ala 
397’ [Figure 3-25]. The pantotheine group of the substrate could be stabilized by the 
residues Arg 100, Leu 101, and Ala 102. Thus, our structural data suggests that for the 
regions of the substrate described above, the acyl-CoA binding mode will be 
conserved.  
 
3.3.1.8 Substrate specificity 
To understand the molecular basis of substrate specificity, the active site of AccD6 
was compared with those of the propionyl-CoA carboxylase !-subunits M. 
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tuberculosis AccD5 and S. coelicolor PccB (Diacovich, et al., 2004). Most residues in 
the acyl-moiety binding region are conserved, except residue Ile 369 of AccD6 at the 
end of the substrate-binding pocket. For carboxyltransferases that have a preference 
for propionyl-CoA as the substrate, this position is occupied by small residues such as 
a Cys (in AccD5), Asp (in S. coelicolor PccB) or Val (in R. denitrificans PccB) 
[Figure 3-25]. The presence of an Ile, a larger and more hydrophobic residue, in 
AccD6 suggests that the property of the residue at this position may play a major role 
in defining the shape of the acyl-CoA binding pocket. Interestingly, the corresponding 
position in the AccD4 sequence is occupied by an Ala residue [Figure 3-25], which 
will presumably favour the binding of longer, hydrophobic acyl chains, in line with 
the observation that the homologs of AccD4 carboxylate acyl-chains at least as long 
as C16 (Portevin, et al., 2005). 
 
 
Figure 3-28. Site of substrate specificity determination. The putative determinant of 
AccD6 substrate specificity, Ile 369’, is located at the end of the substrate-binding pocket. 
Important residues of AccD6 at the acyl-moiety binding region are shown as ‘sticks’ with 
carbon, nitrogen, and oxygen atoms coloured green/cyan, blue, and red, respectively. 
Residues of the AccD5 and S. coelicolor PccB structures are represented with the carbon 
atoms coloured orange and grey, respectively. The position of propionyl-CoA (as in the S. 
coelicolor PccB structure) is indicated, with colouring scheme as in Figure 3-27. The green 
stars represent the location of the conserved oxyanion holes implicated to be essential for 
catalysis. 
 
The size, shape and chemical nature of the acyl-moiety-binding region of the putative 
substrate pocket are defined by a set of conserved residues (such as Leu 108 and Tyr 
368’) from both the monomers, further emphasizing the importance of the dimeric, di-
domain arrangement for substrate recognition, binding, and catalysis. However, a 
couple of non-canonical features were identified in the proximity of the AccD6 active 
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site: the otherwise fully conserved residues Ser 163 and Tyr 167 (AccD5 numbering) 
close to the active site have been replaced by the non-polar Ala 107 and the 
hydrophobic Val 111 respectively, in the AccD6 structure [Figures 3-25 and 3-28]. 
These residues are suitably positioned to dictate the chemical environment of the 
substrate acyl-moiety binding site and therefore, might play direct and important roles 
in the choice of substrate acyl-chain length.  
 
The entrance to the active site of the enzyme is marked by the presence of two 
thoroughly conserved oxyanion-stabilizing holes [Figures 3-25 and 3-28], generated 
by the backbone amide groups of two conserved pairs of residues (Gly 137 – Gly 138 
and Gly 366’ – Ala 367’). It has been proposed that these oxyanion holes help in the 
stabilization of the (1) carboxyl group released from the carboxybiotin (brought into 
the !-subunit active site by the BCCP arm of the "-subunit), (2) ureido enolate 
resulting from the loss of the carboxyl group from carboxybiotin, (3) the acyl enolate 
resulting from the deprotonation of the "-carbon of the substrate acyl-CoA 
(Diacovich, et al., 2004), and hence are absolutely essential for the 
carboxyltransferase activity. 
 
3.3.2 Discussion 
Given the indispensability of fatty acids and mycolic acids in the integrity of the 
mycobacterial cell wall, and hence in virulence and resistance to drugs and host 
immunity, enzymes that catalyse the biosynthesis of these cell wall components are of 
significant biological and therapeutic interest. M. tuberculosis acetyl-CoA 
carboxylase is among the most important of these enzymes as it executes the first 
committed, rate-limiting reaction in the biosynthetic pathways of cell wall lipids. 
Surprisingly, full understanding of the three-dimensional structure and of other 
biophysical properties of this key enzyme has been lacking. In this part of the study, a 
high-resolution crystal structure of AccD6 was determined and a comparative analysis 
with structural homologs was carried out. 
 
The crystal structure of AccD6 has shed light on the molecular basis of its unusual 
quaternary structure. Unlike other actinobacterial carboxyltransferases studied to date, 
AccD6 was found to exist as a homodimer, both in solution and in the crystal 
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structure. The oligomeric state of an YCC !-subunit may be related to its function and 
metabolic regulation (Dakshinamurti & Chauhan, 1988); it was therefore interesting 
to compare the quaternary structure of AccD6 with the hexameric structures of M. 
tuberculosis AccD5, S. coelicolor PccB (Diacovich, et al., 2004), and the 12S domain 
of P. shermanii transcarboxylase (Hall, et al., 2003), and the dimeric structures of 
yeast ACC !-subunit (Zhang, et al., 2003) and glutaconyl-CoA decarboxylase 
(Wendt, et al., 2003). AccD6 bears a higher degree of sequence and structural 
homology to the hexameric !-subunits than to the dimeric ones. Although the 
dimeric, di-domain arrangement is completely conserved in all of these 
carboxyltransferases, the yeast ACC !-subunit possesses unique structural features 
that are believed to prevent hexamer formation (Zhang, et al., 2003). These additional 
structural elements at the N- and C-terminal ends of the protein apparently render it 
unable to form higher oligomers. AccD6 does not contain any homology, sequence or 
structural, to these additional insertion elements of the yeast ACC !-subunit. 
Nevertheless, the protein does not hexamerize; the inability of AccD6 to form the 
canonical hexameric !-subunit ring structure can be attributed to the absence of 
certain secondary structural elements close to its N- and C-terminal ends, as 
confirmed by sequence and structural analyses. 
 
Besides reiterating the importance of the dimeric, di-domain interactions and 
arrangement for carboxyltransferase activity, the crystal structure of AccD6 has shed 
light on the molecular details of the putative cofactor-binding site and substrate-
binding pocket. The structure has also offered insights into the molecular 
determinants of substrate specificity, i.e., what causes the enzymes to differentiate 
acetyl-CoA from propionyl-CoA or long-chain acyl-CoA. AccD6 shares high levels 
of sequence identity with AccD5 and AccD4, but the subunits have differing affinities 
for different substrates. AccD5 acts on both acetyl-CoA and propionyl-CoA in vitro, 
but has a preference for propionyl-CoA that is many-fold higher than that for acetyl-
CoA (Gago, et al., 2006). Based on the genomic location and on genetic and 
biochemical studies in homologs, AccD4 is believed to be the carboxyltransferase 
acting on long-chain acyl-CoA substrates (Portevin, et al., 2005). AccD6 exerts 
comparable levels of activity on acetyl-CoA and propionyl-CoA in vitro (Daniel, et 
al., 2007), but its genomic location and data from knock out studies performed in M. 
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smegmatis have led to the belief that the physiological substrate of AccD6 is acetyl-
CoA (Kurth, et al., 2009). A comparative analysis of the AccD6 structure highlighted 
the potential importance of, among other non-canonical features, the residue Ile 369 
that likely discriminates acetyl-CoA from longer-chain acyl-CoA substrates. 
Sequence and structural alignments reveal that the propionyl-CoA carboxylases have 
less hydrophobic residues at this position, whereas AccD4 has an Ala residue, which 
accommodates longer, more hydrophobic molecules. Systematic mutational analyses 
of the S. coelicolor PccB have proved that alterations at this position result in changes 
in the size, shape, and electrostatic property of the acyl-CoA binding pocket 
(Arabolaza, et al., 2010). It has further been shown that alterations at this key position 
can cause long-range conformational changes that influence protein-CoA phosphate 
binding, a phenomenon critical for the activity of CoA-binding enzymes (Arabolaza, 
et al., 2010). It is hence justifiable to believe that Ile 369 is the major determinant of 
AccD6 substrate specificity. 
 
The fact that AccD6 is the only actinobacterial !-subunit, so far, to be characterised 
as a homodimer, might have implications for the possible molecular evolution of 
these enzymes. The active site architecture and probable mechanism of action are 
conserved in all carboxyltransferases, but the quaternary structures have been 
subjected to variation. Although there is a reasonable understanding of the 
carboxyltransferase mechanism of action, the possibility of enzyme cooperativity in 
the catalytic activity of carboxyltransferases has not been investigated so far; the 
molecular rationale behind assembly into a 400-kDa hexamer remains to be 
understood. It is indeed intriguing that certain members of an enzyme family 
assemble into a large oligomeric structure while another member inherently lacks the 
ability to form such oligomers and yet retains comparable levels of catalytic activity. 
It would be of biological and biochemical interest to further explore the molecular 
basis for these differences.  
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4 Conclusions and Future Perspectives 
The main objective of this study was to gain insights into the three-dimensional 
architecture of Mycobacterium tuberculosis acyl-CoA carboxylases, potential drug 
targets. The propionyl-CoA carboxylase AccA3-AccD5 of M. tuberculosis was 
reconstituted in vitro by expression in the near-native host M. smegmatis. However, 
the carboxyltransferase subunit AccD5 crystallised preferentially over AccA3-AccD5 
/ AccA3, indicating possible instability of the complex. To overcome the problem of 
biochemical heterogeneity arising from the interaction of M. tuberculosis YCC 
subunits with the highly homologous endogenous M. smegmatis counterparts, E. coli 
was resorted to as an expression host; various co-expression and co-purification 
strategies were attempted for the reconstitution of the YCC complexes AccA3-AccD5 
and AccA3-AccD4. Unfortunately, structural data on a holo-YCC complex could not 
be acquired during the study. AccE5, the purported modulator of PCC activity, was 
found to be an intrinsically disordered protein; its association with its binding partners 
AccA3 and AccD5 could not be probed into due to technical constraints. 
 
Another aim of the work was to understand the molecular basis of the differences in 
substrate specificity of the individual carboxyltransferase subunits of M. tuberculosis. 
Biophysical investigation of these proteins revealed unexpected diversity in 
carboxyltransferase subunit quaternary structure. AccD4, the !-subunit that is 
implicated in long-chain acyl-CoA carboxylation, was found to exist as a homotrimer; 
preliminary small angle scattering analysis suggested arrangement of AccD4 
protomers in a fashion different from those observed in the homohexameric !-
subunits characterised so far. Efforts to confirm and validate the SAXS-generated 
model are ongoing.  
 
The high-resolution crystal structure of AccD6, the carboxyltransferase of M. 
tuberculosis acetyl-CoA carboxylase, offered snapshots of the putative active site, 
cofactor-binding site, and substrate-binding pocket of the enzyme. The structural data 
helped elucidate the molecular basis of the unusual homodimeric arrangement of 
AccD6. Comparative analysis with structural homologs identified residues in the 
proximity of the active site that could be responsible for determining variations in 
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substrate preference. The crystal structure(s) of AccD6, in complex with analogs of 
substrate and/or cofactor, would be useful in further understanding the modes of 
binding and the mechanism of carboxyltransferase activity. High-resolution structural 
data on AccD4 would complement such an understanding, besides providing a 
molecular explanation as to how these closely related enzymes utilize their three-
dimensional structures to discriminate between substrates of different chemical 
natures.
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Appendix II: Microbial growth media and electrophoresis reagents 
 
7H9 complete medium 
4.7 g Middlebrook 7H9 medium powder was dissolved in 900 ml water and 
autoclaved (121 °C at 2 bar for 20 min). 100 ml ADS solution (13.9 mM NaCl, 0.5% 
(w/v) BSA, 0.2% (w/v) glucose), 4 ml of 50% (v/v) glycerol and 2.5 ml of 20% (v/v) 
Tween 80 were added. The complete medium was filter-sterilized and stored at 4°C. 
 
7H9 expression medium 
4.7 g Middlebrook 7H9 medium powder was dissolved in 1000 ml water and 
autoclaved. Just before use, 10 ml of 20% (w/v) glucose, 4 ml of 50% (v/v) glycerol 
and 2.5 ml of 20% (v/v) Tween 80 were added. 
 
7H10 agar 
19 g Middlebrook 7H10 agar was dissolved in 900 ml water and autoclaved and 
cooled. 100 ml ADS solution (13.9 mM NaCl, 0.5% (w/v) BSA, 0.2% (w/v) glucose), 
10 ml of 50% (v/v) glycerol, 2.5 ml of 20% (v/v) Tween 80 and 1 ml of hygromycin 
(50 mg/ml commercial available stock) were added just before pouring the medium 
into plastic Petri plates. 
 
Acetamide solution (220X) 
20 g acetamide was dissolved in 31 ml water, filter sterilized and stored at 4 °C. 
 
Agarose gel electrophoresis-running buffer (5X) 
Tris base   54 g 
Boric acid   27.5 g 
0.5 mM EDTA (pH 8.0) 20 ml 
ddH2O    to 1000 ml 
 
Antibiotics 
1000X Kanamycin  50 mg/ml in water 
1000X Chloramphenicol 34 mg/ml in ethanol 
The above stock solutions were filter-sterilized and stored in aliquots at -20 °C. 
    Appendix 
 117 
Coomassie blue safe stain 
To about 500 ml ddH2O, 0.8 g Brilliant Blau G-250 was added and dissolved by 
stirring overnight. 34 ml of 32% (v/v) HCl was added and the volume was made up to 
1000 ml with ddH2O. The staining solution was stored at room temperature, protected 
from light.  
 
DNA sample buffer (6X) 
0.5 M EDTA (pH 8.0) 5 ml 
Glycerol   15 ml 
Bromophenol blue  125 mg 
ddH2O    to 50 ml 
The buffer was filtered and frozen until use. 
 
Luria broth (LB) 
20 g LB granulated powder was dissolved in distilled water to a final volume of 1000 
ml and sterilized by autoclaving. 
 
Luria broth-agar (LB agar)  
37 g LB agar granulated powder was dissolved in distilled water to a final volume of 
1000 ml and sterilized by autoclaving. 
 
Super optimal broth (SOB) 
Tryptone   20 g 
Yeast extract   5 g 
NaCl    0.59 g 
KCl    0.19 g 
The above were dissolved in 980 ml ddH2O, autoclaved and added with 20 ml of 
sterile 1 M MgCl2 after cooling. 
 
Super optimal catabolite repression medium (SOC) 
Yeast extract   2.5 g 
Tryptone   10 g 
5 M NaCl   1 ml 
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3 M KCl   416 µl 
1 M MgCl2   5 ml 
1 M MgSO4   5 ml 
ddH2O    to 495 ml 
The above solution was autoclaved, cooled, added with 5 ml of filter-sterilized 1 M 
glucose and stored at 4°C. 
 
SDS-PAGE gel recipes (for Bio-Rad minigels) 
Resolving gels 
Component 7.5% 12% 15% 
1.5 M Tris-HCl (pH 8.8) 2.5 ml 2.5 ml 2.5 ml 
ddH2O  5.34 ml 4.14 ml 3.34 ml 
10% SDS 0.1 ml 0.1 ml 0.1 ml 
40% acrylamide 2 ml 3.2 ml 4 ml 
20% APS 0.05 ml 0.05 ml 0.05 ml 
TEMED 0.01 ml 0.01 ml 0.01 ml 
 
Stacking gels 
Component 4% 
0.5 M Tris-HCl (pH 6.8) 1.25 ml 
ddH2O  3.14 ml 
10% SDS 0.05 ml 
40% acrylamide 0.53 ml 
20% APS 0.025 ml 
TEMED 0.005 ml 
 
SDS-PAGE running buffer (10X) 
Tris base   151.4 g 
Glycine   720 g 
SDS    50 g 
ddH2O    to 5000 ml 
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SDS-PAGE sample buffer (4X) 
NuPAGE! LDS sample buffer (Invitrogen) supplemented with 10% (v/v) "-ME.  
 
Terrific broth (TB#) 
47.6 g TB granulated powder and 4 ml glycerol were dissolved in distilled water to a 
final volume of 1000 ml and sterilized by autoclaving. 
 
Transformation buffer (TB§) 
PIPES    0.34 g 
CaCl2.6H2O   0.33 g 
KCl.4H2O   1.83 g 
The above were dissolved in 85 ml ddH2O and pH was adjusted to 6.7 with KOH; the 
solution was added with 5.5 ml of 1 M MnCl2.4H2O and the volume was adjusted to 
100 ml with ddH2O; the buffer was filter-sterilized and cooled until use. 
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Appendix III: Buffers for protein purification 
 
All buffers were prepared using Milli-Q grade water deionized to a resistance of 18.2 
mW cm-1 by the Milli-Q system (Millipore). The pH of all buffers was checked using 
a S20-K SevenEasy™ pH meter (Mettler Toledo). Each SEC buffer was filtered 
through a 0.22 µm cellulose membrane filter and degassed before use.  
 
Stock solutions 
(i) Buffers and salts 
HEPES (1 M) 
238.30 g HEPES was dissolved and made up to a volume of 1000 ml in ddH2O, after 
adjustment to the required pH. 
 
Imidazole (2 M) 
136.15 g imidazole was dissolved in ddH2O to a final volume of 1000 ml. 
 
NaCl (3 M) 
175.32 g sodium chloride was dissolved in ddH2O to a final volume of 1000 ml. 
 
KCl (3 M) 
223.65 g potassium chloride was dissolved in ddH2O to a final volume of 1000 ml. 
 
Tris-HCl (1 M) 
121.13 g Tris base was dissolved and made up to a volume of 1000 ml in ddH2O, after 
adjustment to the required pH.  
 
(ii) Other additives 
Glycerol, 1-thioglycerol, NP-40 and "-ME were diluted as per requirement from 
commercially available stock concentrations (99% (v/v), 99% (v/v), 100% (v/v), 14.3 
M respectively). DTT and TCEP powders were added to buffers immediately prior to 
filtration and usage. 
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Appendix IV: Structural characterisation of a D-isomer specific 
2-hydroxyacid dehyrogenase from Lactobacillus delbrueckii ssp. 
bulgaricus 
 
Background 
Hydroxyacid dehydrogenases (HDHs) catalyse the stereospecific conversion of 2-keto 
acids to 2-hydroxyacids and are useful enzymes in the biotechnology industry 
(Hummel, 1999); chiral hydroxyacids are useful as synthons, as precursors for 
valuable chiral products and as flavour enhancing agents in dairy products. HDHs 
belong to either of two evolutionarily distinct subclasses: the D- and L-isomer 
specific HDHs, whose products possess similar biochemical properties but differ in 
chirality (Kochhar, et al., 1992). The genome of Lactobacillus delbrueckii ssp. 
bulgaricus, an economically important lactic acid producing bacterium, codes for 
several of these enzymes whose structural and functional characteristics remain 
poorly understood (van de Guchte, et al., 2006). Given their high economic potential, 
it is of significant scientific interest to gain in-depth knowledge of the substrate 
specificities, reaction kinetics and molecular mechanisms of action of D-isomer 
specific 2-HDHs. 
 
Author’s contribution 
Alongside work related to the main topic of the thesis, effort was invested in the 
structural characterisation of a D-isomer specific 2-HDH (encoded by Ldb1010) of L. 
bulgaricus, both in its apo form and in complex with the cofactor NAD+. Contribution 
made by the author of the thesis to this characterisation was in the form of literature 
review, crystallographic model refinement, structural analysis, and manuscript 
preparation. This work (reprint attached) is the first report of the three-dimensional 
structures of L. bulgaricus D2-HDH, in apo- and cofactor-bound forms. The 
asymmetric unit contained a dimer of dimers of D2-HDH, related by non-
crystallographic symmetry. The structures revealed the presence of conventional 
substrate- and cofactor-binding domains, conserved cofactor-binding sites and in 
addition, non-canonical features of the putative substrate-binding site that might 
dictate substrate-specificity. Results of the study add to existing knowledge in the 
largely unexplored structural proteome of L. bulgaricus. 
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a b s t r a c t
Hydroxyacid dehydrogenases, responsible for the stereospecific conversion of 2-keto acids to 2-hydroxy-
acids in lactic acid producing bacteria, have a range of biotechnology applications including antibiotic
synthesis, flavor development in dairy products and the production of valuable synthons. The genome
of Lactobacillus delbrueckii ssp. bulgaricus, a member of the heterogeneous group of lactic acid bacteria,
encodes multiple hydroxyacid dehydrogenases whose structural and functional properties remain poorly
characterized. Here, we report the apo and coenzyme NAD+ complexed crystal structures of the L. bulgar-
icus D-isomer specific 2-hydroxyacid dehydrogenase, D2-HDH. Comparison with closely related members
of the NAD-dependent dehydrogenase family reveals that whilst the D2-HDH core fold is structurally
conserved, the substrate-binding site has a number of non-canonical features that may influence sub-
strate selection and thus dictate the physiological function of the enzyme.
! 2012 Elsevier Inc. All rights reserved.
1. Introduction
NAD-dependent hydroxyacid dehydrogenases, key players in
carbohydrate metabolism, catalyse the reversible conversion of
keto acids into chiral hydroxy acids, concomitant with the oxida-
tion of NADH to NAD+ (Hummel, 1999). These enzymes belong to
either of two evolutionary distinct subfamilies: the D- and L-isomer
specific hydroxyacid dehydrogenases, whose products differ only
in their chirality (Kochhar et al., 1992b). The genome of Lactobacil-
lus delbrueckii ssp. bulgaricus (L. bulgaricus), a member of the heter-
ogeneous group of lactic-acid producing bacteria, harbors five
genes (Ldb0101, Ldb1010, Ldb0813, Ldb1147 and Ldb2021) that are
predicted to encode different D-isomer specific 2-hydroxyacid
dehydrogenases (van de Guchte et al., 2006). The protein
sequences share only low sequence identities (27–37%). An addi-
tional two genes encoding putative L-isomer specific 2-hydroxy-
acid dehydrogenases (Ldb0120, Ldb0094) have also been reported
(van de Guchte et al., 2006).
In this contribution we have characterized the L. bulgaricus
(strain ATCC 11842) Ldb1010 gene product. The resulting 333-
residue protein, D2-HDH, is annotated to encode a D-isomer
specific 2-hydroxyacid dehydrogenase (van de Guchte et al.,
2006). Although the D2-HDH protein has not directly been
characterized beyond this automatic functional annotation, a 99%
homologous enzyme has been sequenced, cloned and its substrate
specificity characterized (Bernard et al., 1994). The protein, 2-
hydroxyisocaproate dehydrogenase (HO-HxoDH), is virtually
identical to the D2-HDH, with only three amino-acid differences
between the two proteins, all at sites not known to be biologically
relevant (Suppl. Fig. 1). We therefore assume that functional and
structural conclusions are the same for both enzymes.
Given the potential use of chiral hydroxy acids as valuable
synthons and as precursors for useful chiral products in the
biotechnology industry (Hummel, 1999) it is of significant
biological interest to gain in-depth insights into the substrate spec-
ificities, biochemical kinetics and molecular mechanisms of action
of D-isomer specific 2-hydroxyacid dehydrogenase enzymes. As a
step towards this goal we report in this study the recombinant
expression, purification and subsequent three-dimensional
structural characterization of the L. bulgaricus (strain ATCC
11842) D-isomer specific 2-hydroxyacid dehydrogenase (D2-HDH,
encoded by Ldb1010), both in its apo form and in complex with
the cofactor NAD+. A comparison of the D2-HDH structural features
with those of related proteins is presented.
1047-8477/$ - see front matter ! 2012 Elsevier Inc. All rights reserved.
http://dx.doi.org/10.1016/j.jsb.2012.10.009
Abbreviations: D-HicDH, D-2-hydroxyisocaproate dehydrogenase from L. casei;
D2-HDH, D-isomer specific 2-hydroxyacid dehydrogenase; FDH, formate dehydro-
genase ; HGDH, (R)-2-hydroxyglutarate dehydrogenase from Acidaminococcus
fermentans; HO-HxoDH, 2-hydroxyisocaproate (i.e. 2-hydroxy-4-methyl-pentano-
ate) dehydrogenase from L. bulgaricus; IPTG, Isopropyl b-D-1-thiogalactopyranoside;
L. bulgaricus, Lactobacillus delbrueckii subsp. bulgaricus; LDH, lactate dehydrogenase;
NAD, nicotinamide adenine dinucleotide; PCR, Polymerase Chain Reaction; PGDH,
D-3-phosphoglycerate dehydrogenase from E. coli.
⇑ Corresponding author. Present Address: Bayer Pharmaceuticals, Structural
Biology/Lead Discovery, D-13342 Berlin, Germany. Fax: +49 30 468 993724.
E-mail address: sjholton@googlemail.com (S.J. Holton).
1 Present address: Helmholtz Zentrum Muenchen, Institute of Structural Biology,
Ingolstaedter Landstrasse 1, D-85764 Neuherberg, Germany.
Journal of Structural Biology 181 (2013) 179–184
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2. Purification and enzymatic activity of D2-HDH
The Ldb1010 gene coding the full-length D2-HDH (Gene ID:
4084222) was PCR-amplified from L. bulgaricus (strain ATCC
11842) chromosomal DNA and ligated into the pETM-13/LIC vec-
tor, which harbors a non-cleavable C-terminal His6-tag, via a li-
gase-independent cloning strategy. His-tagged D2-HDH was then
expressed heterologously in E. coli BL21 (DE3) pLysS cells cultured
at 37 "C in Terrific Broth (TB) medium supplemented with
30 lg ml!1 kanamycin and 10 lg ml!1 chloramphenicol. Expres-
sion of D2-HDH was induced at OD600nm of 0.9 by the addition of
a final concentration of 0.4 mM IPTG. The cells were incubated
for 16 h at 25 "C and then harvested by centrifugation, resus-
pended in lysis buffer (40 mM HEPES pH 7.4, 300 mM NaCl,
20 mM imidazole, 0.02% (v/v) monothioglycerol (MTG)) supple-
mented with protease inhibitors and stored at !80 "C. Cells were
lysed by freeze–thawing, DNaseI treatment and pulse sonication.
Cell debris was removed by centrifugation and the soluble cellular
fraction was loaded onto Ni–NTA resin pre-equilibrated with lysis
buffer. After extensive washing of the resin with lysis buffer the
protein was eluted using elution buffer (40 mM HEPES pH 7.4,
300 mM NaCl, 300 mM imidazole, 0.02% (v/v) MTG). The eluate
was concentrated using a Vivaspin 20 (10 kDa cutoff, GE Health-
care) and loaded onto a Superdex200 HiLoad (26/60) column
(Pharmacia) pre-equilibrated with gel filtration buffer (40 mM
HEPES pH 7.4, 300 mM NaCl, 0.02% (v/v) MTG). The recombinantly
prepared D2-HDH protein, which includes a non-native C-terminal
hexahistidine tag and a 4-residue linker (Thr Ala Ser Gly linker), is
enzymatically active (Suppl. Fig. 2).
The 2-hydroxyacid dehydrogenase activity of D2-HDH on the
substrate phenylpyruvate follows Michaelis–Menten kinetics, with
a Km of 59.1 ± 14.4 lM and a kcat of 8.48 ± 0.81 s!1. These results
are in the same order of magnitude as those published for HO-
HxoDH (Bernard et al., 1994) supporting our expectation that the
high sequence identity shared between the two proteins translates
to similar biochemical properties. Interestingly, the activity of D2-
HDH also seemed to be inhibited by high concentrations of the
substrate (Suppl. Fig. 2) with a dissociation constant Ki of
1.21 ± 0.26 mM. Substrate inhibition has also been reported for
HO-HxoDH (Bernard et al., 1994).
3. Crystallization, data collection and structure determination
of apo-D2-HDH and D2-HDH-NAD+ complex
Diffraction-quality crystals of apo-D2-HDHwere obtained using
the hanging-drop vapor-diffusion method by mixing equal vol-
umes (400 nl) of protein (10 mg/ml) and reservoir solution (25%
PEG 3350, 200 mM MgCl2, 100 mM HEPES pH7.5), equilibrated
against 100 ll reservoir solution at 19 "C. D2-HDH-NAD+ crystals
were generated by soaking apo crystals overnight with mother li-
quor supplemented with 10 mM NAD+ (Li-salt). Crystals were
briefly transferred to a cryo-protectant solution (mother liquor
supplemented with 30% ethylene glycol) before being flash-frozen
at 100 K. The apo-D2-HDH and NAD+-D2-HDH complex diffraction
datasets were collected at the European Synchrotron Radiation
Facility beamline ID23-1 at 100 K. The data were integrated, scaled
and merged using the programs MOSFLM and SCALA (CCP4, 1994).
Data collection statistics are shown in Table 1.
The structure of D2-HDH was solved by molecular replacement
using the program Phaser (McCoy, 2007). The monomer structure
of D-2-hydroxyisocaproate dehydrogenase (D-HicDH) from Lacto-
bacillus casei (PDB ID: 1DXY (Dengler et al., 1997)) was used as
the search model. Unbiased electron density features indicated a
correct molecular replacement solution. An initial model was built
using the automated model rebuilding protocols in the program
Phenix (Adams et al., 2010). Thereafter, alternative rounds of man-
ual rebuilding using COOT (Emsley et al., 2010) and maximum-like-
lihood refinement (REFMAC5 (Murshudov et al., 1997)) were
implemented. Non-crystallographic symmetry (NCS) restraints
were applied during restrained refinement and, in the later stages,
TLS parameters were also used. Crystallographic refinement and
characteristics of the final models are summarized in Table 1.
The electron density for residues 92 and 93 in protomer A, 91–93
in protomer B, 91–93, 325 and 326 in protomer D was weak and
so these residues were not modeled. The refined apo-D2-HDH
and NAD+-complexed D2-HDH structures have been deposited in
the Protein Data Bank with the accession codes 2yq4 and 2yq5,
respectively.
4. Overall structure of apo-D2-HDH
The overall monomeric structure of the L. bulgaricus D2-HDH
can be described in terms of two compact domains separated by
a deep cleft (Fig. 1). This separation of the substrate binding and
the co-factor binding domains is conserved in other D2-hydroxy-
carboxylate dehydrogenases (Razeto et al., 2002). The asymmetric
unit contains two homo D2-HDH dimers and is consistent with our
observation that the protein can form a dimeric species in solution
(Suppl. Fig. 3). The two protomers adopt an elongated structure
with dimensions of 109 Å " 56 Å " 48 Å. The 2740 Å2 interface be-
tween the two protomers is formed from residues that mainly orig-
inate from the co-factor domain and comprises of predominantly
hydrophobic interactions with an additional number of hydro-
gen-bonding interactions. Solution studies also identified a tetra-
meric D2-HDH solution species that may correspond to a dimer
of dimers (Suppl. Fig. 3).
The co-factor binding domain, formed from residues 109–303,
has a central b-sheet containing six parallel strands that are
flanked on both sides by a-helices. This topology is a variant of
the conventional dinucleotide-binding Rossmann fold (bab) that
is widely conserved among various members of the NAD-
dependent dehydrogenase family (Rao and Rossmann, 1973). The
smaller substrate-binding domain (residues 1–108 and 304–331)
Table 1
Crystallographic statistics.
Native Ligand-bound
Data collection
Space group P212121 P212121
Cell dimensions (Å) 92.21, 108.37, 147.18 92.72, 110.01, 147.74
Wavelength (Å) 0.9334 0.8726
Overall resolution range (Å) 46.72–3.45 49.24–2.75
Highest resolution range (Å) 3.64–3.45 2.90–2.75
Number of unique reflections 19722 (2872)d 39722 (5742)d
Multiplicity 3.1 (3.2) 4.7 (4.8)
Mean I/r(I) 8.0 (2.2) 12.7 (2.6)
Completeness (%) 98.9 (99.7) 99.5 (99.9)
Rsyma 0.167 (0.537) 0.105 (0.556)
Mosaicity (") 0.84 0.51
Refinement
Protein atoms 10154 10162
Other atoms 34 207
Rconvb/Rfreec 0.1828/0.2496 0.1952/0.2634
Rms deviations
Bond lengths (Å) 0.020 0.015
Bond angles (") 1.836 1.626
a Rsym ¼
P
h
P
j jIh;j ! hIhij=
P
h
P
j Ih;jwhere Ih,j is the intensity of the jth observation
of unique reflection h.
b Rconv ¼
P
hjjFohj! jFchjj=
P
hjFohj where Foh and Fch are the observed and cal-
culated structure factor amplitudes for reflection h.
c Rfree is equivalent to Rconv, but is calculated using a 5% disjoint set of reflections
excluded from the maximum likelihood refinement stages.
d Values in parentheses correspond to the highest resolution shell.
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is also characterized by a modified Rossmann fold topology com-
posed of a five-stranded parallel b-sheet flanked by five helices.
The substrate-binding domain has higher average temperature fac-
tors than those from the cofactor-binding domain indicating a
greater inherent flexibility of this domain (Suppl. Fig. 4). A similar
observation in D-LDHb is attributed to a role in domain closure
during catalysis, proposed as an essential feature of the sub-
strate-binding domain (Razeto et al., 2002).
Tertiary structure similarity searches of the PDB database using
PDBeFold (Krissinel and Henrick, 2007) revealed the closest struc-
tural homolog of D2-HDH to be the D-2-hydroxyisocaproate dehy-
drogenase (D-HicDH) from Lactobacillus casei (Dengler et al., 1997)
(Suppl. Table S1). The two structures share an r.m.s.d. of 1.4 Å2 over
309 equivalent Ca atoms and share 34% sequence identity. Both
the core fold and the dimeric assembly are structurally conserved
(Fig. 2). Structurally the largest differences between the two
Fig.1. X-ray crystal structure of D2-HDH. Combined cartoon/surface representation of the D2-HDH dimer. One protomer is colored according to secondary structure content
(helices, sheets and loops are colored green, blue and cream respectively) and the second protomer is colored red with its molecular surface rendered in gray. The NAD+
cofactor that binds in a deep cleft at the base of the interdomain region, is shown in stick representation with C, N, O and P atoms colored cyan, blue, red and orange
respectively. Residues that differ between the L. bulgaricus D2-HDH (strain ATCC 11842) and HO-HxoDH (strain NCIB1178) are highlighted in magenta. The figure was
generated using PyMOL (http://www.pymol.org). (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)
Fig.2. Structural comparison between D2-HDH and D2-hydroxyisocaproate dehydrogenase from Lactobacillus casei. (A) Structural superposition of the D2-HDH protein (blue)
and D2-hydroxy-isocaproate dehydrogenase (D-HicDH) from Lactobacillus casei (green). The surface of the bound NAD+ cofactor is shown in red. The two regions that display
the most significant structural divergence are highlighted; ⁄residues H272-T276 and ⁄ residues H133-F135. In the right hand panel, the molecular interactions with the
dimeric protomer at the ⁄ site are shown in detail. D2-HDH residues are shown in ball and stick representation with carbon, nitrogen and oxygen atoms colored light blue,
royal blue and red, respectively. Hydrogen bonds to the symmetry copy (residues labeled as X’) are shown as red dotted lines. Superimposed in green is the L. casei structure.
Due to the internal symmetry of the D2-HDH dimer the interactions at the ⁄ site are identical. (B) Dimeric complex formation of D2-HDH (blue) and D-HicDH (green). In each
case the dimeric partner protein secondary structure and surface are shown in gray. The complexes are viewed from identical orientations. The location of the ⁄ site, described
in (A), is also shown. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)
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proteins are found at residues 267–280 and 132–138 (Fig. 2A). The
respective sequences are poorly conserved in both of these regions
(Suppl. Fig. 1). As a result of the 2-fold internal symmetry within
the D2-HDH homodimer, each of these two regions in fact interacts
with the other region from the dimeric partner via a series of
hydrogen-bonds (Fig. 2A). Although both of the regions are located
at the dimeric interface, the dimeric assembly in both D2-HDH and
D-HicDH remains otherwise conserved (Fig. 2B). The close struc-
tural homology shared between D2-HDH and D-HicDH also reveals
that the D2-HDH substrate-binding domain is in the ‘‘open’’ con-
formation (Razeto et al., 2002). This conformation is catalytically
inactive and consistent with the fact that no substrate is bound
at the active site (Razeto et al., 2002). Sequence conservation be-
tween D2-HDH and D-HicDH is particularly high for the remainder
of the dimer interface (Suppl. Fig. 5). Many residues located at the
core of the protein fold are also highly conserved. The potential
role of specific active site residue differences between the two pro-
teins is discussed later.
5. Binding of the NAD+ cofactor to D2-HDH
We have also determined the X-ray structure of D2-HDH in
complex with the cofactor NAD+ (Fig. 3). Cofactor binding does
not trigger any major conformational changes to the structure of
the enzyme; the apo-structure protomers share r.m.s.d’s with
those of the NAD+-bound structural equivalents in the range
0.2 Å–0.3 Å. The NAD+ molecule binds in an extended conforma-
tion where the equiplanar adenine ribose and nicotinamide rings
are approximately perpendicular to the adenine ring. The NAD+
conformation is stabilized along its entire length via an extensive
network of hydrogen-bonding, hydrophobic and hydrophilic inter-
actions with the co-factor binding domain. The NAD+ adenine
group binds in a predominantly hydrophobic pocket that is lined
by the side chains of residues Leu206, Thr208, Phe211, Met217,
Val179, Ile154, Tyr177, Pro209 and Leu240. The NAD+ adenine ring
additionally forms a polar interaction with the Thr214 side-chain.
The ribose ring (adjacent to the adenine) forms two hydrogen
bonds with the carboxylate side chain of Asp178, a residue that
is highly conserved between different dehydrogenases. In addition
to directly binding and stabilizing NAD+, it is important in the dis-
crimination between NAD+ and the bulkier NADP+ (Bernard et al.,
1995). The NAD+ pyrophosphate atoms form hydrogen bonds with
the main-chain nitrogen atom from Ile159 as well as with the
main-chain nitrogen and side-chain imidazole ring of His158. Col-
lectively residues in this region of the active site are part of the
NAD+-binding fingerprint motif GxGxxGx(17)D, which extends be-
tween Gly155 and Asp178 in D2-HDH (Wierenga et al., 1986). The
nicotinamide ribose ring does not form any interactions with the
protein. The NAD+ dihydronicotinamide group is flanked by a clus-
ter of hydrophobic residues (Ile107, Ile159, Ala236 and Ala300).
The ability of NAD-dependent dehydrogenases to bind NADH more
tightly than NAD+ has been attributed to such hydrophobic clusters
(Razeto et al., 2002). Lastly, the carboxamide oxygen is held in the
cis-orientation with respect to the C4 N of NAD+ through hydro-
gen-bonding interactions with Asp261 OD2, Cys235 O and
Phe301 N atoms. The combination of hydrophobic and polar inter-
actions with the nicotinamide group ensures the activation of C4 N
atom for the hydride transfer required for the dehydrogenase reac-
tion (Li and Goldstein, 1992). D2-HDH residues involved in the
binding of NAD+ are either absolutely, or conservatively conserved
in related proteins (Suppl. Fig. 1) and is in keeping with the general
observation that NAD+ binding sites are highly conserved between
different HDH proteins (Lesk, 1995).
6. The D2-HDH active site: conserved and non-conserved
features
Our attempts to obtain D2-HDH crystals in complex with both
co-factor and a substrate were unsuccessful. To identify the fea-
tures that regulate D2-HDH substrate specificity and to gain an in-
sight into potential substrate preferences we therefore compared
the D2-HDH structure with related proteins for which both struc-
Fig.3. Binding mode of the cofactor NAD+ to D2-HDH. Interactions formed between the NAD+ cofactor and D2-HDH. D2-HDH residues that interact with the cofactor are
shown in stick representation. Protein carbon atoms are colored according to the region of the cofactor with which they interact (white – adenine, yellow – adenine-ribose,
cyan – pyrophosphate, orange – nicotinamide or magenta – carboxamide). The NAD+ carbon atoms are colored cyan whilst N, O and P atoms are colored blue, red and orange,
respectively. Hydrogen-bonding interactions are depicted in red. The transparent surface of the D2-HDH protein is also shown. (For interpretation of the references to color in
this figure legend, the reader is referred to the web version of this article.)
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tural and biochemical data are available. This analysis confirmed
that the signature triad of active site residues, His298, Glu266
and Arg237, is conserved within the D2-HDH active site (Fig. 4)
and is consistent with our observation that D2-HDH is enzymati-
cally active (Suppl. Fig. 2). By analogy to other members of the
D2-hydroxyacid dehydrogenase family, His298 is expected to func-
tion as the internal acid–base catalyst in the execution of the dehy-
drogenase mechanism, Glu266 to stabilize the protonated form of
the catalytic His298 and lastly Arg237 to stabilize the bound sub-
strate (Dengler et al., 1997; Kochhar et al., 1992a; Razeto et al.,
2002; Taguchi and Ohta, 1993, 1994).
Residues lining the D2-HDH substrate-binding site differ from
related proteins at several key positions that are known to influ-
ence substrate specificity (Suppl. Fig. 1). Two of these residues,
Lys52 and Phe301 in D2-HDH, are located on opposing sides of
the pocket and together dictate both the size and the electrostatic
character of the substrate-binding site (Figs. 3 and 4). Considering
D2-HDH Lys52, a tyrosine and a leucine are found in the equivalent
positions of the L. delbruekii D-lactate dehydrogenase (D-LDHb) and
L. casei D-HicDH proteins, respectively (Suppl. Fig. 1). The size of
the residue at this position plays a steric role in substrate selectiv-
ity: the relatively large size of D-LDHb tyrosine prevents substrates
larger than the native pyruvate from binding whilst the relatively
small leucine contributes towards the broad substrate specificity
of D-HicDH (Dengler et al., 1997; Razeto et al., 2002). Furthermore,
in PGDH, an arginine at this position stabilizes the negative charge
from the phosphoglycerate substrate (Dey et al., 2007). Despite its
larger size, D2-HDH-Lys52 is not appropriately positioned within
the pocket to act as a size filter analogous to the role of Tyr52 in
D-LDHb.
The second site of sequence divergence, Phe301 in D2-HDH, is
highly isosteric with the tyrosine found at the same position in
D-HicDH, and is therefore expected to impose similar constraints
on the substrate specificity, i.e. a preference for aliphatic sub-
strates. In contrast, polar residues at this position are found in en-
zymes with more hydrophilic substrates, for example PGDH and
HGDH (Dey et al., 2007; Martins et al., 2005). Additionally, residues
located at the same position as Trp137’ (originating from the di-
meric protein partner) have also been observed to influence en-
zyme specificity. A smaller alanine residue at this position in D-
HicDH correlates with broad substrate specificity, whilst in PGDH
(substrate: phosphoglycerate) a positively charged lysine is found
at this position. In LDH, substrate-induced domain closure allows
the equivalent tryptophan to shield the substrate from the solvent
(Razeto et al., 2002). This alternative conformation is stabilized by
a hydrogen bond with Pro295 (Pro297 in D2-HDH).
7. Conclusion
In summary, this study is the first to describe the crystal struc-
tures of L. bulgaricus D-2-hydroxyacid dehydrogenase in both its
apo and coenzyme NAD+ complexed form. D2-HDH has a con-
served NAD+ binding site into which the cofactor binds. In contrast
the substrate-binding site contains structural features that may
influence the physiological function and substrate specificity of
D2-HDH. Results of the study add to existing knowledge in the lar-
gely unexplored structural proteome of the economically impor-
tant bacterium L. bulgaricus.
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Abstract
Background: The non-pathogenic bacterium Mycobacterium smegmatis is widely used as a near-native expression
host for the purification of Mycobacterium tuberculosis proteins. Unfortunately, the Hsp60 chaperone GroEL1, which
is relatively highly expressed, is often co-purified with polyhistidine-tagged recombinant proteins as a major
contaminant when using this expression system. This is likely due to a histidine-rich C-terminus in GroEL1.
Results: In order to improve purification efficiency and yield of polyhistidine-tagged mycobacterial target proteins,
we created a mutant version of GroEL1 by removing the coding sequence for the histidine-rich C-terminus, termed
GroEL1∆C. GroEL1∆C, which is a functional protein, is no longer able to bind nickel affinity beads. Using a selection
of challenging test proteins, we show that GroEL1∆C is no longer present in protein samples purified from the
groEL1∆C expression strain and demonstrate the feasibility and advantages of purifying and characterising proteins
produced using this strain.
Conclusions: This novel Mycobacterium smegmatis expression strain allows efficient expression and purification of
mycobacterial proteins while concomitantly removing the troublesome contaminant GroEL1 and consequently
increasing the speed and efficiency of protein purification.
Background
Heterologous expression of recombinant proteins in
Escherichia coli can result in the production of insoluble
inclusion bodies. Recent statistics show that less than
half of the M. tuberculosis (Mtb) proteins expressed in
E. coli are soluble [1]. Therefore, the non-pathogenic
bacterium Mycobacterium smegmatis is often used as an
alternative, more closely related host for the expression
of mycobacterial proteins. Furthermore, M. smegmatis
may also provide mycobacterium-specific chaperones,
which can help correct folding of Mtb proteins [1].
During nickel affinity purification, it has been
observed that a protein of 56 kDa is co-purified with
polyhistidine-tagged recombinant proteins while using
M. smegmatis as an expression system. This contami-
nant was previously identified as the Hsp60 chaperone
GroEL1 of M. smegmatis [1-3]. The protein sequence of
GroEL1 shows a histidine-rich C-terminus (7 out of 11
amino acids are histidines), which is likely to be the rea-
son for the observed nickel sepharose binding [1,2].
Unlike most other bacteria, mycobacteria possess two
Hsp60 chaperone groEL genes, one of which is arranged
in the bicistronic groESL operon [4]. M. smegmatis also
encodes a third Hsp60 protein (Msmeg1978), which is
more distantly related to GroEL1 (Msmeg1583) and
GroEL2 (Msmeg0880) [3]. Although groEL1 of M. smeg-
matis can be found in the same operon as groES, an
arrangement indispensable for the chaperone function
in bacteria, its histidine-rich tail is distinct from the
more typical glycine-methionine-rich C-terminal region
found in GroEL2 [3]. Furthermore, groEL2 is an essen-
tial gene and exists in all actinobacteria, in contrast to
groEL1 [3,5]. Recently, it has been shown that groEL2
and groES are expressed more strongly than groEL1,
which might have arisen from a difference in stability of
the predicted post-transcriptionally cleaved mRNAs for
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groES and groEL1 [5]. Consistent with the current cha-
perone model in mycobacteria, one chaperone, here
GroEL2, would act as the main house keeping chaper-
one in M. smegmatis, with the other chaperones
(GroEL1 and Msmeg1978) adopting more specialised
functions. Indeed, GroEL1 of M. tuberculosis was
recently identified as being associated with nucleotides,
suggesting a role as a DNA chaperone, while GroEL1 of
M. smegmatis was found to have a role in mycolic acid
biosynthesis during biofilm formation [5,6,3].
The co-purification of GroEL1 with histidine-tagged
recombinant proteins can be particularly problematic
since native GroEL1 is expressed at relatively high levels,
meaning that in the case of a low yield of recombinant
protein, GroEL1 may well compete with the protein of
interest for binding sites on nickel affinity beads. Mini-
mal sample manipulation is recommended during pro-
tein purification to improve efficiency. Therefore,
additional steps required to remove GroEL1 can result
in a significant loss of the protein of interest.
In this article, we describe an M. smegmatis expres-
sion strain containing a mutant version of GroEL1,
termed GroEL1∆C, which consists of a groEL1 gene
without a coding sequence for the histidine-rich C-terminal
tail. We show that GroEL1∆C is a functional protein,
which no longer co-purifies when using nickel affinity puri-
fication and we provide evidence that proteins purified
from this strain are correctly folded, active and that they
behave identically to those purified from the original
expression strain. Taken together, our data demonstrate
that M. smegmatis groEL1∆C is a competent protein
expression strain, which allows the efficient removal of the
troublesome contaminant GroEL1 without the require-
ment of additional purification steps.
Methods
Bacterial strains and media
The E. coli strains DH5a (Invitrogen) and HB101 (Pro-
mega) were used for cloning of expression constructs
and the target substrate to generate the mutant version
of groEL1 using standard procedures [7]. Transformants
were selected in Luria Broth containing the appropriate
antibiotics.
M. smegmatis mc2155 was used as the parent (wild
type) strain for the groEL1∆C strain. Both M. smegmatis
strains were maintained in Middlebrook 7H9 or 7H10
medium supplemented with 0.2% (v/v) glycerol, 10%
ADC, 0.05% (v/v) tween-80 and the appropriate
antibiotics.
For biofilm formation, 10 ml of biofilm media was
inoculated with 10 μl of saturated culture and incubated
at 30°C without disturbance [3,8].
For the expression of the recombination proteins in
M. smegmatis in order to create the mutant form of
groEL1, 0.2% succinate (w/v) was added as a carbon
source to 7H9 medium supplemented with 0.2% (v/v)
glycerol, 0.05% (v/v) tween and the appropriate antibio-
tics. Expression of his-tagged recombinant proteins in
M. smegmatis was performed in 7H9 medium supple-
mented with 0.2% (w/v) glucose as carbon source. Acet-
amide was added to a final concentration of 0.2% (w/v)
at 0.5 OD600 and at 2.5 OD600 for the expression of the
recombination proteins and his-tagged recombinant pro-
teins, respectively.
Plasmids, constructs and oligonucleotides
All plasmids and constructs are summarised in Table 1
and oligonucleotides are listed in Table 2. pJV53 was
used to express the recombination proteins [9].
pYUB854 was used for the preparation of the target
substrate to create the groEL1∆C strain [10]. pGH542,
harbouring a δg resolvase, was used to generate an
unmarked deletion [11]. Using the primer pairs
Msmeg1583-F1.2 & Msmeg1583-R1 and Msmeg1583-F2
& Msmeg1583-R2.1, two 500 bp fragments, homologous
to the fragments +1067/+1587 and +1621/+2176 relative
to the translational start of Msmeg1583, were amplified
Table 1 Plasmids and constructs used in this study
Plasmid/
construct
Description Reference
pJV53 Che9c recombination proteins under
control of the acetamidase promoter in
pLAM12
[9]
pYUB854 HygR cassette flanked by gδ-res sites
and 2 MCSs
[10]
pGH542 Expressing an gδ resolvase and
tetracycline resistant
[11]
pEN15 pYUB854 with a 520 bp fragment
harbouring groEL1 (+1067/+1587,
relative to groEL1) inserted upstream of
the HygR cassette and a 555 bp
fragment downstream of groEL1
including the STOP codon of groEL1,
inserted downstream of the HygR
cassette
This paper
pMyNT Mycobacterial overexpression vector Geerlof et al.,
unpublished
data
pMyNT/
PrcA-B
Rv2109-2110 in pMYNT, Rv2110 is N-
terminally his-tagged
[12]
pMyNT/
AccD5E5
Rv3280-3281 in pMYNT. Only his-
tagged Rv3280 seems to express using
this construct.
This paper
pMyNT/
AccA3
Rv3285 in pMyNT This paper
pMyNT/
CFP10-
ESAT6
Rv3874-3875 in pMYNT, Rv3874 is N-
terminally his-tagged
[12]
pMyNT/
ACPS
Rv2523 in pMYNT This paper
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and subsequently ligated AflII-XbaI (F1.2-R1) and Hin-
dIII-SpeI (F2-R2.1) into pYUB854, creating pEN15.
For the expression of M. tuberculosis proteins in
M. smegmatis, the pMyNT expression vector was used
[Geerlof et al., unpublished data]. pMyNT/ACPS,
pMyNT/AccA3 and pMyNT/AccD5 were made as fol-
lows: PCR was performed with primer pair Rv2523-F &
Rv2523-R for ACPS, accA3-F & accA3-R for AccA3 and
accD5E5-F & accD5E5-R for AccD5 and the resulting
fragments were digested with NcoI-HindIII and inserted
into NcoI-HindIII digested pMyNT.
Creation of the groEL1∆C mutant
The groEL1∆C mutant was created using the mycobac-
terial recombineering method [9]. pEN15 was digested
with AflII and SpeI to create the linear target substrate,
which was introduced into mc2155 electrocompetent
cells, expressing the recombinase genes on pJV53 and in
this way creating hygromycin-resistant transformants.
The hygromycin-resistance cassette was removed using
δg resolvase, expressed on pGH542, generating an
unmarked deletion [11].
Southern blot analysis
Genomic DNA (5ug) was isolated as described [9],
digested with the appropriate enzymes, separated on a
0.9% agarose gel and transferred to a positively charged
nylon membrane (Roche). For DNA probe labelling,
hybridisation and detection, the DIG high prime DNA
labelling and detection starter kit 1 (Roche) was used.
Growth curves
Bacterial growth was followed by measuring the optical
densities at a wavelength of 600 nm as a function of
time. Cultures were prepared with 7H9 expression med-
ium (0.2% (w/v) glucose as carbon source) in identical
triplicates for each strain. Duplicate samples were taken
every 4 hours for 40 hours. When the optical density at
600 nm exceeded 1.5, samples were diluted in order to
remain within the linear range of the detector.
Protein expression and purification
All methods related to protein expression in M. smegmatis
were carried out as described [12,13]. Protein-protein
complexes from operon-encoded proteins were expressed
using the native operon structure [9]. In brief, pellets
from 500 ml cultures were dissolved in 30 ml lysis buffer
containing 50 mM Tris-HCl pH 8.0, 300 mM NaCl,
0.5 M urea with protease inhibitor cocktail (Sigma) and
1 mg/ml DNase I (Serva). Resuspended cells were
sonicated four times, each for 5 min (with a 0.3 s
pulse and 0.7 s rest) at 5 min intervals to prevent
overheating, using a Bandelin VW3200 probe at 45%
amplitude. The supernatant was collected after centri-
fugation (30,000 × g) for 1 h at 4°C, filtered through a
0.44 μm filter and loaded onto a nickel affinity sephar-
ose (NiAC) column. After washing with 10 column
volumes of 50 mM Tris-HCl pH 8.0, 300 mM NaCl and
20 mM imidazole, proteins were eluted in 50 mM Tris-
HCl, 100-150 mM NaCl and 250-500 mM imidazole
and subjected to size exclusion chromatography using
either a Superdex 75 (16/60) column (GE Healthcare)
or, for large protein complexes, a Superose 6 (10/300)
(GE Healthcare) with 25 mM Tris-HCl pH 8.0, 150 mM
NaCl and 1 mM DTT as buffer. The collected protein
samples were analysed by SDS-PAGE and concentrated
accordingly.
Circular Dichroism (CD) spectrum analysis
CD measurements were performed on a Jasco J-810
spectropolarimeter. Prior to measurement, samples were
dialysed into 10 mM potassium phosphate, 150 mM
NaCl, pH 7.4. Spectra were recorded between 182 and
260 nm in a 2 mm cuvette with machine settings as
Table 2 Primers used in this study
Primer Sequence (5’-3’) Location 5’ Relative to
Msmeg1583-F1.2 GCGCCTTAAGCGACTGGGATCGCGAGAAGCTGC +1067 Msmeg1583
Msmeg1583-R1 GCGCTCTAGACTCGTCCTCGTCGGCCGGCTTG +1587 Msmeg1583
Msmeg1583-F2 GCGCAAGCTTGATCCATTTCACGCGACACCCCC +1620 Msmeg1583
Msmeg1583-R2.1 GCGCACTAGTGGTGTTCGATCGTCTGGCCGATG +2176 Msmeg1583
accD5E5-F GATCTCATGAGTATGACAAGCGTTACC G +1 Rv3280
accD5E5-R GTCAAAGCTTTTATCGGCGCATGTGCG +2161 Rv3280
accA3-F GATCCCATGGGTATGGCTAGTCACGCC +2 Rv3285
accA3-R GTCAAAGCTTTTACTTGATCTCGGCGAGC +1803 Rv3285
Rv2523-F CATGCCATGGGCATCGTCGGTGTGGGG +1 Rv2523
Rv2523-R CCCAAGCTTACGGGGCCTCCAGGATGGC +391 Rv2523
Restriction sites are presented in bold face. CTTAAG = EcoRI, TCTAGA = XbaI, CCATGG = NcoI, TCATGA = BspHI.
AAGCTT = HindIII, ACTAGT = SpeI.
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follows: 1 nm bandwidth, 1 sec response, 1 nm data
pitch, 100 nm/min scan speed, cell length of 0.1 cm.
Each curve presented is the average of three separate
measurements.
Coupled enzyme assay
Enzymatic activity of the AccD5-AccA3 complex was
estimated by a coupled enzyme assay that follows the
rate of ATP hydrolysis spectrophotometrically [14]. The
production of ADP during the reaction was coupled to
pyruvate kinase and lactate dehydrogenase, and the oxi-
dation of NADH was probed at 340 nm. The assay mix-
ture contained 7 units of pyruvate kinase, 10 units of
lactate dehydrogenase, 50 mM NaHCO3, 3 mM ATP,
0.5 mM phosphoenol pyruvate, 0.2 mM NADH, 0.3 mg/
ml BSA, 100 mM K2HPO4 pH 7.6 and 5 mM MgCl2
and varying concentrations of propionyl-coenzyme A.
Reactions were initiated by the addition of enzyme to
the assay mixture and were maintained at 30°C. Data
were acquired using a Tecan infinite M1000 microplate
reader. The kinetic parameters Km and Vmax were deter-
mined by fitting the mean velocities versus the substrate
concentration to the Michaelis-Menten equation of
enzyme kinetics using nonlinear regression analysis, exe-
cuted by the program Prism 5 (GraphPad Software™).
Results and Discussion
Creation of the groEL1∆C strain
Currently, the role of GroEL1 in protein folding is
uncertain. A closer look at the structure of E. coli
GroEL [15] indicates that, although the C-terminal
region of the protein is not easily accessible, pointing
towards the central cavity of the wheel-like structure
adopted by oligomeric GroEL, the extreme C-terminal
20 amino acids are absent from the model. Similarly,
the GroEL structure of Paracoccus denitrificans also
lacks these residues [16]. These observations suggest
that the C-terminal region of GroEL is highly flexible
and could reach out of the central cavity, allowing in
this way M. smegmatis GroEL1 to bind nickel affinity
beads. Additionally, as native GroEL1 from M. tuberculosis
is oligomeric [17], nickel binding would require only one
accessible histidine-rich region. Therefore, we decided to
change only the last eleven amino acids of the protein,
rather than to make a full knock out strain, in order to
minimise changes to the expression strain. A precise
chromosomal deletion of fragment 1588-1620, relative to
the translational start of groEL1 (Msmeg1583), was cre-
ated using the mycobacterial recombineering technique
[9] (Figure 1A). Southern hybridisation (Figure 1B) was
used to verify that correct homologous recombination
had taken place in the hygromycin-resistant and the
unmarked deletion strain (Figure 1B). The latter strain, in
which the hygromycin resistance cassette has been
removed, has the C-terminal eleven residues of GroEL1,
containing seven histidines, replaced by six non-histidine
residues, which are part of the “scar” sequence left behind
after removal of the resistance cassette (Figure 1A). The
stop codon of this recombinant version of GroEL1 is
TAA, which although rare, is recognised in high G+C
mycobacteria [18]. This unmarked deletion strain,
referred to as M. smegmatis groEL1∆C, is used in all
further experiments.
Ojha et al. reported that the last 18 amino acids of
GroEL1 are essential for the formation of mature bio-
films [3]. Therefore, to test the functionality of the
GroEL1∆C protein, we compared biofilm formation in
both the wild type and groEL1∆C strains. Both strains
were able to form mature biofilms after an incubation
time of 7 days at 30°C, indicating that GroEL1∆C is
indeed fully functional (Figure 2A). Taking into account
the data from Ojha et al., our results could suggest that
either the amino acids important for biofilm formation
are upstream of those removed in the GroEL1∆C pro-
tein, or that removal of the last 18 residues may affect
the folding of at least a part of GroEL1. Additionally, as
this newly created strain was constructed for the overex-
pression of mycobacterial proteins, its growth in 7H9
expression medium was compared to the original
expression strain M. smegmatis mc2155 (Figure 2B). We
observed no significant differences in growth between
the two strains, with both reaching an OD600 of between
2.5-3.0 after approximately 18 hours, at which time
expression is usually induced.
GroEL1∆C is absent during nickel affinity purification of
proteins expressed in M. smegmatis groEL1∆C
To demonstrate the absence of GroEL1∆C as a con-
taminant when using the M. smegmatis groEL1∆C
expression strain, we determined the expression and
purification efficiency of our strain in comparison to the
wild type strain using five different constructs, repre-
senting a variety of different protein molecules, includ-
ing the mycobacterial proteasome, the CFP10-ESAT6
complex, the AccD5-AccA3 dodecameric acyl-CoA car-
boxylase complex and the holo-acyl-carrier protein
synthase (for details, see Table 3). Additionally, we also
used the empty pMyNT vector, to check for GroEL1
binding in the absence of a his-tagged protein. All con-
structs were transformed into both M. smegmatis
mc2155 and groEL1∆C and the resulting transformants
were cultured in 7H9 expression medium and induced
by the addition of acetamide to a final concentration of
35 mM. Eighteen hours after induction, the cells were
collected by centrifugation, lysed and the soluble protein
fraction was passed over a nickel affinity column, with
the elution fraction being analysed by SDS-PAGE
(Figure 3). While GroEL1 was visible in samples purified
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from M. smegmatis mc2155 (Figure 3, lanes a), the protein
was noticeably absent in five out of six protein samples
isolated from the groEL1∆C strain (Figure 3, lanes b). Due
to the fact that AccD5 has a similar size to GroEL1,
we were unable to determine its presence or absence
in samples of the purified acyl-CoA carboxylase com-
plex by SDS-PAGE. Therefore, samples isolated from
gel (Figure 3) were analyzed by mass spectrometry
(Additional file 1). While numerous peptides from
both GroEL1 and AccD5 could be identified from gel
slices deriving from the mc2155 strain, only AccD5
peptides could be detected in the sample obtained
from the groEL1∆C strain (Additional file 1). Likewise,
MALDI-TOF mass spectrometry was performed on the
other protein samples, verifying the absence of GroEL1
peptides in the protein samples derived from M. smeg-
matis groEL1∆C (data not shown).
Proteins purified from M. smegmatis groEL1∆C behave
identically to those purified from the wild type strain
M. smegmatis encodes three forms of the Hsp60 chaper-
one GroEL: Msmeg1583 (GroEL1), Msmeg0880
(GroEL2) and Msmeg1978. However, the precise mole-
cular function of each protein remains unclear.
Figure 1 Construction of the groEL1∆C strain. (A) A schematic representation of the genomic organisation of groEL1 (Msmeg1583) in
M. smegmatis mc2155 (1), the hygromycin-resistant groEL1∆C mutant (2) and the unmarked groEL1∆C deletion strain (3). Msmeg1582 is groES and
Msmeg1581, 1584, 1585 and 1586 encode for proteins of unknown function. Zoom sequence of the C-terminal 40 amino acids of the groEL1
gene product, showing the histidine-rich C-terminal region. In the groEL1∆C strain, the eleven C-terminal amino acids (white) were replaced by
six different residues. HygR = hygromycin-resistance cassette. (B) Southern blot analysis performed with genomic DNA of M. smegmatis mc2155
(1), mc2155 carrying pJV53 (2), two correct hygromycin-resistant groEL1∆C mutants (3-4) and two correct unmarked groEL1∆C deletions (5-6). The
genomic DNA was digested with EcoRI or SacI. The positions of the restriction sites EcoRI and SacI, relative to the start of groEL1, are presented
as a full and dotted vertical line in A, respectively. The PCR product of primer pair Msmeg1583-F1.2 & Msmeg1583-R1 was used as a probe,
shown as a dashed line under the genes in A1. (M) DNA marker VII, DIG labelled (Roche).
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Changing the last 18 amino acids of GroEL1 does not
alter growth but does result in a strong defect in biofilm
formation [3]. To confirm that the newly created recom-
binant version of GroEL1 has no effect on the correct
folding and, ultimately, the function of the proteins
expressed in M. smegmatis groEL1∆C, a number of dif-
ferent proteins and protein complexes have been
expressed and analysed.
In the previous section, we have shown that it is
possible to express and purify potentially challenging
protein complexes, such as the proteasome complex
PrcA-B and the CFP10-ESAT6 complex, from the
recombinant groEL1∆C strain. These data imply that the
proteins isolated from the groEL1∆C strain are correctly
folded, since we were able to observe all components
after purification. In both examples, complex formation
Figure 2 Biofilm formation and growth rates of M. smegmatis mc2 155 and M. smegmatis groEL1∆C are comparable. (A) Both M.
smegmatis mc2 155 (WT) and M. smegmatis groEL1∆C strains are able to form biofilms after an incubation time of 7 days at 30°C. (B) Growth
curve of M. smegmatis mc2155 (WT = black) and M. smegmatis groEL1∆C strains (grey) in 7H9 expression medium. The arrow represents the
typical time of induction in M. smegmatis.
Table 3 List of test proteins used to validate the groEL1∆C expression strain
ORF Annotation Description Expressed ... Mol.
Mass
(kDa)
Rv2109c
Rv2110c
PrcA
PrcB
a- and b-subunit of the mycobacterial proteasome
(a7b7b7a7 subunit organisation)
Using native operon content, producing a 730
kDa multimeric complex
26.8
30.3
Rv3285
Rv3280
AccA3
AccD5
a- and b-subunit from acyl-CoA carboxylase AccD5-
AccA3 complex (a3b3b3a3 subunit organisation)
As monomeric proteins, mixed to form a acyl-
CoA carboxylase complex of 740 kDa
63.8
59.4
Rv3874
Rv3875
CFP10
ESAT6
Potential virulence factor CFP10-ESAT6 complex Using native operon content, producing a
heterodimeric (1:1) complex
10.8
9.9
Rv2523c ACPS Holo-acyl-carrier protein synthase As monomeric protein 14
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requires direct protein-protein interactions between sub-
units of the complex as only one subunit is his-tagged.
Taking our analysis one step further, we directly tested
the structural and functional properties of proteins iso-
lated from the groEL1∆C strain. We used the five
expression constructs described above and transformed
them into both M. smegmatis mc2155 and groEL1∆C.
Proteins were expressed and purified using a nickel affi-
nity column as described above. AccD5 and AccA3 pro-
tein samples were mixed in a 1:1 stoichiometry to form
the high-molecular-weight AccD5-AccA3 complex. Size
exclusion chromatography was performed on all samples
as a final purification step.
Circular dichroism (CD) spectroscopy is a powerful
tool used to visualise the secondary structure properties
of protein samples. We observed that the four protein
samples isolated from groEL1∆C gave virtually identical
CD spectra to those purified from the wild type strain
(Figure 4), implying that they are correctly folded.
Furthermore, the CD spectra of the CFP10-ESAT6 com-
plexes, showing a protein with high helical content, are
comparable to those collected previously [12] and are in
line with the X-ray structure, which consists of a four-
helical bundle complex (PDB ID: 3FAV) [12].
Additionally, we have demonstrated carboxylase activ-
ity of the acyl-CoA carboxylase AccD5-AccA3 complex,
isolated from groEL1∆C, using an enzyme-coupled reac-
tion (Figure 5). Using propionyl-CoA as a substrate,
AccD5-AccA3 showed carboxylase activity with a Km =
0.1301 ± 0.0198 mM and a Vmax = 1.333 ± 0.049 mM
min-1 mg-1, data which are similar to the parameters
determined using the AccD5-AccA3 complex isolated
from E. coli [19], indicating that the AccD5-AccA3 com-
plex isolated from groEL1∆C is a functional carboxylase.
Carboxylase activity requires the a-subunit of the car-
boxylase to be post-translationally biotinylated [19],
implying that the subunits of this large megasynthase
are folded correctly and, in the case of the a-subunit,
correctly post-translationally modified, when isolated
from groEL1∆C.
Conclusions
We have developed an M. smegmatis expression strain
that allows efficient expression and purification of
mycobacterial proteins, multi-subunit protein complexes
and post-translationally modified proteins while conco-
mitantly removing the troublesome contaminant
GroEL1 and consequently increasing the speed and effi-
ciency of protein purification. The M. smegmatis
groEL1∆C strain is particularly suitable for laboratories
performing in vitro activity assays and structural studies
on mycobacterial proteins and protein complexes.
Figure 3 GroEL1∆C is absent from protein samples purified from M. smegmatis groEL1∆C. SDS-PAGE analysis of protein samples isolated
from cells expressing either CFP10-ESAT6 heterodimer (1), a holo-acyl-carrier protein synthase (ACPS) (2), the b- and a-subunit D5 (3) and A3
(4) of the acyl-CoA carboxylase AccD5-AccA3 complex, the PrcA-B complex (5) or the empty expression vector (empty pMyNT) (6). a, proteins
expressed in M. smegmatis mc2155; b, proteins expressed in M. smegmatis groEL1∆C. Purified proteins of interest are labelled with #. Visible
presence of GroEL1 is depicted with *. Squares identify the bands excised for peptide mass fingerprinting. GroEL1 = 56 kDa.
Noens et al. BMC Biotechnology 2011, 11:27
http://www.biomedcentral.com/1472-6750/11/27
Page 7 of 9
Additional material
Additional file 1: GroEL1 is absent from an AccD5 protein sample
derived from M. smegmatis groEL1∆C. Results of peptide mass
fingerprinting analysis of samples excised from SDS-PAGE gel (Figure 3,
boxes). Shown in red are the peptides that could be identified. (a)
Sample derived from M. smegmatis mc2155. (b) Sample derived from M.
smegmatis groEL1∆C.
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gel electroporesis; MALDI-TOF: matrix-assisted laser desorption/ioization
reflection time-of-flight.
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